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ABSTRACT 
Studies of the effect of stress on the immune system provide a way to evaluate the 
coordination of the immune system with other systems in the maintenance of homeostasis. 
The objectives of the present study were to characterize the immunomodulatory effect of 2-
DG, a metabolic stressor, on both primary and secondary immune organs and to examine the 
possible neuroendocrine mechanism(s) mediating 2-DG-induced immunomodulation using 
male, Lewis rats. 
The first study demonstrated that acute and chronic 2-DG administration induced a 
decrease total leukocyte counts, organ weight, IFN-y production, and mitogen response of 
lymphocytes in both spleen and whole blood. The ratio of CD4'^/CD8'^ in the spleen was 
decreased due to a significant increase in CDS'*" T-cell subpopulation. In contrast, there was a 
significant increase in nitrite production in cultures of spleen and blood leukocytes from 2-
DG-injected rats compared with saline-injected controls. Production of DL-l and IL-2 by 
cells from these tissue was significantly reduced in the blood, but not in the spleen. 
Moreover, the kinetics of 2-DG-induced immunomodulatory effects in the spleen and blood 
were different. Hence, acute and repeated 2-DG exposure induced alteration of immune 
function in both spleen and blood. 
The objectives of the second and third projects were to examine the role of peripheral 
catecholamines and adrenal hormones in 2-DG-induced immune alteration. Results indicated 
that the p-adrenergic receptor antagonist nadolol, attenuated 2-DG-induced suppression in the 
spleen, but not in the blood. Adrenalectomy attenuated 2-DG-induced alteration of immune 
parameters in the blood, but did not attenuate altered immune function in the spleen. These 
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data suggest that the sympathetic release of catecholamines is responsible for splenic inmiune 
alterations, whereas adrenal hormones are responsible for immune alterations observed in 
blood leukocytes. Results from the second and third projects also indicate that common 
neuroendocrine pathways exist for several types of stressors which induce 
immunomodulation. 
The characterization of 2-DG modulation of thymic parameters was established in the 
fourth study. Repeated 2-DG administration induced a significant reduction of thymus 
weight, total thymocytes, mitogen responsiveness of T-lymphocytes, and nitric oxide 
production by thymic stromal cells. Additionally, the numbers of 004"*" and CD4*CD8* 
double positive T-cells decreased in the thymus of rats which received multiple 2-DG 
injections, but the numbers of CD8"^ T-cells increased. Moreover, 2-DG-induced an elevation 
of adrenal hormones which initiates a long lasting process of increased apoptosis in the 
thymus. Thus, 2-DG-induced immunomodulation of the thymus may result in the changes of 
immune function in the spleen and blood. 
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CHAPTER 1. GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation begins with an abstract and is followed by a general introduction, 
four papers, and a general conclusion. The abstract provides a summary of the general 
objectives and conclusions. The general introduction includes the dissertation organization, 
an introduction, and a review of the literature. The literature review includes sections 
covering the historical discovery of the effectds of stress on health, the definition of stress, 
the stress-induced physiological response, the evidence of stress effects on immune function. 
2-DG and metabolic stress, effect of 2-DG on the immune system, the mechanism of stress 
effect on the immune system, organization of the immune system, and apoptosis. 
The four papers are written in journal article form for publication. The first paper 
entitled "Characterization of the effect of 2-deoxy-D-glucose (2-DG) on the immune system'' 
has been accepted for publication in Brain, Behavior, and Immunity. The second paper 
entitled "Evidence for the involvement of catecholamines in the 2-DG-induced 
immunomodulatory effect in the spleen" has been submitted for publication in Brain, 
Behavior, and Immunity. The third paper entitled "Adrenal hormones are responsible for 2-
DG-induced immunomodulatory effects in the blood" and the fourth paper entitled " 
Alteration of thymic T cell subset profiles and apoptosis by a metabolic stress" will be 
submitted for publication. 
The last chapter of the dissertation is a general discussion summarizing the results 
presented in the four papers and discussing conclusions drawn from them. A list of 
references cited is included at the end of each chapter. 
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Introduction 
The term "stress" can be defined as a perturbation of the normal homeostasis of the 
body (Kort and Weijma, 1991). Stress can be caused by psychological processes (e.g. 
conditioned fear) or physical means (e.g. electrical shock and drug injection). Emerging 
evidence demonstrates that different forms of stress have modulatory effects on 
immunological function (for review see Hillhouse et al., 1991). For example, stressful events 
such as bereavement (Irwin et al., 1987), academic stress (Kiecolt-Glaser et al., 1986; 
Bonneau et al., 1990), electric shock (Cunnick et al., 1990; Sonnenfeld et al., 1992), restraint 
(Berry et al., 1991; Zwilling et al., 1993), trauma (Wood et al., 1984), and surgery 
(Weissman, 1990) can alter parameters of immune cell fiinction in animals and humans. 
In addition, studies indicate that stress alters the function of immune cells as 
evidenced by decreased concentrations of circulating antibodies (Solomon, 1969), 
suppression of the reactivity of lymphocytes to mitogen (Keller et al., 1981), antigenic 
stimulation (Jasod and McKenzie, 1976), and also decreased natural killer cell (NK) activity 
and increased susceptibility to tumor challenge (Shavit et al., 1984). Hence, the 
consequences of stress-induced alteration of immune cell function may increase an animals 
susceptibility to microbial and neoplastic diseases. There also exists evidence that stress can 
alter health outcomes in humans (Kiecolt-Glaser, 1984; Shoenfeld and Isenberg, 1989; Cohen 
and Williamson, 1991). Stress is correlated with the onset or exacerbation of a variety of 
human diseases involving the immune system such as rheumatoid arthritis, diabetes, cancer, 
and repeated viral infections (Fitzpatrick et al., 1988; Eaton et al., 1979; Jemmott et al., 1984; 
Baker et al., 1981). Therefore, investigating the significance of stress-induced changes of 
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immunity in various psychologic or physiologic diseases should be considered to be of 
particular importance in current biomedical research. 
When the effects of stress on the capacity of the immune system are examined, the 
mechanisms by which stress modulates immune function must be defined. It is not clear by 
which mechanisms the immune system responds to stress exposure. However, it is generally 
accepted that during exposure to stressful events, the neurological and endocrine systems play 
a fundamental role in mediating the changes in immunological function resulting from 
exposure to the stressor (Ader et al., 1991). Communication between the neuroendocrine and 
immune systems has been suggested to occur through neuroendocrine peptides, hormones 
and cytokines (Blalock, 1994; Savino and Dardenne, 1995). Specifically, research by Keller 
and colleagues (1988) using shock as a stressor has identified a role for the hypothalamic-
pituitary-adrenal (HPA) axis in suppression of mitogen-stimulated lymphocyte proliferation 
in the peripheral blood. Additionally, Cunnick (1990) and Irwin (1991) have reported that 
the peripheral release of catecholamines is responsible for suppression of spleen mitogenic 
responses due to shock or central administration of corticortropic releasing hormone (CRH). 
Hence, two possible pathways of immune regulation can be via the sympathetic nervous 
system pathway or via the hypothalamic-pituitary-adrenal axis. However, there have been 
few in vivo studies of the mechanisms responsible for the stress-induced changes of immune 
response. 
In addressing these issues, appropriate animal models can be of substantial benefit. In 
certain experimental models of stress, such as those which entail restraining rodents in a 
suspension harness, the animals lost a significant amount of body weight (Miller et al., 1994), 
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and use of mild electric shock in animals increases locomotor activity and escape behavior. 
Hence, it becomes difficult to separate the effects on the inunune system induced by factors 
such as nutrient deprivation or increased locomotor activity from the immunomodulatory 
effects induced directly by the stress response. Since many illnesses are exacerbated by 
improper dietary intake, drugs of abuse, or disorders of metabolic function, there has been an 
increased interest in the influence of metabolic disorders on immune function such as protein 
calorie malnutrition (Chandra, 1983) or heavy alcohol use (Watson et al., 1984). 
One model system for studying metabolic stress uses 2-deoxy-D-glucose (2-DG). 2-
DG is a glucose analogue, which prevents cellular uptake and utilization of glucose (Brown, 
1962). 2-DG produces metabolic changes which include acute intracellular glucoprivation 
and extracellular hyperglycemia (Smythe et al., 1989). The 2-DG-induced metabolic stress 
invokes changes in the immune, nervous, and endocrine system (Smith and Root, 1969; 
Ritter and Neville, 1976; Pascoe et al., 1989; Cato et al., 1990). These responses are similar 
to those that occur in humans following exposure to a number of physical stressors. 
Moreover, the neural and endocrine response to 2-DG are similar to electric shock, but 
induce behaviors that are distinct from the physical stress of shock. Animals which receive 
2-DG has less motor activity than animals that experience shock (Smith and Epstein, 1969). 
In addition, 2-DG administration does not produce a significant nutrient deprivation (Miller 
et al., 1994). Therefore, the rodent model of 2-DG-induced metabolic stress which is 
examined here may provide a useful model for studying the influences of stress on immune 
cell function. In addition, it has been shown that 2-DG-induced metabolic stress has the 
capacity to modulate the function of lymphocytes (Lysle et al., 1988; Miller et al., 1994). 
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Nevertheless, the characterization of effects of metabolic stress on immune function 
are not well documented, and the possible mechanism(s) underlying 2-DG-induced immune 
modulation is not defined. Therefore, the purpose of this research was to more fully 
characterize the alterations of immune function on a primary immune organ (thymus) and 
secondary immune organs (spleen and blood) due to the metabolic stress of 2-DG 
administration using rats. Moreover, two of the in vivo studies were designed to evaluate the 
mechanisms underlying the capacity of 2-DG-induced metabolic stress to influence immune 
function. 
The concentrations of plasma corticosterone and endogenous glucose were measured 
as indicators of a stress response. To evaluate the cellular immune function, this dissertation 
included a measure of the proliferative response of lymphocytes to various T and B cell 
mitogens, the T-cell subset distribution, nitric oxide production from mitogen stimulated cell 
cultures, and production of the cytokines interleukin-1, interleukin-2, interferon-y, and tumor 
necrosis factor in the spleen and peripheral blood. In addition to the spleen and blood, 
immune parameters of the thymus such as T-cell subset distribution, lymphocyte 
proliferation, and apoptosis were also examined. The results from this study indicated that 
the metabolic stressor, 2-DG, significantly alters cellular immune function and can influence 
the immune system via neuroendocrine pathways common to physical and psychological 
stressors. 
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Literature Review 
Historical discovery of stress effects on health 
The postulated relationships between stress exposure and disease states have had a 
long and colorful history. The historical basis for studying the influence of stress on the 
immune response was derived from clinical observations regarding individuals who became 
sick following stressful situations. The pioneer of investigations on the relation between 
emotion and disease was Ishigami (1919) who studied opsonization of Tubercle bacilli 
among chronic tuberculous patients during active and inactive phases of the disease. He 
found that phagocytic activity decreased during episodes of emotional distress and proposed 
that a stressful life led to immune depression and consequently increases in susceptibility to 
tuberculosis. Later, the work of Cannon and Selye greatly advanced comprehension of the 
role of stress in homeostasis and adaptation. Cannon (1914) provided his theory which is 
called "emergency theory of emotion", and coined the term "fight-or-flight" response in 
which the autonomic nervous system regulates the body for defense against stress. His 
observations provided evidence on the body's physiologic responses to external stimuli but 
this theory did not explain the consequence of stress exposure and body response. Later, the 
coordinated roles of the autonomic nervous system, endocrine system, and immune system in 
the response to stress were greatly clarified by the work of Selye (1936, 1956). His work has 
been reviewed by Munck et al., (1984), who proposed that the most important physiologic 
effect of glucocorticoid secretion is to suppress immunity, thereby interrupting the immune 
response. 
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After the work of Ishigami, Cannon, and Selye, the scientific understanding of stress 
and immunity has progressed slowly over several decades. In that time, much of the 
knowledge on stress was developed from animal studies by Rasmussen (1969) and Solomon 
(1969), which produced evidence for the relationship between stress and decreased 
immunocompetence. These findings led others to investigate the role of stress-induced 
depression of immunity in various psychologic or physiologic diseases. The work of 
Rasmussen and Solomon led current scientists to recognize the importance of stress-related 
immune suppression. Also, there was evidence that such a relationship was possible in man. 
Later, a monumental work that investigated the relation between behavior and immune 
suppression was reported by Ader and Cohen (1975). This work brought about the birth of 
the field of Psychoneuroimmunology (PNI). 
A review examining the effects of stress exposure on medical illnesses was reported 
by Rahe and Arthur (1978). The review demonstrated that significant stress exposure 
precedes the onset or exacerbation of a variety of medical conditions, including allergic, 
autoimmune, neoplastic, and infectious processes. Hence, the scientific interest in the 
influence of stress on immune function has recently resulted in a rapid accumulation of 
information concerning behavioral immunology, immunophysiology, and neuroendocrine-
immunology. However, the methodology on the quantitation of stress and the association of 
stress with the onset of illness has been challenged. Despite methodological difficulties 
which slowed down the progress of investigations of the association of stress with disease, 
the impact of stress on susceptibility to several illnesses is widely accepted. 
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The definition of stress 
Stress, like the air, is a pervasive factor of life, that affects the pathophysiology of 
nearly all psychiatric illnesses and a range of medical illnesses. The term "stress" is defined 
as "the reactions of the body to forces of a deleterious nature, infections, and various 
abnormal states that tend to disturb its normal physiological equilibrium (homeostasis)" 
(Burgess, 1987; Sklar and Anisman, 1981; Stott, 1981; Riley, 1981; Kort and Weijma, 1991). 
In addition, the stimulus that causes such a disruption is called "a stressor." 
Stress has been divided into a number of categories according to the nature and the 
severity of the stress. As such, exteroceptive and interoceptive stress, acute and chronic 
stress have been distinguished. In addition, these categories have been further divided into 
numbers of subcategory, e.g., unavoidable vs. avoidable, severe vs. mild, and physical vs. 
psychological. Furthermore, it is logical that many types of physical stress will have direct 
metabolic consequences (e.g., cold exposure), which implies that stress is very specific in the 
nature of its effect on the individual's physiology (Kort and Weijma, 1991). Thus, it appears 
difficult to compare one stressor with any other type of stressor. 
Generally, we can divide stress into psychological stress and physiological stress 
(physical stress) (Hillhouse et al., 1991). Psychological stress can be differentiated from 
physical stress in that it is subject to cognitive appraisal (Paterson and Neufeld, 1989). 
Psychological stressors have been conceptualized as interactions among external threats, 
internal evaluations of threats, personal resources available to deal with the threat, and 
potential physical and psychological outcomes (Lazarus and Folkman, 1984). These 
interactions are thought to result in emotional responses such as anxiety, fear, anger. 
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excitement, or depression. Physiological stress can generally be categorized under the rubric 
of arousal. Arousal would include such physical alterations as elevated heart rate, blood 
pressure, and respiration, as well as the endocrine changes associated with stress. 
Physiological stress is typically interrelated with emotional presentation, therefore, it is 
difficult to evaluate the outcomes which arise directly from the physiological stress or from 
emotional responses which are induced by physiological arousal. 
In addition, the same "stressful" event affects individuals differently and their stress 
responses can range from extreme to mild to absent. For example, giving a seminar is 
dreaded by some people, but enjoyed by others. Stress is often considered bad and has been 
linked to a variety of stress-related diseases. However, stress is not necessarily bad all the 
time. News of passing Ph.D. defense can markedly affect our homeostasis which modulates 
by elevation of epinephrine concentration, but the stress response is experienced as joy. 
Stress can also be helpful; the stress of winning an event at the Olympic Games helps an 
Olympic runner to practice hard and win future campaigns. Conversely, lack of stress can be 
bad: no competition or punishment causes school failure and crime rate elevation. Stress is 
usually bad for the organism if the experience is unpleasant or intense or chronic; in these 
cases, illness is likely to follow. However, disease only develops in some, not all subjects; 
some species are susceptible to an infectious agent while others are resistant to the 
pathological effects of stress. Such health consequences can include hypertension, cardiac 
arrhythmia, headaches, ulcers, depression, alcoholism, or other stress-related diseases (Vogel 
and Bower, 1991). 
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In conclusion, the influences of stress are complicated and diverse. The consequences 
of stress on the individuals are based on specific genetic vulnerabilities, individual 
experiences, and environmental circumstances (Vogel and Bower, 1991). However, stress 
fluctuates and changes as the person interacts with and responds to the stressor. It is this type 
of change and flux that should be kept in mind when attempting to understand or describe the 
endocrine and immune consequences of stress. 
The stress-induced physiological response 
Common indicators of stress include changes in 1) biochemical parameters such as 
serum norepinephrine, epinephrine, and adrenal steroids, 2) physiological parameters such as 
heart rate and blood pressure, and 3) behavioral effects such as anxiety, fear, and tension 
(Vogel and Bower, 1991). The endocrine reaction to stress is very complex and only partially 
understood. Studies have shown that the final common pathways of neuroendocrine response 
to stress are stimulation of adrenocortical secretion, with consequent increases in serum 
glucocorticoids and activation of the sympathetic nervous system, followed by a release of 
catecholamines. The HPA axis appears to play a central role in coordinating the endocrine, 
autonomic, and behavioral responses to stress. Exposure to stress leads to increased activity 
of the HPA axis on the immune system through the effects of the adrenal hormones such as 
glucocorticoids (Axelrod and Reisine, 1984). An elevated concentration of glucocorticoid in 
plasma is an indicator of stress. The release of catecholamines (norepinephrine and 
epinephrine) constitutes an initial response to stressors, and is controlled via regional 
activation of sympathetic neurons as well as a discharge from the adrenal medulla (Kopin et 
al., 1988). 
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Other hormone systems are also affected by stress. Stress induces secretion of a wide 
variety of hormones such as adrenocorticotropin (ACTH), corticotrophin-releasing factor 
(CRF), vasopressin, ^-endorphin, and oxytocin (Hillhouse et al., 1991). In addition, growth 
hormone and prolactin secretion is increased by physical or psychological stress (Rivier and 
Vale, 1985; Munck et al., 1987). Release of the endogenous opiates has also been shown to 
be elevated during stress conditions. Finally, Wartofsky and Burman (1982) have reported 
thyroid dysfunction during chronic stress exposure. The regulation of the endocrine response 
to stress involves numerous feedback loops. This complicated regulation interactswith the 
immune system to maintain homeostasis in the body. 
Since stress responses induce changes of hormone concentrations in the body, stress 
can be measured by determining adrenal hormone and catecholamine concentrations in 
central and peripheral circulation. Stress and increased corticosteroid levels are very closely 
related, and events are sometimes not classified as stressful until an increase in corticosterone 
is detected. Other parameters that are direcdy or indirectly associated with adrenal activity 
and are directly related to the category of stress can also be used as indicators of a stress 
response. For example, body weight and blood glucose values should be determined. 
The evidence of stress effects on immune function 
Emerging evidence on the immunomodulating properties associated with stress 
exposure suggests that the cellular arm of the immune system is principally affected by the 
experience of stress. Thus, the degree of stress may influence susceptibility to illness and 
prognosis for diseases. For example, the onset and exacerbation of several autoimmune 
diseases has been associated with major life stressors of marriage, divorce, business loss, or 
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death of a family member. Correlational studies of patients with rheumatoid arthritis and 
their female siblings found that the patient was more tense, worried, and moody than the 
healthy sibling (Fitzpatrick et al., 1988). In the last thirty years, a large number of studies 
that examined the relation of stress and immunity were completed in humans and animals. It 
is well recognized that stress can produce alterations in the responsiveness of the immune 
system. The evidence that various stressors can alter immune function in humans and 
animals is briefly summarized below. 
Human studies 
In humans several emotional stressors have been shown to affect various aspects of 
immune function. For example, smdies of bereavement resulting from the death of a spouse 
have been shown to decrease mitogen responses in the peripheral blood (Bartrop et al., 1977; 
Schleifer et al., 1983) and women who are separated or divorced have higher levels of 
antibodies to Epstein-Barr virus than married individuals, an indication of lowered T-cell 
function (Kiecolt-Glaser et al., 1987). In addition, the chronic stress of caring for patients 
with Alzheimer's disease shows a decreased percentage of total T-lymphocytes, T-helper 
lymphocytes, T-cytotoxic lymphocytes, and a reduction in the T-helper : T-cytotoxic cell 
ratio (Kiecolt-Glaser et al., 1987). In addition, the academic stress of examinations in 
medical students is correlated with a decrease in mitogen responsiveness, interleuldn-2 (IL-2) 
production, natural killer cell (NK) function, mRNA content of c-myc and c-myb, the 
glucocorticoid receptor and interferon-y in peripheral blood lymphocytes (PEL) (Kiecolt-
Glaser etal., 1984; Glaser et al., 1993). 
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In addition, a number of studies have examined the relationship between depression 
and immune function. For example, Schleifer and colleagues (1984) reported that depressed 
subjects had lower total T- and B- lymphocyte numbers, as well as lower mitogen-induced 
lymphocyte stimulation. However, these results were not replicated in a follow-up study 
(Schleifer et al., 1985). 
The results of human studies demonstrated a large amount of variability in 
immunological outcomes. The variability seen in human studies may be due to several 
external factors that also affect immune function, such as stress induced changes in sleeping, 
eating, exercising, and other health related habits. Because of the various confounding 
variables in human studies, it has become important to examine the effects of stress using 
well controlled animal models. 
Animal studies 
Murine and rat models have been used extensively to study the stress-immune 
function relationship. Psychoneuroimmunologic studies of stress in rats and mice have 
focused on alterations of lymphocytes in the spleen and blood. Those studies have used 
various physical and psychological stressors, such as surgery (Pollock et al., 1987), electric 
shock (Keller et al., 1981; Laudenslager et al., 1983), rotation (Esterling and Rabin, 1987), 
noise (Monjan and Collector, 1977), conditioned fear (Lysle et al., 1988a), and 2-DG (Lysle 
et al., 1988b). Results of these sttidies provide evidence to support the concept that stress 
affects immune parameters and subsequently influences the outcomes of health. For 
example, presentations of electric shock to rats decreased the responsiveness of lymphocytes 
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to stimulation by mitogens (Lysle, et al., 1987), decreased natural killer cell activity (Shavit 
et al, 1984), and increased susceptibility to mmor challenge (Lewis et al., 1984). 
In addition, other physical stressors such as surgery and restraint have induced a 
reduction in NK cell function, depressed delayed type hypersensitivity, and reduced 
phagocytic activity in affected rats (Pollock et al., 1987; Okimura et al., 1986). Furthermore, 
social isolation of young domestic fowl produced a time-dependent decrease in the T-
lymphocyte mitogen proliferation, a significant increase in B-lymphocyte mitogen 
proliferation at 30 min, which decreased with increased duration of stress, and a significant 
increase in the production of an IL-l-like factor by splenic macrophages from animals 
isolated for 30 min, which decreased in a time-dependent manner to return to baseline by 90 
min (Cunnick et al., 1994). Taken together this series of studies demonstrates that immune 
function can be altered by various stress conditions. 
2-deoxy-D-gIucose (2-DG) and metabolic stress 
2-DG and structure mechanism of action 
The compound 2-deoxy-D-glucose (2-DG) is a nonmetabolizable structural analog of 
glucose (review see Brown, 1962). The difference between 2-DG and glucose is a 
substitution of hydrogen (-H) on the second carbon rather than hydroxyion. The action of 2-
DG was first noted by Cramer and Woodward (1952) who demonstrated the inhibition of 
metabolic blocking agent by competitive inhibition of glucose utilization, and produces a 
anaerobic fermentation of glucose by yeast with the addition of 2-DG. 2-DG acts as central 
neuroglucopenia and a peripheral hyperglycemia. 2-DG competitively inhibits the isomerase 
reaction and a membrane transport system that is shared by glucose and mannose. Sols and 
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Figure 1. The structure of 2-DG 
Crane (1954) demonstrated that the glucose configuration at the second carbon was essential 
for the inhibitory properties of 2-DG (Figure 1). 
Hence. 2-DG produces intracellular hypoglycemia by: (1) acting as a competitive 
inhibitor of the hexokinase and hexoisomerase enzymes in the cell membrane essential for 
the transport of glucose into the cell, and (2) inhibiting glycolysis when 2-DG enters inside 
the cell, 2-DG is converted to the phosphate ester form. Since the phosphorylated production 
of 2-DG is not a substrate for phosphohexoisomerase or glucose-6-phosphate dehydrogenase, 
glycolysis can not continue through the subsequent steps and glucose metabolism is blocked. 
In addition, the physiological responses to the 2-DG blockage of glucose metabolism 
are activation of the adrenal medulla with release of medullary hormones resulting in 
hyperglycemia and fatty acid mobilization. This results in a increased blood glucose level 
following 2-DG administration and has been reported in the rat. dog, and humans (Landau, et 
al.. 1958). There are some reports that the growth of experimental tumors in an animal host 
is retarded by 2-DG administration, but large amounts at frequent intervals are required, and 
side effects limit the usefulness of 2-DG for this purpose (Sokoloff, et al., 1955; Ball, et al.. 
1957). 
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AHvantapes of 2-DG-induced metabolic stress as a model system 
Metabolic stress is an interoceptive physical stress in which the stimuli come from 
internal homeostatic changes. Recently, it has been reported that many diseases are 
exacerbated by metabolic changes including improper dietary intake, drugs of abuse, or 
disorders of metabolic function. For example, roughly 50 % of all cases of liver cirrhosis in 
Western societies is related to alcohol abuse and occur in conjunction with viral or metabolic 
liver diseases (Schuppan et al., 1995). In addition, alcohol consumption causes a marked 
suppression of NK activity in vivo and then promotes tumor metastasis (Ben-Eliyahu et al., 
1996). These reports suggest that metabolic disorders induce immune alterations and should 
be considered an important issue in current biomedical research. As described above, 2-DG 
is a glucose analog that competitively inhibits intracellular glucose metabolism. Because 
neurons are critically dependent on glucose for metabolic activity, the central nervous system 
is especially sensitive to the effects of 2-DG-induced glucoprivation. Therefore, 2-DG is a 
useful tool with which to study the nervous system control of blood glucose homeostasis. 2-
DG-induced glucoprivic effects include strong activation of the HPA axis (Brodows et al., 
1973) with increased adrenomedullary activity (Welle et al., 1980), and stimulation of 
appetite centers (Muller et al., 1972; Miselis and Epstein, 1970). Thus, 2-DG administration 
has been an attractive paradigm to address a wide variety of physiological research questions. 
2-DG has been studied as a metabolic stressor due to its well characterized 
physiological response, which produces all the hallmarks of a physical stressor. 2-DG 
produces stress effects via an acute glucoprivation. The indicators of 2-DG-induced 
metabolic stress include increased glucocorticoid secretion (Smith and Root, 1969), 
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sympathetic discharge (Brown, 1962; Smith and Epstein, 1969), and increased turnover of 
norepinephrine in the brain (Ritter and Neville, 1976) and periphery (Pascoe et al., 1989). In 
addition, these neural and endocrine responses to stress are similar to electric shock, but 
induce behavior that is distinct from the physical stress of shock. Whereas animals that 
experience shock demonstrate increased locomotor activity, animals that receive 2-DG 
experience a decrease in motor activity (Smith and Epstein, 1969). Thus, use of 2-DG 
induces all the neuroendocrine hallmarks of a physical stressor without the confounds of 
increased locomotor activity. Thus, alteration in immune function due to the neuroendocrine 
changes induced by stress should be consistent across stressors; while changes due to 
increased or decreased locomotor activity will differ. Hence, use of 2-DG treatment for 
studying the effect of metabolic stress on the immune system may provide an ideal model to 
examine the relationship of stress on immune function. 
Effects of 2-DG on the immune system 
There are many studies about the immune function changes with psychological or 
physiologic stress. However, few studies have examined metabolic stress-induced changes of 
immune responses. In humans, intravenous administration of 2-DG (50 mg/kg) results in a 
rapid suppression of concanavalin A (Con A) and phytohemagglutinin (PHA) stimulated T-
cell proliferation (Breier et al., 1987). In rodent studies (Lysle et al. 1987; 1988b), 2-DG 
(500 mg/kg, IP) inhibited splenic and blood T-cell proliferation to Con A and PHA in 
Sprague-Dav/ley rats. However, the suppressed reactivity of the splenic lymphocytes 
attenuates with repeated injections, while the reactivity of blood lymphocytes does not. Their 
finding suggests that different immune compartments respond to stress are different. In 
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addition, mitogen stimulation of thymocytes from 2-DG treated rats is reduced after repeated 
injections of 2-DG. Mitogen stimulation of mesenteric lymph nodes from 2-DG-treated rats 
does not differ from saline treated controls. 
Antelman et al. (1990) reported that exposure of rats to a single 2-DG injection 12 
days after immobilization significantly augmented the immunosuppressive effect of 2-DG on 
the response of splenic lymphocytes to mitogen when compared to groups receiving 2-DG 
alone and immobilization one hour before 2-DG. Hence, the immunosuppressive effects of 
an acute stressor can be sensitized with the passage of time. Recently, Miller and colleagues 
(1993, 1994) have shown that one, two, or three injections of 2-DG (500 mg/kg, tail vein) 
into Swiss-Webster mice resulted in depressed T-cell proliferative responses and increased 
the production of interleukins-1, -3 and -6. An attenuation of these immune changes occurs 
following the fourth or fifth injections. These results indicate that the metabolic stress of 2-
DG can alter immune function. However, little work has been done to characterize the 
effects of metabolic stress on innate immunity, such as the function of natural killer cells and 
macrophages. 
The mechanism of stress effects on the immune system 
It is becoming increasingly clear that the immune system is very complex in its 
mechanisms of intercellular molecular communication, and that the neuroendocrine systems 
that impinge upon and regulate the immune system are equally complex in their hormonal 
influences. One purpose of current study is to identify the neuroendocrine mediated 
mechanisms by which metabolic stress affects the immune system. However, there have 
been few in vivo studies of the mechanisms responsible for stress-induced changes of 
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immune response. An interaction between the immune, nervous and endocrine system is 
most commonly postulated as the cause of the pronounced effects of stress on immune 
function. Communication between the neuroendocrine and immune systems has been 
suggested to occur through neuroendocrine peptides, hormones, and cytokines (Blalock, 
1994; Savino and Dardenne, 1995). In general, two possible neuroendocrine pathways of 
immune regulation are the HPA axis and the sympathetic nervous system pathway. 
Hvpothalamic-pituitarv-adrenal axis 
As a consequence of its pivotal role in maintenance of physiological homeostasis, the 
HPA axis serves as a prototype for the coordination of neural information into physiological 
responses. It also is a key player in stress responses. The hypothalamus is functionally 
associated with the pituitary gland and the endocrine system. The pituitary gland lies in the 
sella tursica at the base of the brain, and is connected to the hypothalamus through the 
pituitary or hypophyseal stalk. The anterior pimitary comprises at least five different types of 
secretory cells, each of which contains a particular hormone whose release is directed by one 
or more hypothalamic peptide cell releasing factors or hormones. After release, the pituitary 
hormone, in turn, stimulates a particular target organ whose products provide feedback 
inhibition for the pituitary hormone and/or hypothalamic peptide (Bateman et al., 1989). 
Products of the activated HPA axis such as, ACTH, P-endorphin, glucocorticoid, and 
a number of other peptides, may act as immunomodulators. When the immunosuppressive 
and anti-inflammatory effects of the glucocorticoids were discovered, the HPA axis was 
widely considered the primary neuroendocrine-mediated mechanism underlying stress-
induced immune suppression. Adrenocorticotropic hormone (ACTH) is an immediate 
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product of activating tlie HPA axis and is also correlated with stress-induced immune 
suppression. Stress induces the elevation of glucocorticoids in plasma (Selye, 1956). 
Glucocorticoids are the final products of HPA axis and are crucial mediators of the 
endocrine-immune interaction. The effects of glucocorticoids on the immune system have 
been reviewed (Munck et al., 1984). 
Glucocorticoids 
Glucocorticoids are adrenal steroid hormones which are made in the adrenal cortex. 
The plasma concentration of glucocorticoid is regulated in a negative feedback loop by 
ACTH from the pituitary, whose release is itself regulated by corticortropin-releasing factor 
(CRF) from the hypothalamus. These steroids exhibit a marked circadian rhythm of 
concentration which peak in the range of 0.5 x 10 M at about the time of wakening. Stress 
will increase CRF release and thus raises glucocorticoid level (Cohen, 1992). 
Glucocorticoids enter the cell by diffusion through the plasma membrane and bind to 
a glucocortcoid receptor which is located in the cytoplasm. The effects of glucocorticoid on 
the cells of the immune system are mediated through both soluble cytosolic and nuclear 
corticosteroid receptors. There are two types of glucocorticoid receptors which have been 
characterized by receptor binding studies (Reul and De Kloet, 1985; Miller et al., 1990). 
Type I adrenal steroid receptors (mineralocorticoid receptors) have a high affinity for the 
aldosterone (a mineralocorticoid) and Cortisol and corticosterone (the glucocorticoids), but a 
lower affinity for dexamethasone (a synthetic glucocorticoid). Type n adrenal receptors 
(glucocorticoid receptors) have a high affinity for dexamethasone, but a lower affinity for 
Cortisol, corticosterone, and aldosterone. Glucocorticoids bound to these receptors form a 
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hormone-receptor complex that can bind to a specific site of DNA to inhibit transcription of 
specific genes. The hormone-receptor complex has been shown to bind directly to portions 
of DNA that overlap cyclic AMP-responsive sites, thereby preventing binding and activation 
of these transcription factors and subsequent gene activation (Akerblom et al., 1988). 
The effects of glucocorticoids on the immune system are diverse. Glucocorticoids 
inhibit immune or inflammatory responses by inhibiting the release of proinflammatory 
substances, such as complement components, prostaglandins, histamine, and bradykinins 
(Munck et al., 1984). They inhibit antigen and mitogen-induced lymphocyte proliferation, 
accessory cell antigen presentation, and accessory cell amplification of the antigenic signal 
through inhibition of interleukin-1 production (Lee et al., 1988). Corticosteroids depress 
amplification of lymphocyte proliferation by inhibiting lymphocytic IL-2 production and 
receptor expression. They suppress effector function of lymphocytes at a cellular level by 
inhibiting the generation of helper T lymphocytes and cytotoxic lymphocytes, and they 
restrict mature helper and cytotoxic cell function (Kelso and Munck, 1984). Glucocorticoids 
inhibit the production of several cytokines including interleukin-1 (IL-1), interleukin-2 (IL-2), 
interferon-y (IFN-y), and tumor necrosis factor (TNF), but enhance interleukin-4 (IL-4) 
production (Daynes and Araneo, 1989). In addition to downregulation of cellular function, 
glucocorticoids cause an increase in circulating neutrophils, resulting from 
polymorphonuclear leukocyte egress from the bone marrow stores (Dale et al., 1975). 
Glucocorticoid-induced immune suppression depends on the species, lymphocyte type 
and receptors expressed in the cells. For example, cortisone-resistant species include the 
human, monkey, guinea pig and cortisone-sensitive species include the rat, mouse, hamster. 
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and rabbit. Differential expression of glucocorticoid receptor subtypes in immune organs has 
been reported. Peripheral blood lymphocytes exhibit both Type I and n glucocorticoid 
receptor binding; the spleen has type n glucocorticoid receptors and relatively few type I 
receptors; thymic lymphocytes exhibit Type II binding only (Miller et al., 1990). This 
indicates that different immune compartments differentially respond to glucocorticoids. 
Differential expression of receptors supports the theory that different mechanisms mediate 
stress effects in different immune organs. Specifically Keller and colleagues (1988) have 
identified a role for the UPA in suppression of the blood mitogen response. This work 
concurs with recent work by Cunnick et al. (1990) in which adrenalectomy attenuates the 
stress-induced suppression of the blood mitogen responses, but catecholamine antagonists 
attenuate the stress-induced suppression of splenic mitogen responses. This work indicates 
that various mechanisms are involved in stress induced modulation of immune function and 
are dependent upon the immune organ. 
The action of glucocorticoids on stress-induced changes of physiological function has 
been revised several times. Munck et al. (1984) proposed that the physiological function of 
stress-induced increases in glucocorticoid concentration serves as a mediator to maintain 
physiological homeostasis. The physiological role of glucocorticoids is to increase organic 
metabolism, protein catabolism, gluconeogenesis, liver uptake of amino acids, vascular 
activity and to inhibit glucose uptake and oxidation by many body cells. Glucocorticoids 
may produce their protective effects by inhibiting defense reactions such as the release of 
insulin, lymphokines, and prostaglandins. Thus, they prevent undesirable hypoglycemia. 
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excessive lymphocyte activation, and uncontrolled inflammatory responses (Hillhouse et al., 
1991). 
Sympathetic nervous system pathway 
Stressors activate the sympathetic nervous system along with the HPA axis. For 
example, Smythe et al. (1984, 1989) found that the sympathetic system plays an important 
integrative role in control of peripheral glucose metabolism during neuroglycopenia induced 
by 2-DG. This suggests that 2-DG-induced alterations of immune function also may be 
modulated by the sympathetic nervous system. 
Numerous studies indicate that the sympathetic nervous system plays an important 
role in the modulation of the immune system. The sympathetic nervous system 
communicates with target organs via a two-neuron chain. Preganglionic neuron cell bodies 
are located in the thoracic, lumbar, and sacral spinal cord, where they receive a signal from 
the brain. These preganglionic neurons send cholinergic myelinated axons to ganglia such as 
the paravertebral, prevertebral, and terminal ganglia. The prevertebral ganglia consist of the 
celiac, superior mesenteric, aorticorenal, and inferior mesenteric ganglia. Postganglionic 
axons distribute to cardiac muscle, smooth muscle, secretory glands, and organs of the 
immune system. Cell bodies of axons involved in postganaglionic innervation of the spleen 
are located in the celiac ganglia. The nerve terminals of the postganglionic axons release 
catecholamines, such as norepinephrine, which can interact with cells immediately adjacent 
to, or even distant from the sites of release. 
There is anatomical evidence that the nervous system and specific subsets of 
lymphocytes have direct connections via physical contact between sympathetic nerve endings 
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and T-lymphocytes in the spleen of rats (Felten et al., 1987a, b). Expression of p-adrenergic 
receptors, which bind catecholamines, on T and B lymphocytes and macrophages have been 
reported to further support the interaction of immune and sympathetic nervous system 
(William et al., 1976; Abrass et al., 1985; Fuchs et al., 1988). Additionally, several early 
studies have shown that the blastogenic responses of lymphocytes to T and B cell mitogens, 
IL-2-induced proliferation of lymphocytes, lytic activity of cytotoxic T-cells and T-cell-
dependent antibody production are inhibited by the stimulation of P-adrenergic receptors in 
vitro (review see Madden and Livnat, 1991). The anatomical evidence and presence of P-
adrenergic receptors emphasize the important role of catecholamines in modulation of 
immune function. This interaction is particularly important in the relationship between stress 
exposure and immune modulation in the spleen. 
Catecholamines 
Catecholamines include the substances of dopamine, epinephrine, and 
norepinephrine. This group of monoamines contain a catechol ring and an NHi (amine) 
group and thus, they are called catecholamines. Catecholamines are the hormones secreted 
by the sympathetic nervous system. In peripheral nerves, norepinephrine is a locally 
produced and secreted neurotransmitter; in the adrenal medulla, epinephrine is the major 
secretion product. Catecholamines are stored within granules with ATP and a specific 
protein, such as chromogranin. Catecholamines are released during vesicular exocytosis. 
Catecholamines are catabolized by two enzymes, catecholamine-O-methyltransferase 
(COMT) and monoamine oxidase (MAO). The secretion of catecholamines is regulated by a 
feed back system to prevent further synthesis of catecholamines (Hadley, 1992). 
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The actions of catecholamines are mediated via a and P-adrenergic receptors on the 
effector tissues (Ahlquist, 1948). Four subtypes of catecholamine receptors, the ar, a^-. Pi-, 
and P2 adrenergic receptors, have been identified on the basis of their pharmacological 
properties and physiological effects. Both a and P-adrenergic receptors had different 
affinities for catecholamines and that could be identified by the use of specific agonists and 
antagonists. A number of peripheral organs possess both kinds of receptors and they produce 
opposite effects. However, the effects of a and P-adrenergic receptor activation are not 
always antagonistic. 
Binding of catecholamine to a or p-adrenergic receptors leads to a complex sequence 
of physiological events through modulation of G proteins. It was reported that antibody 
responses, proliferation, and lytic activity could be reduced by P-adrenergic stimulation via 
elevation of intracellular cyclic adenosine monophosphate (cAMP) and in some cases 
enhanced by a-adrenergic stimulation via elevation of cyclic guanosine monophosphate 
(cGMP) concentration (review see Madden and Felten, 1995). However, no simplistic 
pattern has emerged, and it is accepted that catecholamines can differentially affect numerous 
cell types and the function of internal organs. The total effect of catecholamines on cellular 
response will depend on the timing of its release and the integration of enhancing and 
inhibiting events in the reaction. 
^adrenergic receptors 
As mentioned previously, murine lymphoid organs such as the spleen, thymus, and 
lymph nodes receive adrenergic innervation from the sympathetic systems. Furthermore, 
murine lymphocytes possess P-adrenergic receptors. Pharmacologic disruption of this 
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innervation or directly cutting the nerve which connects to the immune organ leads to altered 
immune responsiveness (Madden and Livnat, 1991). These results have led some 
investigators to postulate that the immune system may be modulated in vivo by the 
sympathetic nervous system via p-adrenergic receptors (Livnat et al., 1985; Sanders and 
Munson, 1984). 
Ahlquist (1948) initially proposed a subdivision of catecholamine receptors into a 
and p receptors in order to distinguish different physiological responses elicited by various 
organ systems after exposure to catecholamines, ^-adrenergic receptors are found in a large 
variety of mammalian peripheral tissues; most of these are innervated, but some, such as 
lymphocytes, must be stimulated by circulating catecholamines. Most of the early studies of 
these peripheral P-adrenergic receptors were pharmacological. The rank order of potency for 
a series of catecholamines in different tissues and the selectivities of various agonists and 
antagonist drugs leads to the subdivision of P-adrenergic receptors into Pi and P2 subtypes. 
Occupation of the P-adrenergic receptor by an agonist or hormone leads to a complex 
sequence of events, including an increase of cAMP. The hormone-receptor complex 
becomes coupled to the G-protein which then binds (GTP). Binding of OTP converts 
adenylate cyclase from the inactive to the active form. The activated adenylate cyclase 
converts ATP to cAMP, then cAMP binds to the regulatory subunit of protein kinase A, 
which phosphorylates a variety of proteins, including an ion channel, an ion pump, vesicle 
proteins, and enzymes (Fillenz, 1990). 
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Nadolol 
Nadolol is 2,3-cis-l,2,3,4-tetrahydro-5-(2-hydroxy-3-tert-butylamino) proproxy-2,3-
naphthalene diol, one of a series of compounds synthesized for its P-biocking properties. 
Nadolol is a P-adrenergic receptor antagonist which has the following characteristics: a long 
half-life (22 hr); non-selective for pi or P2 adrenergic receptors, with no partial agonist or 
membrane-stabilizing activity; does not reduce renal function. As nadolol can reduce heart 
rate, diastolic blood pressure, and myocardial oxygen consumption by antagonizing 
sympathetic activation of the heart, nadolol can be used in the treatment of hypertension and 
angina pectoris (Heel et al., 1980). Moreover, the action of nadolol has been attributed to 
inhibition of catecholamine-enhanced irregularities of the heart rate (Gibson et al., 1977). 
Maximum serum concentrations of nadolol occur 3-4 h after oral administration and 
the serum half-life range is 14-24 h. Minimum steady-state serum concentrations of nadolol 
are linearly related to the dose. Nadolol displays low lipid solubility and does not readily 
cross the blood-brain barrier (Antonaccio and DeForrest, 1981). In the current study, 
administration of nadolol is used to determine the role of peripheral P-adrenergic receptors in 
stress-induced immune changes. 
In addition to neuropeptides released by the HPA axis or autonomic nervous system, 
endogenous opioids mediate immune function. Several investigators have demonstrated that 
both endogenous opioids and exogenous opiates suppress NK cell activity. For example, 
Shavit and colleagues (1984) demonstrated that opiates are involved in the stress-induced 
suppression of NK activity by administration of naloxone. Although opiates are involved in 
the shock-induced suppression of splenic NK activity, they are not involved in the 
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suppression of the mitogenic responsiveness of T lymphocytes in the blood or spleen, as 
pretreatment of rats with naltrexone did not prevent shock-induced immune suppression 
(Cunnick et al., 1988). Recently, Irwin and colleagues (1991) identified a sympathetic 
release of norepinephrine in the regulation of NK function. 
Organization of the immune system 
In animals and humans, the immune system is diffuse and involves many diverse 
organs and cells throughout the body. Two major groups of immune organs are the primary 
lymphoid organs and secondary lymphoid organs. Each immune organ consists of 
stmcmrally and functionally diverse immune cells including lymphocytes, granulocytes, 
mononuclear cells, mast cells, and dendritic cells. Primary immune organs consist of the 
thymus and bone marrow and the avian bursa of Fabricius. The function of the primary 
immune organs is to provide an appropriate microenvironment for immature lymphocyte 
differentiation and education. The secondary immune organs include the lymph nodes, the 
spleen, blood, and mucosal or gut associated lymphoid tissue (MALT and GALT) (Kuby, 
1997). 
The main cells of acquired immunity are lymphocytes. Lymphocytes are derived 
from one lineage of hematopoietic stem cells which originate in the bone marrow. The 
hematopoietic stem cell is pluripotent. It differentiates into either a lymphoid stem cell or a 
myeloid stem cell based on the existence of soluble factors in the bone marrow such as 
interleukin-3 or granulocyte-macrophage colony-stimulating factors. The lymphoid stem 
cells can differentiate into either T or B progenitor lymphocytes. The progenitor lymphocytes 
do not interact with antigens but become immature and then mature lymphocytes. The 
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process of maturation in tlie tiiymus and bone marrow provides the immunocompetent T- and 
B-lymphocytes. After maturation, T- and B-Iymphocytes migrate into secondary immune 
organs to respond to pathogens. The mature lymphocytes are in the Go phase of the cell 
cycle. Naive mature lymphocytes start to proliferate into lymphoblasts in the presence of 
antigen specific signals and certain cytokines. Lymphoblasts proliferate and finally 
differentiate into effector cells or into memory cells. In general, lymphocytes constitute of 
20%-40% of the total white blood cells and there are estimated at 10'°-10'^ lymphocytes in 
the human body. 
The maturation of B lymphocytes is a continuous process in the bone marrow. A 
mature B-cell is characterized by membrane-bound immunoglobulin (antibody) and other 
surface molecules such as B220, MHC class n, B7, CD21, CD40, CD 19, and CD32. After 
maturation, B cells leave the bone marrow and migrate into secondary immune organs via the 
circulation. Depending on the interaction of membrane antibody and antigen, the functional 
importance of B-cells is to induce an antigen-specific proliferation of B-cell clones which can 
produce antigen-specific plasma cells. Plasma cells can secrete specific antibodies which 
serve as the effectors of humoral immunity by neutralizing or eliminating invading 
organisms. 
Unlike B-lymphocytes which mature in the bone marrow, the maturation of 
progenitor T-lymphocytes occurs in the thymus. The developmental pathway generates a 
functionally immunocompetent mature T lymphocyte which is self-tolerant and self MHC 
(major histocompatibility complex) restricted. The diversity of the T-cell repertoire is 
derived from T-cell receptor (TCR)-gene rearrangement, positive and negative selection. 
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Positive selection ensures that a T-cell which recognizes self-MHC molecules survive. MHC 
molecules are cell-surface proteins encoded by a complex of genes that are required for 
antigen presentation and T-cell maturation. A deficiency of MHC I and 11 molecules disturbs 
the intrathymic maturation of T-cells and functional performance of T-cells, and can lead to 
increased susceptibility to viral or microbial infections. Negative selection destroys the 
immature T-cell which bears a high affinity receptor for self-MHC alone or self-antigen 
associated with self-MHC molecules. If a T-cell which can react with self-antigen associated 
with self-MHC survives, it may lead to autoimmune diseases. About 98 % of the immature 
thymocytes in the thymus die by apoptosis due to failed use of TCR gene rearrangement, 
positive selection, or negative selection during T-cell development. The surviving T-cells 
mature and differentiate into immunocompetent cells. 
Mature T cells express a distinctive array of membrane molecules such as TCR, CD4, 
CDS, Thy-1, CD3 CD28, and CD45 on the cell membrane. Hence, the different 
developmental stages of T-cells can be described based on the changes in the expression of 
various membrane molecules. Generally, mature T-cells consist of two major functional 
subpopulations: CD4'^ and CDS"^ T cells. CD4'^ T-cells are MHC class n restricted and 
function as T helper cells which play an important role in both humoral and cell-mediated 
immunity. CDS"^ T-cells are class I MHC restricted and function as T cytotoxic cells which 
differentiate into cytotoxic T-lymphocytes following interaction with tumor or virus-infected 
cells. The ratio of CD4'^ and CDS"*" lymphocytes is approximately 2:1 in normal human 
peripheral blood. This ratio may be altered in certain diseases such as immunodeficiency 
disease, autoimmune disease, and other disorders (Kuby, 1997). After maturation, mature T-
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cells leave the thymus and migrate into peripheral immune organs such as the spleen and 
peripheral blood. In secondary immune organs, mature T-cells can be activated to proliferate 
and produce several cytokines. To this end, the function of T-cells is to serve as an effector 
of cellular immunity to directly or indirectly eliminate altered self cells. 
Apoptosis 
Apoptosis is defined as programmed cell death by which cells die following 
activation of specific genes. The process of apoptosis acts as a fundamental component of 
many physiological processes, including embryogenesis, morphogenesis, cell-mediated 
immunity, T- and B-cell maturation, hormone-induced tissue atrophy and tumor regression 
(Walker et al., 1988). Apoptosis can be characterized based on morphological changes 
including plasma and nuclear membrane blebbing, cell shrinkage, chromatin condensation, 
and DNA fragmentation ("ladders") (Cohen, 1993) and biochemical events such as 
endogenous endonuclease and protease activation (Wyllie, 1980). 
Apoptosis can occur in response to an enormous range of physiological and 
toxicological signals such as anti-CD3/TCR antibody, superantigens, or viral infection (Smith 
et al., 1898; Jenkinson et al., 1989; Acha-Orbea et al., 1991; Sen, 1992). One model of 
apoptosis demonstrates the induction of programmed cell death in immature thymocytes by 
exogenously administrated glucocorticoids (Compton and Cidlowski, 1992). Conversely, 
mature thymocytes are resistant to apoptosis induced by glucocorticoids. 
The existence of cell death by apoptosis in in vivo systems is still controversial. 
However, organisms need a strategy such as apoptosis to regulate normal development and 
maintain biological homeostasis. Furthermore, hypo-and hyper-regulation of apoptosis could 
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lead to degenerative diseases, cancer, and autoimmune disease. Recently, a variety of anti­
cancer drugs have been shown to induce extensive apoptosis in rapidly proliferating cell 
populations such as lymphoid tissues and tumors. Hence, triggering tumor cells to undergo 
apoptosis may provide a means of therapeutic interventions. 
In summary, as evidenced by this review, the relation of stress exposure, 
neuroendocrine regulation, and immune regulation is complex. The current study provides a 
series of coherent reproducible experiments documenting 2-DG-induced changes in immune 
function and the mechanisms mediating those effects. 
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CHAPTER 2. CHARACTERIZATION OF THE EFFECT OF 2-DEOXY-D-GLUCOS 
(2DG) ON THE IMMUNE SYSTEM^ 
A paper published in Brain, Behavior, and Immunity^ 
Shiu-Huey Chou^'^, Ljiljana D. Kojic, Kelly Nordyke Messingham, and Joan E. Cunnick" '* 
Abstract 
This study was designed to characterize the effects of the metabolic stress of 
administration of 2-deoxy-D-glucose (2-DG, 500 mg/kg) on immune function. Male Lewis 
rats were exposed to one or five injections (one every 48 hours) of 2-DG. Control rats 
received saline injections. Administration of 2-DG induced a reduction of total leukocytes in 
the spleen, thymus, and blood. The reduction was most prominent in animals that received 
five injections of 2-DG. The ratio of CD4VCD8^ in the spleen was decreased due to a 
significant increase of CDS^ T-cell subpopulation. Additionally, 2-DG induced a 
suppression of mitogenic responsiveness and IFN-y production in both whole blood and 
spleen lymphocytes. The production of IL-l and IL-2 was significantly reduced in the blood, 
but not in the spleen. Conversely, there was a significant increase in nitric oxide production 
in cultures of Con A, PHA, and LPS-stimulated splenocytes from 2-DG-injected animals 
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compared with saline-injected controls. In blood cultures stimulated with Con A and PHA. 
the nitric oxide production of the group that received five injections of 2-DG was 
significantly higher than in the group that received one injection of 2-DG or saline. These 
results demonstrated that the metabolic stress 2-DG induced a down regulation of Th 1 
cellular immune function in a maimer similar to physical and psychological stressors. 
Additionally, the use of 2-DG in rats provided an important model with which to study 
metabolic stress. 
Introduction 
Stress is a pervasive factor of life that contributes to the pathophysiology of nearly all 
psychiatric illnesses and a range of medical illness (Breier, et al., 1991). Stress caused by 
both physical and psychological processes is capable of producing similar and consistent 
changes in physiologic systems. Correlational studies indicate that stress is linked to many 
diseases involving the skeletal system, endocrine system, metabolic system, and immune 
system, such as rheumatoid arthritis, diabetes, cancer, and repeated viral infections (Amkraut. 
et al., 1971; Fitzpatrick et al., 1988; Eaton et al., 1979; Jemmott et al., 1984; Baker et al.. 
1981). 
Many illnesses are exacerbated by improper dietary intake, drugs of abuse, or 
disorders of metabolic function. It is suggested that metabolic disorders can alter the 
function of the immune system and subsequently decrease immune defenses, for example, 
roughly 50% of all cases of liver cirrhosis in Western societies are related to alcohol abuse 
and occur in conjunction with viral or metabolic liver diseases (Schuppan et al., 1995). 
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Additionally, administration of opioid compounds specifically alters macrophage, T-cell, and 
B-cell functions (for review see Sharp et. al., 1995). 
Metabolic dysfimction (metabolic stress) can lead to interoceptive stress originating 
from internal signals (e.g. drug injection). One model system for studying metabolic stress 
uses 2-deoxy-D-glucose (2-DG). 2-DG is a glucose analogue which can prevent cellular 
uptake and utilization of glucose (Brown, 1962). 2-DG produces metabolic changes which 
include acute intracellular glucoprivation and extracellular hyperglycemia (Smj^e et al.. 
1989; Pascoe et al., 1989). In addition. 2-DG-induced stress involves changes in the nervous, 
and endocrine systems such as, increased levels of oxytocin (Cato et al.. 1990), increased 
production of norepinephrine in the brain (Ritter & Neville, 1976) and periphery (Pascoe et 
al.. 1989), and increased glucocorticoid secretion (Smith & Root, 1969). These responses are 
similar to those that occur in humans following exposure to a number of physical stressors. 
Thus, the neural and endocrine response to stressors are similar, but the stressors may induce 
behaviors which are distinct from each other. Whereas animals that experience an 
exteroceptive stress demonstrate increased locomotor activity, animals which experience 
interoceptive stress of 2-DG exhibit a decrease in motor activity (Smith & Epstein, 1969). 
There are several reasons why 2-DG administration is an interesting stress paradigm 
to address the interaction of metabolic stress and the immune system. First, 2-DG induces a 
well characterized physiological response, which produces all the hallmarks of a physical 
stressor. Second, the neural and endocrine response to 2-DG are similar to electric shock, but 
induce behavior which is distinct from the physical stress of shock. Third, neurons are 
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critically dependent on glucose for metabolic activity, the central nervous system is 
especially sensitive to the effects of 2-DG-uiduced glucoprivation. Fourth, many syndromes 
of illnesses induce responses that are similar to those caused by interoceptive stressors which 
affect dietary intake and metabolic functions. However, there are few models which can be 
used to study the effect of metabolic stress on the immime system. Therefore, use of 2-DG 
treatment for studying the effect of metabolic stress on the immune system may provide a 
means to examine the physiological responses induced by microbial or viral infections. 
Previously it has been reported that 2-DG produced suppression of T-cell 
proliferation to Con A and PHA mitogens in humans and rats (Breier, et al., 1987; Lysle et 
al., 1988) and increased production of interleukin-1. 3, and 6 in blood fi-om LPS treated mice 
(Miller et al.. 1993). However, little work has been done to characterize the effects of 
interoceptive or metabolic forms of stress on NK cells, macrophages, or the production of 
cytokines. 
Hence, the purpose of this research was to characterize the effect of the metabolic 
stressor 2-DG on multiple measures of immune function using rats. To evaluate immune 
fimction. this study included a measure of the proliferative response of lymphocytes to 
various T and B cell mitogens, splenic natural killer cell activity, nitric oxide production from 
mitogen-stimulated cell cultures, interleukin-1, interleukin-2 and interferon-y production in 
the spleen and peripheral blood. Additionally, the spleen was examined for T-cell subsets. 
Measurement of endogenous glucose. 2-DG, and corticosterone concentrations in peripheral 
blood were used as indicators of a stress response. The results from this study suggested two 
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major points: 1) metabolic stressors can influence the immune system in a manner common 
to exteroceptive physical and psychological stressors; 2) 2-DG administration causes a 
profound effect on the expression of T helper 1 cell-mediated immune responses. 
Materials and Methods 
Animals 
Inbred male rats of the Lewis strain (55-60 days old; 220-250 g), were purchased 
fi-om Harlan Sprague Dawley laboratories. Upon arrival, the subjects were individually 
caged in a colony room where a 12-h reversed light-dark cycle was maintained through 
artificial illumination. They received firee access to both food and water throughout the 
experiment except as noted, and a 2-week acclimation period prior to the experimental 
manipulation. Additionally, animals were handled on a bi-daily basis to prevent the hyper­
reactivity that occurs when they are left untouched for a prolonged period. All animal 
manipulations were approved by the ISU Committee on Animal Use. 
Reagents and Chemicals 
The culture medium used for all assays were two kinds: "supplemented media" was 
used to designate RPMI-1640, supplemented with L-glutamine (50 mM), gentamicin (50 
jj-g/ml), and Hepes (200 mM)(Gibco Lab.. Grand Island, NY), and "complete media" was 
used to designate "supplemented media" containing 10% Fetal Bovine Serum (FBS; JHR 
Biosciences, Lenexa, KS). The mitogens Concanavalin A (Con A), and Lipopolysaccharide 
(LPS)-from E.coli were purchased from Sigma (St.Louis, MO); and Phytohemagglutinin 
(PHA) was purchased from Burroughs Wellcome (England). Heparin 100 units/ml 
(ELKINS-SINN, NJ) and 2-DG (Sigma) were diluted in Hanks' Balanced Saline Solution 
(HBSS)(Gibco Lab). All cultures were prepared in flat-bottomed tissue culture plates 
(Costar, Cambridge, MA). ^H-thymidine (specific activity 6.7 Ci/mmol), and ^'Chromium 
(specific activity 16.45 GBq/mg(Cr)) fi-om Dupont-New England Nuclear (Wilmington, DE) 
were used as specified below. 
Experimental Paradigm 
Rats were assigned to one control or two experimental groups (n=8/group). Each 
control and experimental animal was injected a total of five times, and subjects were 
manipulated so that groups of rats differed only in the content of the inoculum. Injections 
were performed once per 48 hours, 2 hrs after lights off. For each injection, a total inoculum 
of 0.28 ml/rat/injection was administered subcutaneously. Control rats received a total of 
five injections of sterile Hanks' Balanced Saline Solution (HBSS). The experimental groups 
of animals received a total of five injections comprised of either 4 HBSS plus one 2-DG 
(acute) or five (repeated) exposures to 2-DG (500 mg/kg body wt) dissolved in sterile HBSS. 
Thus, 2 groups of rats received 2-DG on the final test day. For I hour following each 
injection of 2-DG or HBSS, all animals were deprived of food and water. One horn-
following the last injection, each subject was rapidly sacrificed by cervical dislocation with a 
clamp. 
After sacrifice, the animal was placed on its back and a mid-abdominal incision was 
made to expose the abdominal aorta. Blood (5 ml) was collected from all subjects into 
heparinized (10 units/ml blood) syringes through 21 -gauge needles. One ml was aliquoted to 
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a microcentrifuge tube to separate plasma for the glucose assay and another one-ml for 
corticosterone assay. The spleen and thymus were removed and placed in preweighed 
polypropylene tubes containing 8 ml of complete media. Each organ was weighed to the 
nearest mg immediately after removal from the body. Each subject's spleen or thymus was 
dissociated into a single-cell suspension by grinding the thymus and the spleen between the 
frosted ends of two glass slides. The single-cell suspension was collected after 10 min of unit 
gravity sedimentation to remove cell debris and clumps. Subsequently, splenocyte and 
thymocyte suspensions were counted using a Celltrak 2 (NOVA Biomedical.Waltham. MA) 
cell-analyzer to determine the total leukocyte count per organ. Blood leukocyte count/ml was 
also determined by using the CeIltrak-2. 
Plasma Glucose Assay 
The heparinized blood obtained from the abdominal aorta was centrifiiged at 12,000 
rpm for 5 minutes. The level of glucose present in the plasma was measured by two 
methods: one was based upon the glucose oxidase (trinder) reaction which detects 
endogenous glucose and 2-DG and; a second was based upon the hexokinase (HK) reaction, 
which detects only endogenous glucose (both kits from Sigma). For all subjects, plasma was 
obtained from whole blood by centrifugation and stored at -70°C until assayed. On the assay 
day, glucose (Trinder and HK) reagents were prepared according to the instructions. The 
samples were tested in duplicate. The samples were read at 505 nm for trinder and 340 nm 
for HK assay with a spectrophotometer (UVIKON 930, Kontron Instruments). A glucose 
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standard curve was performed with each assay, and sample glucose concentrations were 
calculated based upon linear regression analysis of the standard. 
Plasma Corticosterone Assay 
Plasma (0.5 ml) was collected as describe above. The level of corticosterone present 
in the plasma was determined by a competitive radioimmunoassay sensitive to 0.2 ^g./dl 
corticosterone (Murphy 1967; Lysle et al., 1990a). 
Mitogen Stimulation Assay 
The mitogen assay was performed with splenic and blood leukocytes to assess 
lymphocyte proliferation. Con A and PHA were used as T-lymphocyte mitogens, and LPS as 
a B-lymphocyte mitogen as described previously (Cuimick et al., 1990). 
Natural Killer-Cell Assc^ 
Natural killer-cell activity was assayed in the splenocyte suspensions using an NK 
sensitive tumor target YAC-1 as previously described (Cunnick. et al.. 1990). Radioactivity 
in supemates was determined using a gamma counter (Gamma Trac 1191; TM Analytic. Inc. 
IL). Lytic units (LU) were calculated by using a computer program based on the equations of 
Pross and Maroun (1984). The percent cytotoxicity at all effector:target ratios was utilized to 
determine LU. Lytic units were based on the number of leukocytes per 10^ effectors 
necessary to lyse 20% of targets. 
Nitric Oxide Assay 
Supematants were harvested from cultures of mitogen-stimulated lymphocytes prior 
to pulsing with thymidine. The nitric oxide concenUrations were determined as nitrite by a 
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microplate assay (Stuehr and Nathan, 1989). Fifty [il-sample aliquots, were mixed with 100 
|il of Griess reagent (0.5% sulfanilamide / 0.05% naphthylethylene diamine dihydrochloride 
/ 2.5% H3PO4) and incubated at room temperature for 10 min. The optical density was 
measured m an ELISA microtiter plate reader (BIO Kinetics Reader, BIO-TEK instruments) 
at 550 nm against PBS as a blank. A sodium nitrite (NaN02) standard curve (0-100 jaM) was 
generated in parallel. Results are expressed as the mean of nitrite concentrations in the 
supematants of triplicate wells and analyzed as repeated-measures ANOVA by using the no-
mitogen control and all concentrations of a given mitogen. 
Interferon-y Induction and Assay 
The level of interferon-y in the crude supematants of Con-A-stimulated spleen and 
peripheral blood lymphocytes was measured. Whole spleen leukocytes (2.5 x loVml) were 
incubated in complete media and Con A 3 |ig/ml for 48 hours and whole blood leukocytes 
(1:20 dilution) were incubated in supplemented media and Con A 10 |ag/ml for 72 hr at 37'^C 
in 5% CO2. Culture supematants were harvested and stored at -70°C until the assay (Johnson 
et al., 1981). The interferon was determined by means of a commercial ELISA assay for rat 
interferon-y (Amgen Biologicals.Life Technoloqies). Titers were determined by comparison 
to an interferon-y standard provided in the assay which is calibrated to an international 
reference standard (Sonnenfeld et al., 1992). 
lnterleiikin-2 Induction and Assay 
Interleukin-2 (IL-2) is a T-cell growth factor produced by stimulated T-lymphocytes. 
To test for the functional ability of T-cells to produce IL-2,2.5 x 10^ splenocytes / ml of 
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media were incubated with 3 (ig/ml Con A for 48 hr in a l2-well microculture plate. After 
incubation, the culture supematants were centrifuged (600 xg, 10 min, 4°C). The conditioned 
media was stored at -70°C until assayed for IL-2 activity. Supematants obtained from 
nonstimulated cultures served as "media control." On the assay day, the supematants and a 
positive IL-2 control were serially diluted 1:2 (total of five dilutions) in duplicate in a 96-well 
microtiter plate by using a digital multichannel pipette (Titertek-Plus). The IL-2-dependent 
cell line, CTLL-2, was washed to removed any exogenous lL-2 and was then diluted in 
complete media to Ix lOVml. Then 100 |al of the CTLL-2 cell suspension was plated in each 
well and in control wells containing no lL-2. The plates were incubated for 24 hr at 37 °C in 
a humidified atmosphere of 5% CO2. Each well was pulsed with 1 jj.Ci of ^H-thymidine (50 
|il) for the last 5 hr of the incubation. The cultures were harvested (Skatron Harvester. Model 
#11028, Sterling, VA), and the thymidine incorporation was determined by using a liquid 
scintillation counter (1217 Rackbeta, LBCB-Wallac, Finland). 
Thymocyte Co-Mitogenesis Assay for Interleukin-1 
The ability of biological fluids containing IL-1 to enhance the proliferative response 
of mouse thymocytes stimulated with mitogen was the basis for the bioassay for quantitation 
of IL-1 activity. Whole spleen leukocytes (2.5 x lOVml) were incubated in complete media 
and LPS 5 [ig/ml for 48 hours while whole blood leukocytes (1:20 dilution) were incubated 
in supplemented media and LPS 5|ig/ml for 72 hours at 37"C in 5% CO2. Culture 
supematants were harvested and stored at -70°C until the assay. On the assay day, the 
supematants were serially diluted 1:2 in duplicate in a 96- well microtiter plate. Fresh 
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mouse-thymocyte suspension (10^ cells / lOOul), prepared from 5-6 weeks old C3H/HeJ 
mice (Jackson Laboratories), mixed with PHA, was added to the LPS-stimulated or control 
superaatants (final concentration of PHA 2.5 fig/ml). The plates were incubated for 72 hours 
at 37 °C in a humidified atmosphere of 5 % COi. Each well was pulsed with 1 fiCi of "'H-
thymidine for the last 16-18 hours of the incubation. The cultures were harvested using a 
Skatron Harvester. Thymidine incorporation was determined by using a scintillation counter. 
Flow Cytometric Analysis of Lymphocyte Subsets 
The positive percentages of CDA* and CD8^ lymphocyte subsets were studied by 
fluorescent-cell-surface staining with monoclonal antibodies and analysis on an EPICS 
PROFILE-1 flow cytometer. Monoclonal mouse antibodies to lymphocyte populations were 
purchased from PharMingen or Bioproducts for Science. The anti-CD4 antibody (W3/25) 
was conjugated to fluorescein iso-thiocyanate (FITC), and the anti-CDS antibody (OX-8) 
biotinylated for conjugation to avidin phycoerythrin (PE) (Vector Labs) to be used for double 
staining. The FITC or Biotin-conjugated mouse IgGl,k-isotype standard antibodies 
(PharMingen, San Diego, CA) were used as control antibodies. Spleen suspension diluted in 
HBSS supplemented with 6 % FBS (25 fil) were suspended in 100 fil of cold PBS/Azide 
(0.2%) and incubated in the dark at 4°C for 20 min with 5-10 |j.l of the monoclonal antibodies 
or isotypic control antibodies. The erythrocytes were lysed with 2 ml fresh lysing solution 
(ammonium chloride 8.02 g, sodium bicarbonate 0.84 g, and EDTA disodium 0.37 g in 1 liter 
distilled water) for 10 min at room temperature. The remaining lymphocytes were washed 
twice with PBS/Azide. The avidin-PE solution (300 |il) was incubated with the cells for 20 
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min (4°C). The cells were washed 2 more times with PBS/Azide and placed in 2% 
paraformaldehyde prior to analysis. 
Statistical Treatment of Data 
A computerized program for analysis of variance (ANOVA; Statistix, NH Analytical 
Software) was used to assess differences among experimental and control groups. For the 
present experiment to characterize the effects of 2-DG, an ANOVA to compare 3 stress-
levels (saline injection/non-stress, IX 2-DG injection/acute stress, and 5X 2-DG 
injection/chronic stress) was used to assess significance of the various measures. The level of 
significance for the F test was set at P < 0.05. 
Results 
Plasma Corticosterone Level 
An elevated level of corticosterone in plasma provided an indicator of stress. The 
results of the assay for plasma corticosterone (Table 1) demonstrated a pronounced stress 
effect in the 2-DG treated groups. An analysis of variance demonstrated a significant 
increase in corticosterone due to overall treatment effect, F (2,18) = 76.00, p < 0.0001. 
Orthogonal contrasts indicated that the groups that received 2-DG injection had significantly 
elevated levels of plasma corticosterone relative to the saline-injected control group, F (1,18) 
= 149.08, p < 0.0001. In addition, the plasma corticosterone levels were inversely correlated 
with the number of lymphocytes in thymus (r = -0.61,/? < 0.01) and blood (r = -0.561, p< 
0.01). However, the corticosterone level of the group that received five 2-DG injections was 
not significantly different from that of the group receiving one 2-DG injection. 
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Endogenous Plasma Glucose and Plasma 2-DG Levels 
The glucose oxidase method was used to measure total plasma glucose (endogenous 
glucose and 2-DG), while the hexokinase reaction provided of a measure of endogenous 
glucose alone. The difference between the assays gave us levels of plasma 2-DG. Levels of 
plasma glucose (Table 1) were directly related to the levels of corticosterone in circulation (r 
= 0.85,/7 < 0.0001). Injection of 2-DG resulted in nearly a threefold increase in plasma 
glucose level. As can be see in Table 1, all groups that received one or five injections of 2-
DG had a marked increase of endogenous plasma glucose in comparison with the control 
groups. Analysis of plasma glucose levels showed a significant effect of treatment, F (2,18) 
= 284.81, p < 0.0001. Orthogonal contrasts indicated a significant drug effect, F (1,18) = 
550.37,/? < 0.0001, and also indicated that the elevation of plasma glucose in the five-
injection group was significantly lower than in the one-injection group, F (1.18) = 19.10./? < 
0.0001. 
The plasma levels of 2-DG (Table I) were 30-50 mg/dl one hour after injection. 
Furthermore, the 2-DG levels in the animals that received five injections of 2-DG were 
significantly less than for the animals which received one injection, F (1,18) = 6.76. p < 0.02. 
Quantification of Immune Organ Weight and Leukocyte Content 
Organ weight, body weight, and adrenal gland weight. The body weight, organ 
weight of spleen, thymus, and adrenal gland were determined (Table 1). Treatment did not 
significantly affect total body weight (Table I). The overall average body weight was 290.33 
mg / per rat. Additionally, the treatments did not significantly affect adrenal gland weight 
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among the groups. For the spleen, analysis of variance indicated a significant effect due to 
treatment, F (2,18) = 3.91,/? < 0.04. Contrasts showed the groups that received 2-DG 
injections had marginally decreased spleen weight in comparison with the saline control 
group, F (1,18) = 3.69, p < 0.08. However, the decrease of spleen weight for the group that 
received five injections of 2-DG was significantly different than the group that received 
saline injections, F (1,18) = 7.18, p < 0.02. 
A significant main effect of treatment existed for thymus weight. F (2,18) = 19.83, p 
< 0.0001. Orthogonal contrasts indicated that 2-DG induced a reduction in thymus weight in 
comparison with the saline treated control, F (1,18) = 11.76, p < 0.003. Moreover, the 
thymus weight for the group that received five injections of 2-DG was significantly decreased 
compared with the group that received one injection of 2-DG, F (1,18) = 27.98, p < 0.0001. 
An ancillary contrast showed no significant difference in thymus weight between the group 
that received one injection of 2-DG and the group that received saline injections. 
Leukocyte counts. The leukocytes in spleen, thymus, and peripheral blood were 
enumerated (Table 1). In the spleen there was a main effect of treatment, F (2. 18) = 4.00, p 
< 0.04. This effect was due to a significant decrease of leukoc>te number in the five-
injection group in comparison with the groups that received saline injection, F (1. 18) = 4.71, 
p < 0.05. There also was no significant difference between the group that received one 
injection of 2-DG and the saline-injection group. 
There was a significant main effect of treatment on the number of leukocytes in the 
thymus, F (2, 18) = 17.81, p < 0.0001. Orthogonal contrasts indicated that one and five 
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injections 2-DG induced a reduction of thymic leukocytes/organ in comparison with the 
saline injected group. F (L 18) = 17.81,/? < O.OOI. The reduction of leukocytes/thymus was 
greatest in the group that received five injections of 2-DG compared with the group that 
received one injection of 2-DG, F (1,18) = 17.81, ;7 < 0.001. 
There was a main effect of treatment on the number of leukocytes/ml of blood. F (2. 
18) = 7.16, < 0.006. The results showed a significant decrease in blood-leukocyte number 
in the groups that received one or five 2-DG injections in comparison with the saline-treated 
group. F (1.18) = 12.96,/7 < 0.003. However, no significant difference was found in the 
group that received five injections of 2-DG and one injection of 2-DG. In addition, the 
glucose levels were inversely correlated with the number of lymphocytes in the thymus (r = -
0.4377. p < 0.04) and blood (r = -0.5821, p < 0.01 ). 
Response to Mitogen Stimulation 
Spleen assay. The proliferative response of splenic leukocytes to various mitogens 
was measured as an indicator of functional potential. The mitogen-stimulation assay showed 
comparable effects across all concentrations of Con A, PHA, and LPS. Analysis of variance 
of the optimal concentrations of mitogen (Con A 3 |ag/ml; PHA 5 |ag/ml; and LPS 2.5 fig/ml; 
Table 2) showed significant drug effects. F (2, 20) > 3.80, p < 0.04. These results indicated 
that the one injection group showed significant suppression in comparison with saline-
injection group, F (1,20) >5.60,/? < 0.03. Polynomial contrasts showed a significant linear 
effect, indicating that repeated 2-DG injections induced an attenuation of suppression. An 
additional contrast showed that the difference between 5 X 2-DG and saline was not 
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significant when stimulated with Con A, F (1,20) < 1, but was significantly different with 
PHA and LPS stimulation, F (1,20) > 7.00, p < 0.02. 
Whole-blood assay. The proliferative response of blood leukocytes to various 
mitogens was measured as an indicator of functional potential. The results of the whole-
blood assay showed comparable effects across all concentrations of Con A and PHA. 
Analysis of variance of these optimal concentrations of mitogen (Con A 10 ng/ml and PHA 5 
Hg/ml; Table 2) showed a significant treatment effect for Con A and PHA, F (2,19) > 39.04, p 
< 0.0001. Orthogonal contrasts indicated that there was a significant suppressive effect of 2-
DG injection. F (1,19) > 76.00, P < 0.0001. There was no significant difference between 
groups receiving five 2-DG injections and one 2-DG injection. Moreover, there was no 
attenuation of suppression of the peripheral blood lymphocyte response to mitogen in the 
group that received five injections of 2-DG. 
Response of Nitric Oxide (NO) Production 
In conjunction with mitogen induced blastogenesis, the production of nitric oxide 
(NO) was measured in the same culture prior to the addition of ^H-thymidine. The nitric 
oxide production of mononuclear cells in spleen, and blood was measured as an indicator of 
macrophage fimction. As nitric oxide was rapidly reduced to the stable products nitrite and 
nitrate, nitric oxide production was quantified from the concentration of nitrite. 
NO assay-Spleen. Nitrite production from spleen mononuclear cells stimulated with 
the optimal concentration of mitogen Con A (3 |ag/ml), PHA (5 |ag/ml), and LPS (2.5 |ig/ml) 
were analyzed and indicated a significant effect of treatment, F (2, 20) > 3.70, p < 0.05 
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(Table 2). Orthogonal contrasts indicated a significant increase in nitrite in Con A and PHA-
stimulated cultures of splenocytes from 2-DG injected animals in comparison to saline 
injected animals, F (1, 20) > 4.28, p < 0.05. Additionally, there was more nitrite in cultures 
of Con A and PHA-stimulated splenocytes from acutely stressed (IX 2-DG) animals than 
from chronically stressed (5 X 2-DG) groups, F (1,20) > 7.23,/? < 0.02. However, the nitrite 
production in spleen cultures stimulated with LPS indicated that the groups that received five 
injections of 2-DG had less nitrite than eidier the group receiving one injection of 2-DG or 
the saline-injection group. F (1, 20) > 7.29, p < 0.02. 
NO assay- Blood. The production of nitrite from whole blood mononuclear cells 
stimulated with the optimal concentration of Con A (10 jig/ml) and PHA (5 |ig/ml) were 
analyzed. The optimal concentration of mitogens showed a marginal treatment effect, F (2. 
20) > 2.80, p < 0.08. There was no difference between animals treated with one injection of 
2-DG and saline-treated animals, F (1,20) < 1. However, the nitrite production of the group 
that received five 2-DG injections was greater than the groups that received one injection of 
2-DG and saline injections, F (1,20) > 5.70, p< 0.03. 
Natural Killer Cell Assay 
Natural killer-cell function of splenic leukocytes was measured using four effector to 
target ratios and analyzed as Lytic Units (LU). The results of the natural killer-cell assay are 
displayed in Figure 1. Analysis of LU showed a significant treatment effect among the 
groups. F (2. 18) = 9.64, p < 0.006. Orthogonal contrasts indicated that the groups that 
received 2-DG injections demonstrated significantly suppressed natural-killer cell activity 
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relative to the saline-treated control group, F (1,11)= 19.00,/? < 0.002. However, 
comparison of both one- and five-injection 2-DG treated groups indicated no significant 
difference between the groups, F (1.11) < 1. Thus, one 2-DG injection suppressed splenic 
natural killer-cell activity, and this suppression showed no evidence of increase or attenuation 
after repeated 2-DG injection. Hence, a metabolic stressor induces substantial suppression of 
splenic natural killer-cell activity. 
Effects of 2-DG on Cytokine Production 
Interferon-y production. Con-A-stimulated supematants of splenocytes and blood 
leukocytes from stressed rats and nonstressed rats were tested for their ability to produce 
interferon-y (IFN-y). The induction of IFN-y by 3 fig/ral Con A for spleen and 10 |ig/ml for 
blood was evaluated by testing the supernatant fluids of the cultures from the same cell 
sources as those used in the lL-2 assay. In the spleen (Fig. 2A), there was a marginal effect 
of treatment, F (2. 17) = 3.85, p < 0.06. Orthogonal contrasts showed that the groups which 
received 2-DG injections had significantly decreased splenic IFN-y production in comparison 
with the saline control group. F (1,17) = 1.61,p< 0.02. A comparison between the group 
that received five injections of 2-DG and the group that received one injection of 2-DG 
demonstrated no significant difference in IFN-y production, F (1,17) < 1. 
Production of IFN-y by blood leukocytes (Fig. 3 A) demonstrated a significant effect 
due to treatment, F (2. 17) = 9.66, p < 0.004. Orthogonal contrasts indicated that 2-DG 
induced a significant decrease in interferon-y production of blood, F (1, 17) = 19.27, P < 
0.001, in comparison with the saline treated controls. However, there was no difference 
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between those groups that received five injections and those that received one injection of 2-
DG, F (1, 17) < I. These resuhs indicate that the metabolic stress of 2-DG induced 
suppression of Con A stimulated IFN-y production in spienocytes and blood leukocytes. 
Interleukin-2 (IL-2) production. Production of IL-2 was induced in cultures of 
lymphocytes in response to the T- cell mitogen. Con A. IL-2 was measured by using the IL-
2-dependent cell line, CTLL-2. Overall analysis of variance of IL-2 production by splenic 
supematants did not demonstrate any significant alteration due to treatment (Fig. 2B). 
Analysis of variance of IL-2 production using the optimal dilution (1/4) of 
supernatant from blood leukocyte cultures showed a marginally significant main effect of 
treatment, F (2. 17) = 3.39, p < 0.06 (Fig. 3B). Orthogonal contrasts demonstrated that 2-DG 
induced a significant reduction of IL-2 production in comparison with the saline-treated 
control. F (1, 17) = 4.45, p = 0.05. Also, there was a significant difference between group 
which received one injections and saline injection of 2-DG, F (1, 17) = 6.71,p < 0.02. 
However, there is no difference between group which received five injections and one 
injection of 2-DG. 
These results indicated that the stress of 2-DG induced a suppression of IL-2 
production in the blood, but not in the spleen. This pattern differs from that observed for the 
production of IFN-y. 
Interleukin-l (IL-l) production. The production of IL-1 was used to measure the 
functional activity of macrophages. LPS was used to induce IL-1 production in cultures of 
leukocytes. IL-1 production was measured using the thymocyte costimulation bioassay. 
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Analysis of macrophage production of IL-I in splenic supematants did not indicate any 
significant change due to treatment (Fig. 2C). 
Analysis of variance of IL-1 production using the optimal dilution (1/4) of 
supernatant from blood leukocyte cultures showed a significant treatment effect, F (2.23) = 
38.40. p < 0.0001 (Fig. 3C). Orthogonal contrasts demonstrated that 2-DG induced a 
pronounced suppression of IL-1 production in comparison to the saline treated control. F 
(1.23) = 75.00, p < 0.0001. However, there was no significant difference in suppression 
between animals that received one and those that received five injection(s) of 2-DG. These 
results indicated that the metabolic stress of 2-DG induced a suppression of IL-1 production 
in the blood, but not in the spleen. This pattem was consistent with the results of IL-2 
production. Also, the outcome of cytokines production (IFN-y, IL-2, IL-1) was in agreement 
with the hypothesis that different compartments of the immune system are differentially 
affected by a stressor. 
Flow Cytometric Analysis of Lymphocyte Subsets 
In order to identify changes in CD4 and CDS positive T-cell subsets, aliquots of 
splenocytes were stained with the monoclonal antibodies W3/25 (anti-CD4) and OX-8 (anti-
CD8). Analysis of variance of the percentage of CD4^ and CD8^ population demonstrated a 
significant treatment effect, F (2, 18) > 4.20,/? < 0.03. Orthogonal contrasts indicated no 
significant difference in CD4^ population between the groups that received 2-DG and saline 
injection (Fig. 4A). However, 2-DG injection induced a significant increase in CD8+ 
population, F (1, 18) = 8.47, p < 0.01 (Fig. 4B). As there was a decrease in the number of 
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leukocytes in spleens from animals receiving five injections of 2-DG, we also analyzed the 
data as number of CD4 and CDS cells per spleen. These analysis were similar to those 
described for the percent CD4 and CDS positive data and demonstrated no significant change 
in the number of CD4 cells per spleen (grand mean: 226.93 x 106) and a significant increase 
in the number of CDS cells per spleen in rats which received 1X2DG and 5X2DG compared 
to saline treated controls (means: 45.1, 50.7, 37.5 x 106, respectively), F(1.I8) = 6.55, p < 
0.02. 
The ratio of CD4'^: CDS^ cells demonstrated a significant treatment effect, F (2. 18) > 4.20. p 
< 0.03, which was due to the increase in CDS^ lymphocytes. Animals receiving 2-DG had 
significantly lower ratio than saline treated animals, F (1, 18) = 8.04, p < 0.01 (Fig. 4C). The 
percent of CD8^ population and the ratio of CD4^ to CDS^ between groups that received one 
or five injections of 2-DG did not differ. 
Discussion 
The present study was designed to characterize the alterations of immune function 
due to the metabolic stress of 2-DG on both innate and adaptive immunity. Results indicated 
that metabolic stress has a profound effect on the expression of immunological parameters 
that play a major role in the expression of cell-mediated immune responses. 
This study showed that a reduction of lymphocyte content was induced in the spleen, 
thymus, and blood of rats that received repeated injections of 2-DG. Similar patterns were 
also observed in measurement of organ weight in spleen and thymus. As expected, 2-DG 
induced increased secretion of corticosterone and exaggerated plasma hyperglycemia. Data 
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analysis indicated ±at the increased plasma corticosterone concentration was positively 
correlated with an increase in endogenous glucose but was inversely correlated with the 
decrease of blood lymphocytes. Therefore, the effects of 2-DG on lymphocyte number could 
be explained because of the production of stress hormones (e.g., corticosterone and 
catecholamine). Synthetic glucocorticoids have well-known immimosuppressive effects in 
vitro and in vivo, whereas the immunologic influence of endogenous glucocorticoids at 
physiological levels is less clear (Munck, et al., 1984). Recently, studies by Dhabhar and his 
colleagues (1995) suggest that corticosterone released during physiologically relevant 
conditions plays an important role in regulating the trafficking of leukocytes between the 
blood and other immune compartments and this redistribution can affect an immune response 
to potential or ongoing immune challenges. 
Beside of the reduction of splenocytes, splenic T-cell subpopulations also changed in 
animals that received one or five 2-DG injection. Interestingly, the percentage of CD4^ T-
cell subpopulation did not change, in contrast, the percentage of CD8^ T-cell subpopulation 
was increased in 2-DG treated animals. The present study did not examine the mechanism of 
increase of CD8^ T-cell population or its role in long term immune suppression / regulation. 
However, the role of CD8^ T suppressor remains controversial. 
2-DG-induced metabolic stress altered the function of innate immune mechanisms. 
Natural killer-cell (NK) activity, was significantly suppressed in the spleen after 2-DG 
administration, implicating the influence of 2-DG-induced metabolic stress on the capacity of 
resistance to pathogenic microorganisms and neoplastic diseases. The functional level of 
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macrophages were examined through the production of nitric oxide (NO) and IL-1. Results 
indicated more nitrite in cultures of spleen and blood lymphocytes from 2-DG-stressed 
animals than from saline-treated animals. Although macrophage secreted more NO in 2-DG-
stressed rats than saline-treated rats, lL-1 production in peripheral blood was decreased after 
2-DG administration. This shift towards increased NO production may be an evolutionarily 
adaptive response for increased bactericidal activity, if wounds became infected. Contrary to 
our results. Miller et al (1993) reported that administration of 2-DG in mice could enhance 
the lL-1 activity in blood plasma. However, mice have been shown to respond differently 
than rats to physical stressors (Lysle et al, 1990b). Moreover, Miller and colleagues (1993) 
examined lL-1 activity in the plasma of 2-DG and LPS treated mice, whereas our study 
measured IL-1 production in vitro. 
Previous research reports that 2-DG administration suppresses lymphocyte 
blastogenesis (Lysle et al., 1988). The mitogen proliferation data obtained from the current 
study replicates the previous work demonstrating the ability of 2-DG to suppress T-cell 
mitogenic responses in blood and spleen to Con A and PHA. That work is extended in that 
this study showing 2-DG also induced suppression of the splenic B-cell mitogen response to 
LPS. Suppression of LPS mitogen suggested that humoral responses can be suppressed by 2-
DG. The present study demonstrated an inverse correlation between blastogenesis and nitrite 
production in the spleen and blood. Excess NO production may have contributed to the 
inhibited lymphocyte proliferation. Previous work shows that murine macrophages act as 
suppressor cells to down-regulate lymphocyte-dependent immune events (Mills, 1991). In 
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addition, a nitric oxide synthase (NOS)-dependent suppressor activity on mitogen-induced 
lymphoid proliferation responses in splenocytes has been reported in Fisher rat (Mills. 1991; 
Albina et al., 1991), and spontaneously hypertensive rats (Pascual et al.. 1993). Recently. 
Lysle and colleagues (1995) provided evidence that morphine and an aversive Palovian 
conditioned stimulus induce an increase in macrophage-derived NO which is directly 
involved in the suppressed proliferative response of splenic lymphocytes to mitogen. Those 
studies provide a reference for the present results and suggest that the increased NO 
production in 2-DG-treated rats induced the decrease of splenic lymphocyte proliferation. 
However, the relationship of NO production to blood lymphocyte proliferation needs further 
study. 
Consistent with other stress studies, 2-DG not only inhibited T lymphocyte 
proliferation, but also influenced the production of T-cell-derived cytokines. Studies using 
electric shock in rats (Sonnenfeld et al., 1992) and examination stress in humans (Glaser et 
al., 1986) have shown a decrease of IL-2 and IFN-y. The results of this study indicated that 
IFN-y production by spleen and blood lymphocytes of rats is inhibited after the metabolic 
stress of 2-DG administration. Alternatively, data also indicated a reduction in the level of 
IL-2 production by peripheral blood lymphocytes fi-om 2-DG treated rats, but not by splenic 
lymphocytes. This pattem is similar to effects seen with other stressors (Cunnick et. 
al.,1991), but differs from that observed for the production of IFN-y. The reduction of IL-2 
and IFN-y in 2-DG-treated animals suggests metabolic stress has a profound effect on the T-
helper 1 cell population. 
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In the current study, 2-DG produced a suppression of splenic T-cell function with a 
single exposure and a habituation of splenic suppression with multiple exposures. In 
contrast, the suppressive effect for the whole-blood lymphocytes did not show any 
attenuation of suppression over repeated administration. Moreover, 2-DG induced 
depression of IL-1 and IL-2 production in cultures of blood lymphocytes, but not in cultures 
of splenic lymphocytes. These results are consistent with other research showing that stress 
differentially affects various compartments of the immune system, such as the spleen and 
blood. (Lysle et. al., 1988; Cunnick et al., 1990). The reason for the differential effects 
across compartments of the immune system is not readily apparent from this study. 
However, Cunnick and colleagues (1990) provided evidence that catecholamines are 
responsible for splenic immune suppression and that adrenal hormones are responsible for 
blood lymphocyte suppression in a model of physical stress. Our laboratory is in the process 
of investigating the mechanisms involved in the 2-DG-induced immune changes (paper in 
preparation). 
In sunmiary, these studies demonstrate that the metabolic stressor, 2-DG, can alter 
cellular immune function which are T-helper 1 cell predominant. In addition, the immune 
changes induced by 2-DG are consistent with other stress studies using the physical stress of 
shock and aversive conditioning. In the past, use of mild electric shock to study 
immunological effects of stress in animals has shown increased locomotor activity which has 
made conclusions complicated and often controversial. Conversely, animals which 
experience interoceptive stress of 2-DG exhibited a decrease in motor activity (Smith & 
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Epstein, 1969). Hence, the use of 2-DG on rats provides a ideal model for the study of 
metabolic stress. It also provides insight about immime function during pathogenic 
conditions which alter metabolism. 
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Table 1. Effects of 1 and 5 injections of 2-DG (500 mg/kg) and saline injection(s) on the plasma corticosterone, endogenous 
glucose, 2-DG, leukocytes number, total body weight, and organs weight. 
Injection Manipulation 
IX 2-DG 5X 2-DG Saline 
Plasma level 
Corticosterone (|Jg/dl) 
Endogenous glucose (mg/dl) 
2-DG (mg/dl) 
41.26 ±3.45 
319.5 ±8.12 
52.04 ± 5.34 
48.02 ±6.19 
283.6 ±8.21 
33.90 ±5.83 
2.74 ± 1.99" 
135 ±0.46 
0 
Leukocyte number 
Spleen (x 10 /organ) 
Thymus (x 10'^ /organ) 
Blood (x 10"^ / ml) 
420.3 ± 13.06 
561 ± 19.45 
3.563 ±0.33 
373.8 ± 14.6 
478.2 ± 14.72 
3.038 ±0.39 
411.7 ± 13.48 
591.2 ±24.06 
4.69 ± 0.39 
Total body weight (gm) 
Organ weight (mg) 
Spleen 
Thymus 
Adrenal gland 
296.7 ± 6.72 
562.6 ± 14.3 
455.4 ± 18 
63.75 ± 1.4 
279 ± 6.94 
507.4 ± 20 
337.2 ± 17 
69.75 ± 3.2 
296.5 ± 5.64 
580 ± 25 
462.6 ± 17 
66 ± 1.8 
a. Data are expressed as the mean ± SE; n = 8/grp 
Table 2. Effects of 1 and 5 injections of 2-DG (500 nig/kg) and saline injection(s) on the mitogen responsiveness and nitric oxide 
production of splenic and peripheral blood leukocytes. 
Injection Manipulation 
1 X 2-DG 5X 2-DG Saline 
Mitogen response (cpm x 10"^)" 
Spleen Con A 197.5 ±32.93 239.9 ± 23.76 279.3 ±7.88'' 
PHA 43.81 ± 17.12 89.95 ± 25.53 169.2 ±23.23 
LPS 27.33 ±2.127 30.69 ± 1.74 39.09 ± 2.45 
Blood Con A 4.71 ± 1.41 4.92 ± 1.63 44.06 ±5.68 
PHA 0.90 ±0.12 0.865 ±0.16 10.41 ± 1.43 
Nitrite production ((imole/ml)' 
Spleen Con A 8.32 ±0.807 7.57 ± 1.01 6.35 ± 1.14 
PHA 11.80± 1.53 10.24 ± 1.61 9.44 ± 1.74 
LPS 7.84 ± 1.31 6.01 ± 1.12 7.852 ± 1.65 
Blood Con A 5.33 ±2.72 10.60 ±3.67 6.08 ± 1.61 
PHA 4.51 ± 1.49 10.01 ±3.81 5.10±0.71 
a. Mitogen stimulation was induced in cultured splenocytes and blood leukocytes with the optimal concentration of Con A 
(3ng/ml on spleen, IO)ig/ml on blood), PHA (5ng/ml), and LPS (2.5)ag/ml). 
b. Results are expressed as mean / 5 x 10 ^ leukocytes. 
c. Production of nitric oxide by splenocyte and blood leukocyte cultures incubated with 3 ng/ml or 10 ng/ml ConA, 
5 ng/ml PHA, or 2.5 ng/ml LPS. Nitric oxide was measured as nitrite in supernatant by use of the Griess reagent in the 
supernatant of blastogenesis cultures. 
d. Data are expressed as the mean ± SE of average triplicate counts per minute; n = 8 /grp. 
e. Nitrite are expressed as mean ± SE of average triplicate }imole/ml; n = 8 /grp. 
Figure 1. Splenic NK activity expressed as (A): percent cytotoxicity and (B): lytic units (LU) 
for rats receiving 1 or 5 injections of 2-DG (500 mg/kg) or saline injections. 
Results are expressed as the mean (± SE); n = 4 / grp. 
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Figure 2. Effect of 1 or 5 injections of 2-DG (500 mg/ml) and saline injections on the IFN-y 
(A), IL-2 (B), and IL-1 (C) production of splenocytes. IFN-y and IL-2 production 
were induced in cultured splenocytes with 3 mg / ml Con A and IL-1 production 
was induced with 2.5 ^ig/^ll LPS. Results of IFN-y production were expressed as 
the mean (± SE) of units/ml (1 unit = 250 pg); n = 6 / grp. Results of IL-2 and IL-
1 production were expressed as the mean (± SE) of the average duplicate counts 
per minute; n = 8 / grp. 
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Figure 3. Effect of 1 or 5 injections of 2-DG (500 mg/ml) and saline injections on the IFN-y 
(A), L-2 (B), and IL-1 (C) production of blood leukocytes. IFN-y and lL-2 
production were induced in cultured blood leukocytes with 10 mg / ml Con A and 
IL-1 production was induced with 2.5 [ig/ml LPS. Results of IFN-y production 
was expressed as the mean (± SE) of units/ml (I unit = 250 pg); n = 6 / grp. 
Results of IL-2 and IL-1 production were expressed as the mean (± SE) of the 
average duplicate counts per minute; n = 8 / grp. 
CPM (X 10"^) CPM (X 10 "^) UNITS / ml 
Figure 4. Effect of 1 and 5 injections of 2-DG (500 mg/kg) and saline injections on T-cell 
subpopulations in spleen, expressed as the percent positive cells staining with 
antibody to A: CD4 (W3/25), B: CDS (0X8), or C: % CD4^ / % CD8 Results 
are expressed as the mean (± SB); n = 8 / grp. 
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CHAPTER 3. EVTOENCE FOR CATECHOLAMINES INVOLVEMENT IN THE 2-
DG-INDUCED IMMUNOMODULATORY EFFECTS IN SPLEEN 
A paper submitted to Brain, Behavior, and Immunity 
Shiu-Huey Chou, Ljiljana D. Kojic, and Joan E. Cunnick 
Abstract 
The role of catecholamines in immune changes associated with the metabolic stress of 
2-deoxy-D-gIucose (2-DG) was examined in this study. Male Lewis rats were pretreated 
with the nonselective |3-adrenergic receptor antagonist, nadolol (0-0.5 mg/kg), and then 
received either a saline or 2-DG (500 mg/kg) injection. Nadolol attenuated the 2-DG-
induced suppression of splenic T-cell mitogenic response and interferon-y production and 
increased nitric oxide production by macrophages in a dose-dependent manner. Conversely, 
nadolol did not attenuate the 2-DG-induced changes in immune parameters in peripheral 
blood leukocytes. These results suggest that the peripheral release of catecholamines is 
responsible for 2-DG-induced splenic immune alterations, whereas the peripheral release of 
catecholamine is not responsible for 2-DG-induced blood immune alterations. Furthermore, 
the neuroendocrine mechanisms responsible for splenic immune changes induced by the 
metabolic stress of 2-DG administration were the same as those involved in immune changes 
induced by physical and psychological stress. Thus, this study suggests that common 
neuroendocrine pathways exist for several types of stress-induced immunomodulations. 
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Introduction 
The glucose analogue 2-DG induces metabolic stress by preventing cellular uptake 
and utilization of glucose. In rodent studies, acute administration of 2-DG inhibited splenic 
and blood T-cell proliferation induced by Concanavalin A (Con A) and Phytohemagglutinin 
(PHA) mitogens in Sprague-Dawley rats (Lysle et al., 1988). Similar results were also 
observed in Swiss-Webster mice (Miller et al., 1994). 
Although, the administration of 2-DG to Lewis rats produced suppression of T-cell 
proliferation after one injection, after multiple (5) injections the immune suppression of 
splenic T-cell responses was attenuated, but not the suppression of blood T-cell responses. In 
addition, production of IL-I and IL-2 in peripheral blood cultures was significantly 
decreased, but not in spleen (Chou et al., 1996). This finding suggests that different immune 
compartments are uniquely affected by stress, and the regulation of the immune response in 
spleen and blood is mediated by different mechanisms. 
The mechanisms by which 2-DG exerts the immune suppressive effects is still 
unclear. Although 2-DG can affect intracellular glucose metabolism, it is unlikely that 
changes in immune ftmction are a direct effect of 2-DG. In vitro incubation of naive T-cells 
with varying concentrations of 2-DG did not result in a reduction in cell number or viability 
(Miller et al., 1994). 
An interaction between the immune, nervous, and endocrine system is most 
commonly postulated as the cause of the pronounced effects of stress on immune function 
(for review, see Madden & Felten, 1995). As a metabolic stressor, 2-DG administration has 
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been shown to alter turnover of norepinephrine in the brain (Ritter & Neville, 1976) and 
peripheral blood (Pascoe et al., 1989) and increase glucocorticoid production (Smith & Root. 
1969). Hence, neuroendocrine regulation may provide a possible mechanism for 2-DG-
mediated immune modulation. In a rat model of physical stress, catecholamines are 
responsible for splenic immune suppression, whereas adrenal hormones are responsible for 
blood lymphocyte suppression (Cunnick et al., 1990). In mice, administration of propranolol, 
a B-adrenergic receptor antagonist, does not attenuate splenic mitogen suppression induced 
by 2-DG treatment. However, inhibition of splenic T-cell proliferation is attenuated in 
hypophysectomized and adrenalectomized mice (Miller et al., 1994). Therefore, the 
mechanism by which stress modulates the interaction between the immune and 
neuroendocrine system may vary depending upon species or stressor. 
Catecholamines have an important role in the modulation of the immune system (for 
review, see Madden & Livnat, 1991). T-lymphocytes are in direct physical contact with 
sympathetic nerve endings in the spleen of rats (Felten et al.. 1985; Felton & Olschowka. 
1987). Also, P-adrenergic receptors are expressed on T- and B- lymphocytes, macrophages, 
and neutrophils (Williams et al., 1976; Fuchs et al., 1988; Abrass et al., 1985; Galant et al., 
1978). Additionally, several studies show that the blastogenic responses of lymphocytes to 
mitogens, IL-2-induced proliferation of lymphocytes, the lytic activity of cytotoxic T-cells, 
and T-cell-dependent antibody production are modulated by the stimulation of P-adrenergic 
receptor in vitro ( for review, see Madden & Livnat, 1991). Moreover, numerous studies 
provide evidence for the involvement of P-adrenergic receptors in the immunomodulatory 
effects of physical and psychological stress (Luecken & Lysle, 1992; Fecho et al., 1993). 
Thus, there is strong evidence to suggest a role for catecholamines in 2-DG-induced 
immunomodulation. 
The purpose of the current research is to examine the role of the sympathetic release 
of catecholamines in 2-DG-induced immune alteration, as measured by mitogenic responses, 
natural killer-cell activity, mononuclear cell-derived nitric oxide production, and interferon-y 
(IFN-y) production in spleen and blood. The nonselective 6-adrenergic receptor antagonist 
nadolol was used to block the binding of catecholamines to their receptors and to determine 
whether the antagonist could prevent 2-DG-induced immune alterations. This study suggests 
that catecholamines are the mechanism underlying the capacity of 2-DG-induced metabolic 
stress to influence immune cell potential in the spleen, but not in the blood, of rats. 
Materials and Methods 
Animals 
Inbred male rats of the Lewis strain (55-60 days old, 220-250 g) were purchased from 
Harlan-Sprague-Dawley laboratories (Indianapolis, Indiana). Upon arrival, the subjects were 
individually caged in a colony room where a 12-h reversed light-dark cycle was maintained 
through artificial illumination. They received firee access to both food and water throughout 
the experiment, except as noted, and a 2-week acclimation period before the experimental 
manipulation. Additionally, animals were handled every two days to prevent the hyper­
reactivity that occurs when they are lefit untouched for a prolonged period. All animal 
manipulations were approved by the Iowa State University Committee on Animal Use. 
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Reagents and Chemicals 
The assays employed two kinds of culture media: "supplemented mediimi" refers to 
RPMI-1640 supplemented with L-glutamine (2 mM), gentamicin (50 jig/ml), and Hepes (10 
mM)(Gibco Lab., Grand Island, NY), and "complete medium" refers to"supplemented 
medium" containing 10% Fetal Bovine Senun (FBS) (JHR Biosciences, Lenexa. KS). The 
mitogens Con A, and Lipopolysaccharide (LPS) from Escherichia.coli were purchased from 
Sigma (St. Louis, MO), and PHA was purchased from Burroughs Wellcome (England). 
Heparin (100 units/ml, ELKINS-SINN, NJ) and 2-DG (Sigma) was diluted in Hanks' 
Balanced Saline Solution (HBSS)(Gibco Lab.). All cultures were prepared in flat-bottomed 
96-welIs tissue culture plates (Costar. Cambridge, MA). [^Hjthymidine (specific activity 6.7 
Ci/mmol), and Chromium (specific activity 16.45 GBq/mg(Cr)) from Dupont-New 
England Nuclear (Wilmington, DE) were used as specified below. 
Experimental Paradigm: Nadolol and 2-D Treatments 
Animals were treated with nadolol, a P-adrenergic receptor antagonist 2 hr into the 
dark phase of light-dark cycle. Rats were randomly assigned to one of four nadolol treatment 
groups (6 rats/group),which received subcutaneous (SC) nadolol (0, 0.05, 0.1, or 0.5 mg/kg 
body wt) (The SQUIBB Instimte, Princeton, NJ). Nadolol, a form of propranolol (cis-5[3-
[(Ll-dimethylethl) amino]-2 hydroxy-propoxy]-l,2,3,4-tetrahydro-2,3-naphthalenediol) that 
does not cross the blood-brain barrier, was dissolved in dimethyl sulfoxide (DMSO), diluted 
in HBSS and administered. The vehicle control (0 mg/kg nadolol) for the receptor 
antagonists was an equal volume of HBSS/1% DMSO. 
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2-DG (500 mg/kg, SC) or saline (HBSS, equivolume) was administrated thirty 
minutes after the nadolol injection to subgroups of each nadolol treatment. A non-injected 
control group consisted of animals without nadolol, saline, or 2-DG injections. Animals were 
sacrificed 60 min after their last injection, as previously described (Chou et al.. 1996). The 
sixty minute time course was chosen to enable a comparison of stressor induced changes with 
the physical stress model of shock (16 shocks in 64-min session) (Lysle et al., 1987). 
Tissue Collection and Preparation of Leukocytes 
Blood and Plasma Blood (5 ml) was collected from the abdominal aorta through 21-
gauge needles into heparinized (100 units/ml blood) syringes. One milliliter was aliquoted to 
a microcentriftige tube to separate plasma for the glucose assay, and another one milliliter 
was aliquoted for the corticosterone assay. The remaining blood was diluted to a final 
dilution of 1:20 with supplemented media for use in mitogen stimulation assay, nitric oxide 
assay, and IFN-y induction. The leukocyte count/ml was determined by using the Celltrak-2 
(NOVA Biomedical, Waltham, MA) prior to blood dilution. 
Spleen The spleens were removed and placed in preweighed polypropylene tubes 
containing 8 ml of complete medium. Immediately after removal from the body, each organ 
was weighed to the nearest mg. Each subject's spleen was dissociated into a single-cell 
suspension by grinding the spleen between the frosted ends of two glass slides. The single-
cell suspension was collected after 10 min of unit gravity sedimentation to remove cell debris 
and clumps. Subsequently, the splenocyte suspensions were enumerated by using a Celltrak 
2 cell-analyzer to determine the total leukocyte count per organ. 
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Plasma Glucose Assay 
The level of glucose present in the plasma was measured by two methods: one was 
based upon the glucose oxidase (Trinder) reaction, which detects endogenous glucose and 2-
DG, and the second was based upon the hexokinase (HK) reaction, which detects only 
endogenous glucose (Sigma. St. Louis. MO). For all subjects, plasma was obtained from 
whole blood by centrifugation (12,000 rpm/5 min) and stored at -70OC until assayed. The 
samples were tested in duplicate and read at 505 nm for the Trinder and 340 nm for the HK 
assay with a spectrophotometer (UVIKON 930, Kontron Instruments AG, Switzerland). A 
glucose standard curve was performed with each assay, and sample glucose concentrations 
were calculated based upon linear regression analysis of the standard. 
Plasma Corticosterone Assay 
Plasma (0.5 ml) was collected as described previously. The level of corticosterone 
present in the plasma was determined by a competitive radioimmunoassay sensitive to 0.2 
|ig/dl corticosterone (Murphy 1967; Lysle et al., 1990). 
Mitogen Stimulation Assay 
The mitogen assay was performed with splenic and blood leukocytes to assess 
lymphocyte proliferation. Con A and PHA were used as T-lymphocyte mitogens, and LPS as 
a B-Iymphocyte mitogen, as described previously (Cunnick et al., 1990). 
Natural Killer-Cell Assay 
Natural killer-cell activity was assayed in the splenocyte suspensions using the NK 
sensitive tumor target YAC-l, as previously described (Cunnick et al., 1990). Radioactivity 
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in supematants was determined by using a gamma counter (Gamma Trac 1191, TM 
Analytic, ElkGrove Villageinc, IL). Lytic units (LU) were calculated by using a computer 
program based on the equations of Pross and Maroun (1984). The percent cytotoxicity at all 
effector:target ratios was utilized to determine LU. Lytic units were based on the number of 
leukocytes per 10^ effectors necessary to lyse 20% of targets. 
Nitric Oxide Assay 
Supematants were harvested from cultures of mitogen-stimulated lymphocytes before 
pulsing with thymidine. The nitric oxide concentrations were determined by measuring 
nitrite in a micropiate assay (Stuehr and Nathan, 1989). Sample aliquots (50 |il) were mixed 
with 100 nl of Griess reagent (0.5% sulfanilamide/0.05% naphthylethylene diamine 
dihydrochloride/2.5% H3PO4) and incubated at room temperature for 10 min. The optical 
density was measured in an ELISA microtiter plate reader (BIO Kinetics Reader, BIO-TEK 
Instruments. Winooski, VT) at 550 nm against PBS as a blank. A sodium nitrite (NaN02) 
standard curve (0-100 |iM) was generated in parallel. Results are expressed as the mean of 
nitrite concentrations in the supematants of triplicate wells and analyzed as repeated-
measures analysis of variance (ANOVA) by using the no-mitogen control and all 
concentrations of a given mitogen. 
IFN-y Induction and Assay 
The level of IFN-y in the crude supematants of Con-A-stimulated spleen and 
peripheral blood lymphocytes was measured. Whole spleen leukocytes (2.5 x 1 O^/ml) were 
incubated in complete medium and Con A (3 fig/ml) for 48 hours, and whole blood 
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leukocytes (1:20 dilution) were incubated in supplemented medium and Con A (10 |ig/ml) 
for 72 hr; both were at 370C in 5% C02- Culture supematants were harvested and stored at -
70OC until the assay (Johnson et al., 1981). IFN-y was determined by means of a commercial 
ELISA assay for rat IFN-y (GIBCO BRL. Life Technologies, Gaithersburg. MD). Titers 
were determined by comparison to a provided IFN-y standard, which is calibrated to an 
international reference standard (Sonnenfeld et al., 1992). 
Statistical Treatment of Data 
A computerized program for ANOVA (Statistix, NH Analytical Software) was used 
to assess differences among experimental and control groups. For the present experiment to 
assess the effects of nadolol administration on attenuation of acute stress effects of 2-DG. a I 
X 9 ANOVA was used to determine the overall effects of treatments and means square error 
(M.S.E.) for all data. Contrasts were designed to provide a 2 (stress) x 4 (nadolol dose) + 1 
(no injection control vs. saline injection control) of the 9 groups. There were two levels of 
stress (2-DG injection and saline injection) and four levels of nadolol (0, 0.05. 0.1. and 0.5 
mg/kg), except where noted. The level of significance for the F test was set at P < 0.05. 
Results 
Plasma Corticosterone Level 
An elevated level of plasma corticosterone provided an indicator of stress (Table 1). 
Overall ANOVA indicated a significant effect of the treatments. F(8,41) = 36.40,/? < 0.0001. 
All groups that received 2-DG had a marked increase of plasma corticosterone (mean = 
47.31 ± 0.287 mg/dl across all doses of nadolol) in comparison with the saline injection 
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groups, F(l, 41) = 273.90,/? < 0.0001. There were no other significant differences among the 
groups. These findings indicate that the p-adrenergic receptor antagonist, nadolol, does not 
modulate the production of corticosterone induced by stress. 
Endogenous Plasma Glucose and Plasma 2-DG Levels 
The glucose oxidase method was used to measure total plasma glucose (endogenous 
glucose and 2-DG), whereas the hexokinase reaction provided a measure of endogenous 
glucose alone. The difference between the assays indicates the level of plasma 2-DG. The 
mean plasma level of 2-DG was 35.41 mg/dl one hour after injection for all 2-DG-treated 
groups and did not differ significantly among groups which received 2-DG. All groups that 
received 2-DG (500 mg/kg) injections had a significant increase in endogenous plasma 
glucose in comparison with the saline treated group (Table 1). Analysis of plasma glucose 
levels showed a significant difference among the groups, F(8,41) = 124.90, p < 0.0001. 
Orthogonal contrasts revealed a significant increase due to the 2-DG treatment, F(l, 41) = 
859.66,/? < 0.0001, and a significant interaction between 2-DG and nadolol treatments, F (3. 
41) = 3.74,/? < 0.02. The interaction had a significant linear effect, F (1, 41) = 6.86,/? < 0.02. 
with the highest glucose at the 0 mg/kg dose of nadolol. However, comparison of the no-
injection control group with the saline/nadolol (0-0.5 mg/kg) control group showed no 
significant effect of the injection procedure. 
Leukocyte Counts 
The number of leukocytes in spleen and peripheral blood were determined, and the 
results are shown in Table 2. Enumeration and analysis of total splenic leukocytes showed 
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no significant difference between 2-DG-treated and control rats (grand mean = 4.10 x 10® 
leukocytes/spleen). Overall analysis of blood leukocytes showed a significant difference 
among the groups, F(8,41) = 12.07,/? < 0.0001. Orthogonal contrasts indicated that the 
stress of 2-DG injection reduced blood leukocytes in comparison with the saline treatment. 
F(l. 41) = 162\,p< 0.0001. There was no dose effect of nadolol on blood leukocyte 
number. There was, however, a marginal interaction between 2-DG and nadolol treatments. 
F(3. 41) = 2.656, p < 0.07. The disparity of changes in leukocyte numbers in the spleen and 
blood further emphasizes the differences in stress-induced mechanisms of change in these 
two lymphoid organs. 
Natural Killer-Cell Activity 
The natural killer-cell function of splenic leukocytes was measured by using four 
effector to target ratios and was analyzed as Lytic Units (LU) with the results displayed in 
Table 2. Although there was no significant overall effect of treatment, orthogonal contrasts 
of the pre-planned 2x4 analysis showed that 2-DG treatment significantly decreased the 
natural killer activit)-' in comparison with the saline treated groups, F(l, 41) = 12.460,/? < 
0.001. There was no significant difference between the no-injection control group and 
saline/nadolol control group. In addition, there was, no main effect for nadolol, nor was there 
a significant interaction of 2-DG with nadolol. Thus, the administration of nadolol did not 
attenuate the 2-DG-induced suppression of natural-killer cell activity. 
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Mitogen Stimulation 
Spleen assay. The mitogen stimulation assay using splenic lymphocytes showed 
comparable effects for all concentrations of Con A, PHA, and LPS. Only the results of the 
spleen mitogen assay using the optimal concentration of Con A (3 |ig/ml) and LPS (2.5 
|ig/ml) have been displayed in Figure 1 (A & B) as representative data. Except where noted, 
the PHA data (not shown) was similar to that for Con A stimulation as both are T-cell 
mitogens. Overall ANOVA of optimum concentrations showed a significant difference 
among the groups, F(8,41) > 2.60, p < 0.03. Comparison of the no-injection control group 
with the nonstressed control animals, injected with saline/nadolol (0-0.5 mg/kg), showed no 
significant effect of the injection procedure except in LPS, F(l, 41) = 12.67, p < 0.002. There 
was a significant 2-DG-induced suppression of mitogen proliferation, F(1,41) > 7.80, p < 
0.01. Contrasts demonstrated a significant quadratic dose effect of nadolol for Con A F( 1. 
41) = 4.161. /? < 0.05, whereas contrasts demonstrated a significant linear effect of nadolol 
dose for PHA, F(l, 41) = 19.71.p < 0.0001, which resulted in increased mitogen proliferation 
with increased nadolol dose. Additionally, the mitogen assay for PHA showed a significant 
interaction between 2-DG treatment and nadolol injection, F(3,41) = 3.87, p < 0.02, whereas 
the assay for Con A showed a marginal interaction of 2-DG treatment and nadolol injection. 
F(3,41) = 2.32, p < 0.09. These interactions were due to a significant amount of suppression 
caused by 2-DG in the 0 mg/kg dose of nadolol, which was attenuated in the 0.1 mg/kg dose 
of nadolol. However, assay for LPS stimulation showed no dose-dependent effect of nadolol 
and no interaction between 2-DG and nadolol. 
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Whole-blood assay. The effect of nadolol on the proliferation of blood leukocytes in 
response to Con A and PHA was examined. The results of the blood mitogen assay using the 
optimal concentration of Con A (10 ^ig/ml) is displayed in Figure IC. Overall ANOVA 
showed a significant difference among the groups, F(8,41) > 19.40,/? < 0.0001. A contrast 
of the no-injection control group with the saline/nadolol group showed no significant effect 
of the injection procedure. The analysis revealed a significant suppressive effect of the 2-DG 
treatment on the lymphocyte response to Con A, F(l, 41) = 264.71,/? < 0.0001, and to PHA. 
F(l. 41) = 120.30,/? < 0.0001. However, there was no attenuation of the suppression by 
nadolol treatment nor an interaction between 2-DG and nadolol. 
Nitric Oxide (NO) Production 
Spleen. NO production was measured by converting NO to the more easily detectable 
form nitrite. The results of nitrite assays of supematants fi-om spleen mononuclear cells 
stimulated with the optimal concentration of mitogen Con A (3 |ig/ml) or LPS (2.5 |ig/ml) are 
displayed in Figure 2, panels A & B, respectively. Nitrite production by PHA (5 (ig/ml) 
stimulated splenocyte cultures was also examined (data not shown) and provided results 
similar to those for Con A. Overall ANOVA of nitrite induced by all mitogens showed 
significant differences among the groups, F(8,41) > 3.60. P < 0.003. Comparison of the no-
injection control group with the nonstressed control group animals that received 
saline/nadolol (0-0.5 mg/kg) treatment showed no significant effect of the injection 
procedure. 
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Analysis of orthogonal contrasts revealed that the groups that received 2-DG/nadolol 
(0-0.5 mg/kg) had significantly increased nitrite production compared with the saline/nadolol 
(0-0.5 mg/kg) control groups. F(1,41) > 6.20,p< 0.02. The analysis also showed a linear 
effect of nadolol injection, F(3,41) > 5.32, p < 0.004, in which nitrite production was 
decreased in a dose-dependent manner by nadolol, F(l. 41) > 12.67,p < 0.001. In addition, 
there was a significant interaction between 2-DG and nadolol in Con-A-stimulated splenocyte 
cultures. F(3. 41) > 2.84./? < 0.05. which indicates that nadolol reversed the 2-DG-induced 
increase in nitrite production. 
Whole blood. Nitrite assays of supematants fi-om whole blood cultures stimulated 
with the optimal concentration of mitogen Con A (10 mg/ml) (Fig. 2C) and PHA (5 |ig/ml) 
(data not shown) demonstrated similar results. Overall ANOVA of nitrite production showed 
a marginal difference among the groups, F(8,41) > 2.07, p < 0.07, for Con A and PHA. 
Comparison of the no-injection control group with the saline/nadolol (0-0.5 mg/kg) 
nonstressed animals showed no significant effect of the injection procedure. Analysis 
revealed that 2-DG treatment significantly increased the nitrite production in comparison 
with saline injection treatment, F(l. 41) = 6.76, P < 0.02. However, there was no effect of 
nadolol nor significant interaction between 2-DG and nadolol. 
IFN-y Production 
The results of IFN-y assays of spleen and blood are displayed in Figure 3, panel A & 
B, respectively. Since 2-DG-induced changes in splenic mitogen responses and mononuclear 
cell-derived nitric oxide production were attenuated equally by 0.1 and 0.5 mg/kg nadolol. 
92 
effects of three levels of nadolol (0,0.05, 0.1 mg/kg) on IFN-y production were examined in 
the spleen. Overall statistical analysis of IFN-y production by splenocytes (Fig. 3 A) 
demonstrated a marginally significant effect among the groups, F(8.21) = 2.53, p < 0.06. 
Comparison of the no-injection control group with the nonstressed control group that 
received saline/nadolol treatment showed no significant effect of the injection procedure. 
The analysis revealed a significant decrease in IFN-y production in 2-DG/nadoIol-(0-
0.1 mg/kg) injected animals in comparison with saline/nadolol-injected animals, F(1.21) = 
10.63, p < 0.004. Analysis of 2-DG and saline groups at each concentration of nadolol 
showed a significant decrease in IFN-y production in groups injected with 2-DG + 0 mg/kg 
nadolol, F(l, 21) = 8.64,/? < 0.01, a marginal decrease in IFN-y in groups injected with 2-DG 
+ 0.05 mg/kg nadolol, F(l. 21) = 3.61, p < 0.08, and no significant effect in groups injected 
with 2-DG + 0.1 mg/kg nadolol. These results demonstrate that nadolol attenuated the 2-DG-
induced suppression of IFN-y production. There was no significant interaction between 2-DG 
and nadolol. 
Analysis of the production of IFN-y by peripheral blood lymphocytes (Fig. 3B) 
showed a significant difference among the groups, F(8, 27) = 10.45,/? < 0.0001. There was 
no significant effect of the injection procedure as there was no difference between the no-
injection control group and the nonstressed, saline/nadolol control group. Moreover, the 
analysis indicates a significant decrease in IFN-y production in 2-DG-injected animals in 
comparison with saline-injected animals. F(l. 27) = 68.89, p < 0.0001. There was no effect 
of nadolol, nor an interaction between stress and nadolol injection. 
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Discussion 
The present research examined the mechanism underlying the immunomodulatory 
effects induced by an acute injection of 2-DG. It had been argued that the inhibition of T-cell 
proliferation is caused by 2-DG-induced cytolytic and cytotoxic activity. Previously. Michl 
et al. (1976) had shown that 2-DG is not toxic to leukocytes, such as macrophages and 
phagocytes. Miller et al. (1994) also provided evidence that in vitro incubation of murine T-
cells with varying concentrations of 2-DG does not result in a reduction in cell number or 
viability. As mentioned previously. 2-DG may have an inhibitory effect on mitogenic 
stimulation simply by blocking the lymphocyte's utilization of glucose. However, results 
from the present study demonstrated that the suppression of mitogenesis is not due to a 
blockage of lymphocyte glucose utilization because the suppression of the splenic 
lymphocyte response to Con A, PHA, and LPS mitogens could be prevented by subcutaneous 
administration of nadolol, a nonselective P-adrenergic receptor antagonist. In addition, 
nadolol prevented 2-DG-induced suppression of splenic IFN-y production and increase in NO 
production. Because nadolol does not cross the blood-brain barrier (Antonaccio & 
DeForrest, 1981), these findings indicate that 2-DG-induced immune suppression of splenic 
lymphocytes is due to catecholamines released from peripheral sympathetic neurons. 
Enhancement of splenic NO production is found in other stress models (Fecho et al.. 
1994; Lysle. et al., 1995). In addition, NO production has been causally linked to the 
suppression of splenic mitogen responses (Mills. 1991; Lysle et al., 1995). Thus, in the 
spleen, it is not surprising to find a mechanism that attenuates suppressed mitogen responses 
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and increased NO production. As IFN-y can up-regulate NO production, it is interesting that 
increased NO suppresses T-cell production of IFN-y as negative feedback control. 
Acute 2-DG administration also induced changes in peripheral blood blastogenesis. 
IFN-y production, and NO production. However, nadolol administration was unable to 
attenuate these effects. Although splenic and peripheral blood leukocytes (PBL) possess P-
adrenergic receptors, it is not surprising to find that catecholamines released during stress do 
not affect PBL responses. The concentration of catecholamines is expected to be much 
higher in the area surrounding the neuronal terminus, and re-uptake mechanisms are active 
for unbound catecholamines. Moreover, the concentration of catecholamines in plasma 
decreases rapidly owing to the plasma volume of blood. 
In the current study, the suppression of splenic natural killer (NK) cell activity was 
not prevented by nadolol administration. This outcome suggests that 2-DG-induced 
suppression of NK cell activity is not modulated by a sympathetic pathway. Another study 
also reported that morphine-induced suppression of NK cell activity was not attenuated by 
nadolol (Fecho et al., 1993). Together, these studies support work indicating that NK 
function is altered via opioid binding (Shavit et al., 1984). However, this is in contrast to 
work by Irwin et al. (1991) in humans and rats, which indicates a regulation of NK function 
by norepinephrine. Therefore, the regulation of NK fianction may occur through multiple 
immunomodulatory mechanisms that are dependent on the animal species or type of stress. 
It has been reported that administering the P-adrenergic receptor antagonist 
propranolol did not reverse the inhibited T-cell proliferation of splenocytes in 2-DG-treated 
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mice (Miller et al., 1994). The difference in results between this mouse study and the current 
study could be explained by the different route of 2-DG administration used (subcutaneous in 
the current study and intravenous in the mouse study), the different P-adrenergic receptor 
antagonists used, and/or dosages of p-blocker used (multiple doses of nadolol were evaluated 
in the current study and a single dose of propanolol was used in the mouse study). In 
addition, the responses of IFN-y production in rats and mice exposed to physical stress differ 
(Berry et al., 1991; Rose et al., 1984). Hence, there may exist differences in the way that rats 
and mice respond to this stressor. 
Current results also indicate that acute 2-DG injections induced a reduction in total 
blood leukocytes. This change was not attenuated by nadolol. These findings suggest that P-
adrenergic receptors are not involved in the altered trafficking of blood leukocytes. It has 
been reported that adrenal glucocorticoids released during stress may play a key role in 
regulating redistribution of leukocytes between the blood and other immune organs (Dhabhar 
et al., 1995). Nevertheless, the relationship between adrenal hormones and 2-DG-induced 
immunomodulation in the blood was not examined in the present paper. 
Although the mechanism of 2-DG-induced immune alterations of blood lymphocytes 
is probably not via P-receptors or by catecholamine release, some reports suggest a possible 
relation between immune suppression and adrenal cortical hormones (Cupps & Fauci, 1982; 
Kelso & Munck, 1984). Additionally, Cunnick et al. (1990) have reported that adrenal 
hormones are responsible for shock-induced suppression of blood mitogenic responses. 
Alternatively, the peripheral blood system is enriched with several circulating hormones that 
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are produced during periods of metabolic stress (Ritter & Neville, 1976; Pascoe et al.. 1989; 
Smith & Root, 1969) and have the capacity to modulate the activity of peripheral blood 
lymphocytes (Byron, 1972). Therefore, our laboratory is currently investigating the 
involvement of adrenal hormones in the 2-DG-induced immunomodulatory effects in the 
blood. 
In conclusion, the results of the present smdy clearly demonstrate that peripheral p-
adrenergic receptors and catecholamines are involved in 2-DG-induced effects on the 
proliferative responses of leukocytes to mitogens, on nitric oxide production, and on IFN-y 
production in the spleen, but are not involved in 2-DG-induced changes in leukocyte ftinction 
in the blood. These findings indicate that immmie suppression in blood and splenic 
lymphocytes are mediated by separate pathways. Hence, the current study, associated with 
previous work, supports evidence that different mechanisms are operating in stress-induced 
immune changes. In addition, these findings suggest that the metabolic stress of 2-DG 
administration induces immune modulation of splenic lymphocytes via mechanisms similar 
to physical, psychological, and morphine-induced stress (Cunnick et al., 1990; Luecken & 
Lysle. 1992). That similitude is important because it implicates a concept that different types 
of stressors can induce similar outcomes of immune modulation and there may exist a 
common neuroendocrine pathway to respond to stress exposure. Many illness are considered 
stressors and induce metabolic changes that are stressful; but it is difficult to remove the 
immunomodulatory effects of infection from those of the metabolic stress of illness. This 2-
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DG model of metabolic stress presents a means to examine the metabolic stress of illness and 
provides reproducible results for comparison with other types of stressors. 
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Table 1. Effect of nadolol dosage on plasma corticosterone, endogenous glucose, and 2-DG levels in rats receiving 2-DG, saline, 
or noinjections. 
Nadolol (mg/kg) ° 
0 
Corticosterone (ng/dl) 
Saline'' 9.6±2.7 " 
2 - D G 4 7 . 8 ± 2 . 6  
Noinjection = 17.0±4.5 
0.05 0.1 
5.3±2.6 
46.3±5.0 
14.2±2.7 
48.4±3.3 
0.5 
12.2±3.2 
46.7±2.5 
Endogenous glucose (mg/dl) 
Saline 127.1±4.2 
2-DG 295.2±8.5 
Noinjection = 119.3±2.4 
133.0±5.2 
267.0±7.6 
122.4±3.6 
271.7±6.8 
130.9±6.5 
255.5±12.8 
2-DG (mg/dl) 
Saline 
2-DG 
Noinjection = 0 
0 
41.7±10.2 
0 
24.4±12.5 
0 
33.1±5.9 
0 
42.4±ll.2 
a. Nadolol or nadolol vehicle (HBSS/2% DMSO) was injected subcutaneously 30 min prior to 2-DG exposure. 
b. Rats received 500 mg/kg of 2-DG (stress group) or of saline (control group). 
c. The no-injection group served as a baseline control. 
d. Results are expressed as the mean ± SB; n = 4-6/group. 
Table 2. Effect of naiolol dosage on total leukocyte counts for the spleen, leukocytes per milliliter of blood, and splenic 
natural killer-cell activity for animals receiving 2-DG, saline, or noinjections. 
Nadolol (nig/kg)" 
0 005 Ol ^ 
Leukocyte counts/spleen (x 10 
Saline ^ 442.3±29.9 d 
2-DG" 445.7±20.6 
Noinjection = 396.3±34.5 
Leukocyte counts/ml blood (x 10 
Saline 5.0±0.2 
2-DG 2.5±0.3 
Noinjection = 5.2±0.5 
Splenic natural killer-cell activity ' 
Saline 24.9±06 
2-DG 9.3±0.4 
Noinjection = 17.2±2.3 
a. Nadolol or nadolol vehicle (HBSS/2% DMSO) was injected subcutaneously 30 min prior to 2-DG exposure. 
b. Rats received 500 mg/kg of 2-DG (stress group) or of saline (control group). 
c. The no-injection group served as a baseline control. 
d. Results are expressed as the mean ± SE; n = 4-6/group. 
e. Results are expressed as the mean (± SE) of LU (20%)/10 ; n = 4-6/group 
428.9±17.3 
403.9±20.6 
391.3±19.9 
384.0±29.1 
414.6±31.6 
379.5±32.7 
5.6±0.4 
2.7±0.3 
4.7±0.3 
3.4±0.3 
5.0±0.3 
3.4±0.4 
27.7±6.9 
9.6±0.7 
23.2±9.8 
12.4±1.2 
19.8±4.7 
8.7±0.5 
Figure 1. Proliferative responses of splenic leukocytes and peripheral blood leukocytes to the 
optimal concentrations of mitogens Con A and LPS as noted in panels A-C. Rats 
were injected subcutaneously (SC) with the vehicle (HBSS/2% DMSO,) or with 
0.05, 0.1, or 0.5 mg/kg nadolol 30 min. before stress manipulation. Each stress rat 
received a 500 mg/kg 2-DG injection and nonstressed controls received saline 
injections. The no-injection group remained in the home cage. Results are 
expressed as the mean (± SE) of count per min; n=4-6/grp. 
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A: Spleen-Con A (3 fig/ml) 
B: Spleen-LPS (2.5 ^ g/ml) 
C: Blood-Con A (10 ^g/mi) 
NO INJ 0.00 0.05 0.10 0.50 
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^ No injection control 
• 2DG (500 mg/kg) 
• Saline 
Figure 2. Production of nitric oxide by splenocyte cultures and peripheral blood leukocyte 
cultures incubated with the optimal concentration of mitogens Con A and LPS as 
indicated in panels A-C. Nitrite was measured as an indicator of nitric oxide 
production in the supernatant of the mitogen induced blastogenesis cultures (Fig. 
1). Rats were injected subcutaneously (SC) with the vehicle (HBSS/2% DMSO) or 
with 0.05, 0.1, or 0.5 mg/kg nadolol 30 min before stress manipulation. Each 
stress rat received a 500 mg/kg 2-DG injection and nonstressed controls received 
saline injections. The no-injection group remained in the home cage. Results are 
expressed as the mean (± SE) of count per min; n=4-6/grp. 
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A: Spleen-Con A (3 ^ g/ml) 
B: Spleen-LPS (2.5 Mg/mi) 
^ No injection control 
• 2DG (500 mg/kg) 
* Saline 
C: Blood-Con A (10 |iig/ml) 
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Figure 3. Interferon-y (IFN-y) production by splenocytes and peripheral blood leukocytes 
stimulated with the mitogen Con A (3 [ig/ ml for spleen and 10 |ag/nil for blood). 
Rats were injected subcutaneously (SC) with the vehicle (HBSS/2% DMSO) or 
with 0.05, 0.1, or 0.5 mg/kg nadolol 30 min before stress manipulation. Each 
stress rat received a 500 mg/kg 2-DG injection and nonstressed controls received 
saline injections. The no-injection group remained in the home cage. Results are 
expressed as the mean (± SE) of units/ml (1 unit = 250 pg.); n=4-6/grp. 
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CHAPTER 4. ADRENAL HORMONES ARE RESPONSIBLE FOR 2-DG-INDUCED 
IMMUNOMODULATORY EFFECTS IN THE BLOOD 
A paper submitted to Journal of Neuroimmunology 
Shiu-Huey Chou and Joan E. Cunnick 
Abstract 
Administration of 2-DG induces the secretion of several hormones including 
glucocorticoids and catecholamines. Although peripheral release of catecholamines is 
involved in 2-DG-induced immune modulation of splenocytes, they are not responsible for 2-
DG-induced immune alterations of peripheral blood leukocytes. In this study, 2-DG 
administration to adrenalectomized, sham operated, and unoperated rats demonstrated that 
adrenalectomy prevented the 2-DG-induced leukopenia and suppression of the mitogenic 
responses of peripheral blood leukocytes, but did not attenuate the changes of splenic 
lymphocytes. Furthermore, adrenalectomy attenuated the 2-DG-mduced suppression of IL-2, 
IFN-y, and TNF production by Con A-stimulated peripheral blood leukocytes (PBL). 
Conversely, the TNF production by stimulated splenocytes was enhanced in 2-DG treated 
rats, and this enhancement was exacerbated in ADX rats. These results indicated that adrenal 
hormones mediate 2-DG-induced immunomodulation PBL. In addition, it is likely that the 
stress-induced release of adrenal hormones serves to prevent an exaggeration of immune 
responses. 
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1. Introduction 
The immune system is regulated not only by cytokines and leukocytes, it 
communicates bidirectionally with the nervous system and endocrine system throughout the 
body, which leads to complex networks of systemic regulation (Blalock, 1994; Savino and 
Dardenne, 1995). In addition, stress-induced alterations of immune parameters provide 
strong evidence for an interaction between the immune and central nervous system. In 
general, the sympathetic nervous system and hypothalamic-pituitary-adrenal pathway are the 
two major mediating components of neuroendocrine-immune interaction. This is supported 
by ample anatomic and pharmacological evidence (for review see Madden and Felten, 1995). 
Maintenance of homeostasis within the immime system is a function of both pathways. 
The hypothalamic-pituitary-adrenal (HPA) axis is a primary pathway underlying 
stress-induced immunomodulation. Exposure to stress leads to an increased output of the 
hypothalamic-pituitary-adrenal axis (HPA) and changes in the immune system through the 
effects of glucocorticoids (Axelrod and Reisine, 1984). Furthermore, an elevated 
glucocorticoid concentration in the plasma is an indicator of stress. Glucocorticoids are 
involved in regulating many physiological fimctions including glucose metabolism, water 
balance, hepatic nutrition, neurological activity, and cardiovascular circulation. The effects 
of glucocorticoids on the immune system are very diverse and have been extensively 
reviewed (Munck et al., 1984; Bateman et al., 1989, Madden and Felten, 1995). In the past, 
glucocorticoids were recognized as immune suppressors more than immune regulators. For 
example, glucocorticoids cause leukopenia and neutrophilia, reduce the production of several 
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cytokines, inhibit NK cell activity, and suppress T-cell proliferation (Munck et al., 1984). 
Moreover, glucocorticoids have been identified as key mediators in certain inflammatory and 
autoimmune diseases (Sternberg, 1992; Wick, et al., 1993). Recently, the action of 
glucocorticoids in immune regulation has been re-evaluated. In fact, glucocorticoids may act 
in both positive and negative ways in immune regulation (Munck and Naray-Fejes-Toth, 
1994). Although many actions of glucocorticoids are deemed "inunune suppression," in 
actuality glucocorticoids may serve to shift an immune response firom cellular (THi) to a 
humoral (TH2) response (Derijk and Sternberg, 1994; Brinkmann and Kxistofic, 1995; 
Ram'irez et al., 1996). Hence, stress-induced elevation of glucocorticoids may serve as a 
regulator to maintain the homeostasis of the immune system. 
Administration of 2-deoxy-D-gIucose (2-DG), a metabolic stressor, has been reported 
to alter immune parameters in mice, rats, and humans (Breier et al., 1987; Lysle et al., 1988; 
Miller et al., 1993, 1994; Chou et al., 1996). Administration of 2-DG to rats induces changes 
in immune response that are kinetically different in the spleen and blood. For example, IL-1 
and IL-2 production were suppressed in the blood, but not in the spleen. Additionally, the 
suppression of mitogen-stimulated lymphocyte proliferation is attenuated after repeated 2-DG 
injections in the spleen, but not in the peripheral blood. This suggests that more than one 
mechanism is responsible for 2-DG-induced immune changes. 
Administration of 2-DG induces all the hallmarks of a stressor (Smythe et al., 1989) 
including increased epinephrine, norepinephrine, and glucocorticoid production (Ritter and 
Neville, 1976; Pascoe et al., 1989; Smith and Root, 1969). Extended investigations in our 
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laboratory indicate that the peripheral release of catecholamines is responsible for 2-DG-
induced immunomodulation in the spleen. Subcutaneous administration of nadolol, a 
nonselective P-adrenergic receptor antagonist prevents 2-DG-induced changes in splenic 
immune function, however, nadolol does not attenuate the 2-DG-induced changes in immune 
parameters in peripheral blood (Chou et al., submitted). These findings indicate that another 
mechanism such as glucocorticoid release, is involved in 2-DG-induced immunomodulation 
of PBL fimction. Administration of exogenous glucocorticoids induces lymphopenia and 
alteration in cell trafficking (Hall, 1986), also seen with 2-DG administration (Chou et al.. 
1996). In addition, adrenal hormones are involved in suppression of PBL function induced 
by electric shock (Cunnick et al., 1990). Stress-induced lymphopenia is prevented in 
adrenalectomized rats and reduced by a glucocorticoid synthesis inhibitor (Keller et al., 1983; 
Dhabhar et al., 1995, 1996). 
As nadolol administration prevented epinephrine and norepinephrine from binding to 
P-adrenergic receptor, but did not alter 2-DG effects on PBL fimction. we posmlated that 
glucocorticoids were responsible for the observed changes. The present study was designed 
to test whether adrenal hormones are involved in 2-DG-induced immunomodulation in the 
blood. Adrenalectomy prevents the release of baseline and stress-induced glucocorticoids 
and interrupts the interaction between the HPA axis and the immune system. If the immune 
changes due to 2-DG injection do not occur in adrenalectomized group, then a mechanistic 
role for adrenal hormones is supported. 
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2. Materials and methods 
Animals 
Inbred male rats of the Lewis strain (62 days old, 220-270 g) were purchased from 
Harlan Sprague Dawley laboratories (Indianapolis, Indiana). Animals were adrenalectomized 
or sham-adrenalectomized by Harlan Sprague Dawley laboratories and shipped one week 
after surgery along with unoperated control animals of the same age. Upon arrival, the 
subjects were individually caged in a colony room in which a 12-h reversed light-dark cycle 
was maintained through artificial illumination. They received free access to both food and 
water (0.9% saline for the adrenalectomized rats) throughout the experiment except as noted, 
and a 3-week acclimation period before the experimental manipulation. Additionally. 
animals were handled every two days to prevent the hyper-reactivity that occurs when they 
are left untouched for a prolonged period. 
Reagents and Chemicals 
The culture medium used for all assays were two kinds: "supplemented media" was 
used to designate RPMI-1640, supplemented with L-glutamine (2 mM), gentamicin (50 
|j.g/ml), and Hepes (10 mM)(Gibco Lab., Grand Island, NY), and "complete media" was used 
to designate "supplemented media" containing 10% Fetal Bovine Serum (FBS) (JHR 
Biosciences, Lenexa, KS). The mitogens Concanavalin A (Con A), and Lipopolysaccharide 
(LPS)-from E.coli were purchased from Sigma Chemical. (St. Louis, MO); 
Phytohemagglutinin (PHA) was purchased from Burroughs Wellcome (England). Heparin 
100 units/ml (ELKINS-SINN, NJ) and 2-DG (Sigma Chemistry) were diluted in Hanks' 
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Balanced Saline Solution (HBSS)(Gibco Lab). All cultures were prepared in flat-bottomed 
tissue culture plates (Costar, Cambridge, MA). ^H-thymidine (specific activity 6.7 Ci/mmol). 
and ^^Chromium (specific activity 16.45 GBq/mg(Cr)) from Dupont-New England Nuclear 
(Wilmington, DE) were used as specified in the following section. 
Experimental Paradigm 
To determine the role of glucocorticoids in 2-DG-induced immune alteration, 
adrenalectomized (ADX), sham-adrenalectomized (SHAM), or unoperated (UNOP) male rats 
were evaluated. The experiment was performed in two replications. The animals in the 
surgery-treatment groups were assigned to two subgroups (n = 6). One subgroup received a 
single injection of 2-DG, 500 mg/kg body weight, dissolved in sterile HESS. The other 
group received a single injection of sterile HESS as controls. Injection was administered 
subcutaneously and performed 2-hr into the dark phase. For 60 min following each injection 
of 2-DG or HBSS. animals were deprived of food and water. Sixty min following the 
injection, each subject was rapidly sacrificed by cervical dislocation with a clamp. 
After sacrifice, blood was collected via the abdominal aorta into heparinized syringes. 
The spleen was removed, placed in preweighed polypropylene tubes containing 8 ml of 
complete media, weighed and dissociated into a single-cell suspension. Spleen and blood 
leukocytes were enumerated (Celltrak 2, NOVA Biomedical, Waltham, MA). Splenocytes 
were diluted to 5 x 10 ^ / ml with complete media and blood was diluted 1:10 with 
supplemented media. Diluted splenocytes and blood were subsequently used for specific 
functional assays. 
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Plasma Glucose Assay 
The concentration of glucose present in the plasma was measured by two methods: 
one was based upon the glucose oxidase (Trinder) reaction, which detects endogenous 
glucose and 2-DG, and a second was based upon the hexokinase (HK) reaction, which detects 
only endogenous glucose (Sigma, St. Louis, MO). For all subjects, plasma was obtained 
from 1 ml whole blood by centrifugation (12,000 rpm/5 min) and stored at -TO^C until 
assayed. The samples were tested in duplicate and read at 505 nm for Trinder and 340 nm 
for HK assay with a spectrophotometer (UVIKON 930, Kontron Instruments AG, 
Switzerland). A glucose standard curve was performed with each assay, and the glucose 
concentration of experimental samples was calculated based upon linear regression analysis 
of the standard. 
Plasma Corticosterone Assay 
To test for the completeness of adrenalectomy and effectiveness of stress, plasma 
samples were assayed for corticosterone. Plasma samples were obtained by centrifugation of 
whole blood (1 ml) and were stored at -70 °C. Plasma corticosterone concentration was 
determined by using a standard radioimmunoassay kit for rat corticosterone (ICN, 
Biomedical, Inc., CA). The error for the corticosterone radioassay is 0.2 |ig/dl and values 
below this level, as in the ADX groups, can be interpreted as lack of corticosterone. 
Mitogen Stimulation Assay 
The mitogen assay was performed with splenic and blood leukocytes to assess 
lymphocyte proliferation. Con A and PHA were used as T-lymphocyte mitogens and LPS as 
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a B-Iymphocyte mitogen as described previously (Cunnick et al., 1990). 
Natural Killer-Cell Assay 
Natural killer-cell activity was assayed in the splenocyte suspensions by using an NK 
sensitive tumor target YAC-1 as previously described (Cimnick, et al., 1990). Radioactivity 
(Cr ^') in supematants was determined by using a gamma counter (Gamma Trac 1191; TM 
Analytic, INC., IL). Lytic units (LU) were calculated by using a computer program based on 
the equations of Pross and Maroun (1984). The percentage cytotoxicity at all effector:target 
ratios was utilized to determine LU. Lytic units were based on the number of leukocytes per 
10^ effectors necessary to lyse 20% of targets. 
Nitric Oxide Assay 
Supematants were collected from cultures of mitogen-stimulated lymphocytes before 
pulsing with thymidine to determine nitric oxide production. Nitrite concentrations were 
determined by a microplate assay as a determination of nitric oxide production (Stuehr and 
Nathan, 1989). Sample aliquots (50 |il) were mixed with 100 |il of Griess reagent ( 0.5% 
sulfanilamide / 0.05% naphthylethylene diamine dihydrochloride / 2.5% H3PO4) and 
incubated at room temperature for 10 min. The optical density was measured in an ELISA 
microliter plate reader (BIO Kinetics Reader, BIO-TEK Instruments, Winooski, VT) at 550 
nm against PBS as a blank. A sodium nitrite (NaN02) standard curve (0-100 nM) was 
generated in parallel. Results are expressed as the mean of nitrite concentrations in the 
supematants of triplicate wells and analyzed as repeated-measures ANOVA by using the no-
mitogen control and all concentrations of a given mitogen. 
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Interferon--^ (IFN-y) Induction and Assay 
The concentration of interferon in the supematants of Con-A-stimulated spleen and 
6 
peripheral blood lymphocytes was measured. Whole spleen leukocytes (2.5 x 10 /ml) were 
incubated in complete media and Con A (3 jig/ml) for 48-h and whole blood leukocytes (1:20 
dilution) were incubated in supplemented media and Con A (10 |i.g/ml) for 72-h; both at 
370c in 5% CO2. Culture supematants were harvested and stored at -TO^C until the assay 
(Johnson et al., 1981). IFN-y was determined by means of a commercial ELISA assay for rat 
IFN-y (GIBCO BRL Life Technologies, Gaithersburg, MD). Titers were determined by 
comparison to an IFN-y standard supplied with the kit. Data is reported as units/ml (1 unit = 
250 pg./ml) 
Interleukin-2 Induction and Assay 
Interleukin-2 (IL-2) is a T-cell growth factor produced by stimulated T-lymphocytes. 
The culture supematants for measuring IL-2 production by splenocyte and blood leukocytes 
were obtained as for the IFN-y assay. Supematants obtained from nonstimulated cultures 
served as "media control." On the assay day, the supematants and a positive IL-2 control 
were serially diluted 1:2 (total of five dilutions) in duplicate in a 96-well microtiter plate by 
using a digital multichannel pipette (Titertek-PIus). The IL-2-dependent cell line, CTLL-2, 
was washed to remove any exogenous IL-2 and was then diluted in complete media to 1 x 
5 
10 /ml. The CTLL-2 cell suspension (100 |j,l) was plated in each well and in control wells 
containing no IL-2. The plates were incubated for 24 hr at 27°C in a humidified atmosphere 
of 5 % C02. Each well was pulsed with 1 ^Ci of H-thymidine (50 |il) for the last 5 hr of 
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the incubation. The cultures were harvested (Skatron Harvester, Model #11028, Sterling, 
VA), and the thymidine incorporation was determined using a liquid scintillation counter 
(1217 Rackbeta, LKB-Wallac, Finland). Half-max. units were calculated with software from 
Lilly Research Laboratories. 
Tumor Necrosis Factor (TNF) Assay 
TNF production by stimulated splenic or blood leukocytes was measured in 
supematants as for the lL-2 and IFN-y assay. The ability of splenocytes or blood leukocytes 
to produce TNF was determined by using a TNF-sensitive, Actinomycin D-treated murine 
L929 fibroblasts cell line. This assay, however, caimot distinguish between the a and P 
forms of TNF. 
Briefly, L929 cells were collected and washed once in complete media. The cells 
were diluted to 2.5 x 10 ^ /ml and 100 |il of suspension added to a 96 wells plate. The plate 
were incubated 18-24 hr. At this time, the growth of L929 cells were stopped by adding 10 
|il of Actinomycin-D(60 ^g/ml, Sigma). To test for the presence of TNF, 100 ^1 of diluted 
supematants were add to wells in triplicate and incubated for 24 hr at 37 °C in a COt (5 %) 
incubator. The plate was washed twice with phosphate-buffered saline (PBS) and stained 
with 0.2% crystal violet / 2% formalin in PBS. The fixed cells were washed several times 
with tap water and allowed to dry overnight at room temperature. Ethanol (50%) in PBS 
(100 |ul) was added to each well of the plates to dissolve the stain-fixed cells. The optical 
density was measured in an ELISA microtiter plate reader at 550-595 run. A TNF standard 
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curve (0-100 units/ml) was generated in parallel on each plate. The TNF content of each 
sample was calculated from the standard curve and reported as units/ml. 
Statistical Treatment of Data 
A computerized program for analysis of variance (ANOVA; Statistix, NH Analytical 
Software) was used to assess differences among experimental and control groups. For the 
present experiment to assess the effects of adrenalectomy on attenuation of acute stress 
effects of 2-DG, a two (treatment) x three (surgery) analysis was used. One factor was 
treatment, a 2-DG injection or saline injection. The second factor was surgery, 
adrenalectomy (ADX), sham operation or no operation. The significance level for all 
analyses was set at a probability of less than or equal to 0.05. 
3. Results 
Plasma Corticosterone and Endogenous Glucose 
The results of the assay for plasma corticosterone are presented in Table I. An 
analysis of variance demonstrated a significant increase in corticosterone due to 2-DG 
treatment, F(l, 35) = 306.49,/? < 0.0001 and a significant main effect of surgery. F(2. 35) = 
126.46, p < 0.0001. Orthogonal contrasts of surgery demonstrated that the plasma 
corticosterone concentration of the sham-operated group was significantly elevated in 
comparison v^ath the unoperated group, F(l, 35) = 4.33, p < 0.05. In contrast, the 
corticosterone concentration in the adrenalectomy (ADX) group was significantly suppressed 
in comparison with the sham-operated groups and the unoperated groups, F(l, 35) = 248.69, 
p < 0.0001. The analysis also showed a significant interaction of 2-DG treatment and 
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surgery, F(2, 35) = 76.47, p < 0.0001. Contrasts demonstrated a highly significant interaction 
of 2-DG treatment and surgery between the ADX group and the unoperated and the sham-
operated groups, F(l, 35) > 103.43, p < 0.0001. But, there was no interaction of 2-DG and 
surgery between the sham-operated group and the unoperated group. Thus, the 
adrenalectomy operations were highly effective in eliminating baseline levels of 
corticosterone and preventing the normal stress-induced rise in corticosterone levels. 
Adrenalectomy also affected the level of plasma glucose induced by stress (Table 1). 
Analysis of plasma glucose levels showed a significant increase in endogenous glucose due 
to 2-DG injection, F(l, 35) = 1440.27,/? < 0.0001. In addition, there was a significant main 
effect of surgery, F(2, 35) = 230.92,/? < 0.0001. Orthogonal contrasts indicated that the 
plasma glucose concentration of the ADX group was significantly lower than sham-operated 
and unoperated groups, F(l, 35) = 459.67,/? < 0.0001. There was no difference in plasma 
glucose between the sham-operated group and unoperated group. Moreover. ANOVA 
indicated a significant interaction of surgery and 2-DG treatment, F(2, 35) = 196.78, p < 
0.0001. Contrasts demonstrated that there was significant of 2-DG and surgery interaction 
between the unoperated and sham-operated groups and the ADX group, F(l, 35) = 393.23,/? 
< 0.0001. Therefore, rats lacking adrenal glands failed to display the exaggerated 
concentration of glucose during 2-DG administration. 
Leukocyte Enumeration 
The leukocytes in the spleen and peripheral blood were enumerated (Table 2). There 
was no significant main effect of surgery or 2-DG injection on the number of leukocytes in 
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the spleen. But, there was a significant decrease in the number of peripheral blood 
leukocytes (PBL) from rats that received 2-DG, F(l, 35) = 12.32, p < 0.002. In contrast, 
there was no main effect of surgery on peripheral blood leukocyte counts or a significant 
interaction between surgery and 2-DG treatment. Ancillary contrasts, however, demonstrate 
that the decreased number of PBL's was significant in the stressed SHAM-operated and 
unoperated groups, but was not significant in the stressed ADX-operated group when 
compared with their respective saline treated controls. Thus, adrenalectomy blunted the 2-
DG-induced leukopenia normally seen in unoperated rats. 
Response to Mitogen Stimulation 
Blood. The blood leukocyte responses to the optimal concentrations of Con A (5 |ig/ml) 
and PHA (5 |ig/ml) are summarized in Figure 1, panels A and B, respectively. The analysis 
of both Con A and PHA stimulated culttires demonstrated a significant main effect of 
surgery, F(2, 35) > 8.9,/? < 0.002. Orthogonal contrasts of surgery revealed no difference 
between the unoperated and sham-operated groups; however, these two groups were 
significantly lower than the ADX groups, F(1,35) > 27.98, p < 0.0001. Analysis of variance 
of the blood leukocyte responses to the optimal concentration of Con A and PHA also 
showed a significant main effect for 2-DG treatment (F(l, 35) = 28.10, p < 0.0001 for Con A 
and F(l, 35) = 4.20, P < 0.05 for PHA). Orthogonal contrast indicated that animals that 
received 2-DG injection in both sham-operated and unoperated groups showed a suppression 
comparison to saline injection. F (1, 35) > 6.67, p < 0.02. Conversely, there was no 
significant 2-DG effect in 2-DG treated and saline treated of the ADX group. Most 
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importantly, there was a significant interaction of 2-DG treatment and surgery for Con A 
stimulated PBL, F(2, 35) = 5.43, p < 0.02. Orthogonal contrasts revealed that the interaction 
of the unoperated and sham-operated groups was not significant, but the interaction of these 
groups and the ADX group was significant, F(l, 35) = 10.69,/? < 0.004. Therefore, these 
data demonstrate an attenuation of 2-DG-induced inrniime suppression in rats lacking adrenal 
glands. 
Spleen. The response of the spleen lymphocytes to Con A, PHA, and LPS were 
summarized in Table 3. The analysis of variance of the spleen leukocyte responses to the 
optimal concentration of mitogen (Con A, 1.5 ^ig/ml; PHA, 0.5 |ag/ml; and LPS, 2.5 |ig/ml) 
showed a significant main effect of 2-DG treatment, F(l, 35) > 12.83,/? < 0.002. This 
demonstrates that 2-DG can induce a pronounced decrease in the mitogenic response of 
splenic lymphocytes. In addition, there was a significant main effect of surgery in splenocyte 
responses to Con A, F(2, 35) = 4.07, p < 0.04, but there was no main effect of surgery in 
responses to PHA and LPS. Orthogonal contrasts of the Con A response revealed that the 
sham-operated group was significantly lower than the unoperated group, F(l, 35) = 5.38,/? < 
0.03; however, the ADX group was not significantly different firom the unoperated group. In 
addition, there was no interaction of surgery and 2-DG treatment. These results indicate that 
adrenalectomy did not attenuate the 2-DG-induced immune suppression of splenic 
lymphocytes. Furthermore, the sham operation procedure exacerbated the 2-DG-induced 
suppression of the Con A mitogenic response of splenic lymphocyte. 
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Natural Killer Cell Activity 
Natural killer cell function of splenic leukocytes was measured by using four effector 
to target ratios and analyzed as Lytic Units (LU) (Figure 2). Overall, ANOVA showed that 
2-DG injection induced a significant decrease of natural killer cell activity, F(l, 35) = 26.82, 
p < 0.0001, and there was a significant main effect of surgery, F(2, 35) = 36.98, p < 0.0001. 
Orthogonal contrasts of surgery revealed that the ADX group had significantly lower natural 
killer cell activity than the sham-operated and unoperated groups; however, there was no 
significant difference between the sham-operated and unoperated groups. In addition, there 
was no significant interaction between the surgery and 2-DG treatment. 
Cytokine Production 
Interferon-y (IFN-y) and IL-2 
Blood. The results of IFN-y and IL-2 production by blood lymphocytes are displayed 
in Figure 3. Administration of 2-DG significantly suppressed IFN-y production from cultures 
of blood lymphocytes, F(l, 35) = 25.84,/? < 0.0001 (Fig. 3A). Analysis of variance 
demonstrated a significant main effect of surgery, F(2, 35) = 5.45, p < 0.02. Orthogonal 
contrasts indicated that there was no difference between the unoperated and sham-operated 
groups; however, these groups were significantly lower than the ADX group, F(l,35) = 8.58, 
p < 0.008. Interestingly, the interaction of 2-DG treatment and surgery was significant for 
IFN-y production, F(2. 35) = 3.32,/? < 0.05. Orthogonal contrasts revealed that the 
interaction of the unoperated and sham-operated groups was not significant, but the 
interaction of these groups and the ADX groups was significant, F(l, 35) = 5.02, p < 0.04. 
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Thus, ADX-operation attenuated 2-DG-induced suppression of IFN-y production by Con A-
stimulated blood lymphocytes. 
Overall ANOVA revealed no significant main effect of 2-DG treatment on con A-
stimulated IL-2 production in cultures of blood lymphocytes (Fig. 3B), but there v^ras a 
significant main effect of surgery, F(2, 35) = 10.83, p < 0.0005. Importantly, there v^^as a 
significant interaction between surgery and 2-DG treatment, F(2,35) = 5.74, /? < 0.01. 
Orthogonal contrasts of surgery revealed that the ADX group showed higher IL-2 production 
than the sham-operated and unoperated groups, F (1, 35) = 21.07,/? < 0.0002. There was no 
significant difference between sham-operated groups and unoperated groups. The significant 
interaction was due to a significant suppression of IL-2 production in both sham-operated and 
unoperated groups F(l, 35) = 7.40, P < 0.02, whereas IL-2 production was significantly 
enhanced by 2-DG in the ADX group F(1, 35) = 21.07, P < 0.0002. Therefore, the 2-DG 
induced suppression of IL-2 production by Con A-stimulated blood lymphocytes is induced 
by adrenal hormones. Furthermore, without adrenal honnones, the production of IL-2 was 
exacerbated in response to stress. 
Spleen. The results of IFN-y and IL-2 production by spleen lymphocytes were 
displayed in Table 3. The cultures of splenocytes from rats that received a 2-DG injection 
contained significantly less IFN-y (F(l, 35) = 4.74, p< 0.05) and IL-2 (F(l, 35) = 11.48, p < 
0.003) compared with those from rats injected with saline. But, there was no main effect of 
surgery and no significant interaction between surgery and 2-DG treatment for splenic IFN-y 
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and IL-2 production. These data demonstrate that adrenalectomy did not attenuate the 2-DG-
induced reduction of IFN-y and IL-2 production by Con A stimulated splenic lymphocytes. 
Tumor Necrosis Factors (TNF) 
Blood. The result of TNF production from Con A-stimulated blood leukocytes is 
summarized in Figure 3C. The induction of TNF was evaluated by testing the supernatant 
fluids of the cultures from the same cell source as those used in the IL-2 and IFN-y assay. 
ANOVA indicated that the production of TNF by Con A-stimulated blood leukocytes was 
decreased because of 2-DG administration, F(l, 35) = 3.04,/? < 0.09 and there was a 
significant main effect of surgery, F(2, 35) = I8.71,p < 0.0001. Orthogonal contrasts 
indicated that there was no difference between sham-operated and unoperated groups; 
however, PBL from the ADX group produced more TNF than the sham-operated and 
unoperated groups, F(l, 35) = 37.45, p < 0.0001. Importantly, there was a significant 
interaction between 2-DG treatment and surgery, F (2, 35) = 4.28,;? < 0.03. The production 
of TNF by leukocytes from the ADX group was not significantly altered by 2-DG 
administration. Hence, these data indicated that 2-DG-induced changes of TNF production in 
Con A-stimulated cultures of blood leukocytes is mediated by adrenal hormones. 
Spleen. The result of TNF production from Con A stimulated splenocytes was 
summarized Table 3. Analysis of variance demonstrated a significant increase in TNF 
production due to 2-DG treatment, F(l, 33) = 5.49, p < 0.03 and a significant main effect of 
the surgery. F(2, 33) = 7.57, p < 0.004. Orthogonal contrasts of surgery indicated that the 
TNF concentration of the sham-operated group was significantly elevated in comparison with 
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the unoperated group, F(l, 33) = 4.97, p < 0.04. The ADX group also showed a significantly 
higher production of TNF than unoperated groups, F(l, 33) = 15.05, p < 0.001; however, 
there was no significant difference between the ADX and sham-operated groups. In addition, 
there was no significant interaction between 2-DG treatment and surgery. Hence. 2-DG 
administration enhanced the production of TNF in Con A-stimulated splenocytes and the 
stress of surgery exacerbated the 2-DG-induced stress response in a manner similar to a 
sensitization response. 
4. Discussion 
The cells in the blood are bathed by a variety of hormones including glucocorticoids 
and catecholamines. Our previous studies suggested that 2-DG-induced immunomodulation 
in the blood was not due to a peripheral release of catecholamines (Chou et al., submitted). 
Glucocorticoids are profoundly elevated after 2-DG administration (Smith and Root, 1969; 
Lysle et al., 1988; Chou et al., 1996). Generally, glucocorticoids, the end products of 
hypothalamic-pituitary-adrenal axis activation, are widely considered as the primary 
mediators underlying stress-induced immime changes. It is well known that physiologic and 
pharmacologic doses of corticosterone have a profound effect on a variety of immune 
parameters (Cupps and Fauci, 1982; Munch et al., 1984). The current study clearly 
demonstrated that the 2-DG-induced changes of peripheral blood immune cell function were 
attenuated in adrenalectomized rats. Adrenalectomy did not attenuate the 2-DG-induced 
changes of immune parameters of splenocytes. These findings are consistent with our 
previous investigation that 2-DG-induced immunomodulation in the spleen was mediated by 
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the peripheral release of catecholamines. Furthermore, it supports our hypothesis that the 
changes of blood leukocyte function are mediated by an adrenal hormone such as 
corticosterone. 
In the present study, the 2-DG-induced elevation of endogenous glucose was blunted 
by adrenalectomy because 2-DG treated ADX rats did not display the same increase of 
endogenous glucose as saline injected ADX rats. This difference can be partly explained 
because glucocorticoids are the major, but not sole, hormone to regulate glucose metabolism. 
Norepinephrine or other sympathetic neuropeptides are also involved in glucose homeostasis 
(Smythe et al., 1989; Pascoe et al., 1989). 
A change in the number of peripheral blood leukocytes is a common stress response 
(Naliboff et al., 1991; Dhabhar et al., 1994). Our laboratory reported that the number of 
leukocytes in blood was reduced in rats receiving one or multiple injections of 2-DG (Chou 
et al., 1996). The cause of the leukopenia is not due to 2-DG cytotoxicity of T-cell (Miller et 
al., 1994) or noradrenergic activity (Chou et al., submitted). The stress-induced changes in 
blood leukocytes is probably due to cell redistribution mediated by glucocorticoids released 
by the adrenal gland (Dhabhar et al., 1995,1996). The present study supports the theory of 
glucocorticoid-induced redistribution of PBL, as adrenalectomy attenuated the 2-DG-induced 
reduction of leukocytes. 
Most importantly, the present study demonstrated that the 2-DG-induced changes in 
blood leukocyte function are also adrenal-dependent. Adrenalectomy prevented the 
suppression of PBL proliferation to Con A and PHA; however, adrenalectomy did not 
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attenuate the suppression of the splenic lymphocyte responses to Con A, PHA, and LPS. 
These data emphasize the mechanistic differences that mediate stress-induced change in the 
two lymphoid compartments. Observations from this study also indicated that the response 
of blood lymphocytes to T-cell mitogens in the ADX group were higher than in the sham-
operated and unoperated groups, and in some instances, 2-DG exacerbated the increased T-
cell responses. Thus, glucocorticoids play an important role in maintaining a balanced 
immune response, without these hormones, stress may exacerbate physiological responses. 
The stress of 2-DG administration inhibited IL-2 in the blood and IFN-y in both 
spleen and blood as seen previously (Chou et al., 1996). The suppression of IFN-y 
production by splenocytes from 2-DG treated animals is mediated by peripheral release of 
catecholamines (Chou et al., submitted). In the present study, adrenalectomy prevented 2-
DG-induced reduction of IL-2 and IFN-y production by peripheral blood leukocytes, 
implicating adrenal hormones in homeostasis of blood lymphocyte responsiveness. 
Glucocorticoids affect T-cell growth and differentiation by inhibiting IL-2 secretion and IL-2 
receptor expression (Gillis et al., 1979). Therefore, administration of 2-DG elevated 
glucocorticoid levels in peripheral blood, which directly or indirectly affected IL-2 secretion 
and T-cell proliferation. By down-regulating T-cell growth, IFN-y production was also 
influenced by glucocorticoids. This concurs with the research of others showing that 
exogenous glucocorticoids decrease the production of IL-2, IFN-y, and TNF at physiological 
and pharmacological concentration in vivo and in vitro (Gillis et al., 1979; Kelso and Munck. 
1984; Dupont et al., 1985; Perretti et al., 1993). Furthermore, studies examining stress 
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(Glaser et al., 1986), electric shock (Sonnenfeld et al., 1992), and microgravity (Berry et al., 
1991) demonstrate that stress can inhibit cytokine production. 
We extend our previous work by showing that 2-DG induced suppression of TNF 
production by blood leukocytes, whereas the production of TNF in the spleen was enhanced 
after 2-DG administration. The present study demonstrates that the change of TNF 
production by blood lymphocytes was also adrenal-dependent. TNF is an inflammatory and 
antiviral cytokine. It is not surprising that 2-DG induced stress also disturbs the balance of 
TNF production. It is well accepted that the actions of glucocorticoids are antiinflammatory 
and induce immune suppression. Removal of the adrenal glands has been reported to 
exacerbate many aspects of acute inflammation and increase susceptibility to endotoxic shock 
(Perretti et al., 1993). Additionally, adrenalectomy enhances the sensitivity of animals to the 
toxic action of these cytokines (Bertini et al., 1988). Recently, the role of glucocorticoids as 
essential in mediating physiological function has been revised (Munck and Naray-Fejes-Toth, 
1994; Derijk and Sternberg, 1994). They suggest that the immune suppression induced by 
glucocorticoids may serve as a buffer to optimize host responses during external stimuli such 
as stress. Without this mediator, the balance of physiologic activity may be interrupted and 
subsequently cause unexpected tissue damages. The present study supports this theory 
because IL-2 and TNF production was significantly increased in 2-DG treated rats lacking 
adrenal glands, demonstrating the importance of glucocorticoids in homeostasis. 
As expected, 2-DG induced a suppression of splenic NK cell activity. This 
suppression of NK activity was not attenuated in adrenalectomized rats. Moreover, the 
baseline NK activity in ADX rats was significantly lower than in the sham-operated and 
129 
unoperated groups. This may indicate that glucocorticoids are important mediators in 
recovering from surgical treatment and reestablishing homeostatic irmnune function. 
Conversely, it could be interpreted that the ADX rats were under a different and consistent 
metabolic stress since surgery, and this activated pathways that suppress NK activity. It has 
been reported that NK cell activity is modulated via opioids (Shavit et al., 1984) or 
norepinephrine (Irwin, 1991); however, we previously reported that 2-DG-induced 
suppression of splenic NK activity was not blocked by the administration of nadolol, a B-
adrenergic receptor antagonist. This was intriguing because other splenic immune functions 
altered by 2-DG are prevented by nadolol (Chou et al. submitted). 
The present study supports our hypothesis that adrenal hormones are responsible for 
2-DG-induced immunomodulation in the blood. These data also point out that the action of 
glucocorticoids on immune flmction are involved in more than immune suppression. 
Combined with the results of previous research, this study supports the general concept that 
communication exists between the immune system and the neuroendocrine system. 
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Table 1. Plasma corticosterone and endogenous glucose levels in 
adrenalectomized (ADX), sham-operated (SHAM) or unoperated (UNOP) 
rats that received 2-DG (500 mg/kg) or saline injection. 
2-DG SALINE 
Corticosterone (ng/dl) 
ADX 2.0 ±0.7* 1.9 ±0.4 
SHAM 66.1 ±4.3 13.5 ±2.3 
UNOP 63.4 ±4.2 5.5 ±2.2 
Endogenous Glucose (mg/dl) 
ADX 152.6 ±5.1 110.8 ±6.7 
SHAM 339.4 ±8.1 123.2 ±7.8 
UNOP 335.0 ±9.2 112.8 ±5.6 
* Mean ± SB 
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Table 2. Total Ieiikoc)^e counts for the spleen and total leukocj^e counts per 
milliliter of blood in adrenalectomized (ADX), sham-operated (SHAM) or 
unoperated (UNOP) rats that received 2-DG (500 mg/kg) or saline injection. 
2-DG SALINE 
Spleen 
ADX 386.9±48.8 ** 443.6±15.6 
SHAM 427.7 ±21.9 453.2 ±15.3 
UNOP 428.4 ± 15.4 449.3 ±21.8 
Blood *** 
ADX 
SHAM 
UNOP 
3.7 ±0.5 
2.7 ±0.2 
2.3 ± 0.3 
4.2 ± 0.4 
3.9 ±0.4 
4.3 ± 0.6 
* number of 10 ^ leukocytes / spleen 
** Mean (± SE ) 
*** number x 10 ® leukocytes/ ml blood 
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Table 3. Effects of 2-DG injection on the proliferative response of splenocytes 
to the mitogens Con A, PHA, and LPS and the production of IFN-y, IL-2, and 
TNF by Con A stimulated splenocytes from adrenalectomized (ADX), sham-
operated (SHAMX^djinoperated(UNOP)^s^^ 
2-DG Saline 
Mitogen Response (cpm x 10 
Con A (1.5 |ig/ml) 
ADX 
SHAM 
UNOP 
) 
117.0± 18.4» 
64.2 ± 18.9 
122.0 ±21.0 
162.0 ± 13.8 
141.0 ± 14.4 
149.0 ± 17.9 
PHA (0.5 lag/ml) 
ADX 
SHAM 
UNOP 
2.7 ±0.8 
4.1 ±0.6 
3.8 ± 0.4 
4.8 ±0.6 
5.2 ±0.8 
4.8 ± 0.6 
LPS (2.5 ng/ml) 
ADX 
SHAM 
LfNOP 
9.7 ± 2.4 
9.4 ± 1.7 
11.6 ±0.5 
16.6 ± 1.3 
16.1 ± 1.8 
16.9 ± 1.2 
Cytokin Production 
IFN-y (Units/ml) 
ADX 
SHAM 
UNOP 
143.0 ±9.7 
118.3 ±33.6 
148.3 ±6.8 
161.5 ±7.2 
149.8 ±9.8 
159.2 ±7.0 
lL-2 (1/2 MAX) 
ADX 
SHAM 
UNOP 
19.1 ±3.0 
18.22 ±3.96 
15.2 ±3.6 
22.8 ± 5.9 
24.3 ± 6.8 
24.3 ±4.1 
TNF (Units/ml) 
ADX 
SHAM 
UNOP 
286.5 ±27.5 
219.0 ±47.3 
172.4 ± 13.4 
205.1 ±20.8 
198.3 ± 19.1 
142.6 ± 16.1 
* Mean ± SE, n = 5-6 / grp 
Figure 1. Proliferative response of whole blood lymphocytes to (A) Con A 5 |ig/ml and (B) 
PHA 5 |ig/ml from adrenalectomized (ADX), sham-operated (SHAM), and 
unoperated (UNOP) rats. Stressed rats received 2-DG, 500 mg/kg subcutaneously, 
and control rats received an equal volume of saline. Results are expressed as the 
mean (± SE) of counts per min (cpm); n = 6/group. 
137 
BLOOD BLASTOGENESIS 
A. Con A = 5 ^g/ml 
60 r 
50 -
40 -
o 
£ 30 -
t 20 -
10 -
0 
2-DG 
SALINE 
B. PHA = 5 ^g/Inl 
6 r 
5 
r) 4 -I 
o 
H 3 -
9 _ 
1 -
0 
ADX SHAM UNOP 
Figure 2. Splenic NK cell activity expressed as lytic units (LU) from adrenalectomized 
(ADX), sham-operated (SHAM), and unoperated (UNOP) rats. Stressed rats 
received 2-DG, 500 mg/kg subcutaneously, and control rats received an equal 
volume of saline. Results are expressed as the mean (± SE); n = 6/group. 
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Figure 3. Effects of 2-DG injection on the (A) IFN-y, (B) IL-2, and (C) TNF production by 
Con A stimulated whole blood leukocytes fi-om adrenalectomized (ADX), sham-
operated (SHAM), and unoperated (UNOP) rats. Stressed rats received 2-DG, 500 
mg/kg subcutaneously, and control rats received an equal volume of saline. 
Results of IFN-y and TNF production were expressed as the mean (± SE) of units / 
ml (1 unit = 250 pg.). Results of IL-2 were expressed as the mean (± SE) of half 
Max Units.; n = 6/group. 
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CHAPTER 5. ALTERATION OF THYMIC T CELL SUBSET PROFILES AND 
APOPTOSIS BY A METABOLIC STRESS 
A paper to be submitted to Cellular Immunology 
Shiu-Huey Chou, Kirsten L. Gruis, and Joan E. Cunnick 
Abstract 
The proper development and function of mature T-lymphocytes depends upon the 
interaction of immature T-ljonphocytes with the microenvironment of the thymus. In adults, 
the thymus seems involuted but maintains the ability to educate and reseed mature T-
lymphocytes into the periphery. In the present study, 2-deoxy-D-gIucose (2-DG, 500 mg/kg) 
was administered to male, Lewis rats to examine the effects of metabolic stress on adult 
thymocytes. The thymic parameters of weight, profile of T-lymphocyte subsets, sensitivity 
to corticosterone-induced apoptosis, nitrite production by thymic macrophages and mitogen-
induced blastogenesis of thymocytes were measured. Results indicated that responsiveness 
to Con A, PHA, and LPS and nitrite production of thymocytes from rats exposed to chronic 
stress (5 injections 2-DG) was decreased. 2-DG administration (1, 4, or 5 injections) 
increased thymocyte apoptosis in the presence of a basal concentrations of corticosterone (0.1 
HM). The increase in apoptosis was correlated with a decrease in total thymocytes and 
thymus size in the 4 and 5 injection groups. Adrenalectomy attenuated both the baseline rate 
and 2-DG-induced increase in the rate of apoptosis in thymus. As expected, 2-DG-induced 
thymic involution occurred with a significant decrease in the CD4^ and CD4^CD8^ T-cell 
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subsets in the thymus of rats receiving 4 or 5 injections. Interestingly, the numbers of CDS" 
thymocytes increased in response to multiple injections of 2-DG. These differences could be 
due to stress-induced changes that alter CD4 and CDS subset maturation. This study 
demonstrates that chronic stress initiates a process of increased apoptosis in the thymus that 
alters the cellular profile of thymocyte subsets resulting in an increse of the CDS^ cell subset. 
These changes can be seen up to 48 hr after 2-DG injection or 2 weeks after sham-surgery. 
Introduction 
It is well accepted that stress can affect health by modifying the function of 
lymphocytes fi"om secondary immune compartments such as the spleen and blood. Relatively 
few studies, however, have examined the extent of stress effects on primary immune 
compartments such as thymus. Exposure to stress is known to accelerate thymic involution 
as evidenced by a decrease in the number of thymocytes and thymus weight (Andersen, 1935; 
Selye, 1936, 1950; Dougherty, 1952). Immobilization stress in C3H/H mice has been 
reported to change the ratio of the T-cell subsets in the thymus, specifically by inducing an 
increase of immature T-cells (CD4^CDS^)(Teshima et al., 1991). In addition, moderate 
exercise in rats induces an increase in the percentage of CD4^ and CD8^ (single positive) T-
cells and a decrease in the percentage of double positive CD4^CDS" thymocytes (Ferry, et al., 
1992). 
The thymus is a primary immune organ involved in the establishment, maintenance, 
and regulation of host immunity. In adults, the thymus seems involuted but still plays an 
important role in restoring the pool of competent T-cells and maintaining the ability to 
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respond to antigens. Stress-induced changes in the thymus may result in a prolonged 
alteration of the functional capability of T-cells. Because thymic T-cells migrate to 
peripheral immime organs, these changes may alter T-cell interactions and responses in 
secondary immune organs. Therefore, an evaluation of stress-induced modulation of 
thymocytes can provide a explanation for long-term changes observed in secondary immune 
organs. 
Our laboratory previously reported that administration of 2-deoxy-D-glucose (2-DG). 
a metabolic stressor, induced a decrease in the number of leukocytes in the spleen, blood, and 
thymus (Chou et al., 1996). In addition, repeated 2-DG exposure changed the profile of T-
cell subpopulations in the spleen, resulting in an increase of CD8^ T-cells and a decrease in 
the ratio of CD4^ : CD8^ T-cells. Lysle et al. (1988) reported that the chronic stress of 
repeated administration of 2-DG was able to suppress the response of thymocytes to various 
mitogens. Both acute and repeated 2-DG administration induced alterations in spleen and 
blood lymphocyte function, such as a suppression of T-cell mitogen responses, a decrease of 
natural killer cell activity, and a reduction of cytokine (IL-2, IFN-y) production (Chou et al., 
1996). Therefore, the question arises: Are the outcomes of immunomodulation in the 
secondary immune organs consistent with observed functional changes in a primary immune 
organ such as the thymus? In addition, how does stress affect apoptosis, a naturally 
occurring process in the thymus by which cells die through activation of specific genes that 
tum on endonuclease activity? In the thymus, apoptosis has a critical function in positive and 
negative selection which deletes unneeded and self-reactive T-cells. Thus, an increased 
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propericity to alteration of the undergo apoptotic cell death in the thymus may have important 
consequences when coupled with functional changes during stress. 
Adrenal hormones such as glucocorticoids are involved in thymopoiesis (Cohen. 
1989). Primarily, about 90-95% cortical lymphocytes within the thymus are induced to enter 
programmed cell death followings administration of physiological concentrations of 
glucocorticoids (Cohen, 1992; Compton and Cidlowski, 1986; Compton et al., 1991). Stress 
elevates endogenous glucocorticoid concentrations. Thus, it is not surprising that physical 
stress (forced exercise) induces glucocorticoid-mediated apoptosis of rat thymocytes 
(Concordet and Ferry, 1993), implicating adrenal hormones in stress-induced apoptosis. 
Increased rates of apoptosis may reduce the number of functional T-cells that can migrate to 
peripheral organs. Hence, identification of the ways in which stress influences T-cell 
function remains an interesting subject for further study. 
The purpose of the current research was to characterize the alteration of thymic 
cellular parameters and function after acute and chronic administration of 2-DG in rats. To 
evaluate the long-term consequences of stress-induced immune alteration, the sensitivity of 
thymocytes to corticosterone-induced apoptosis at basal and stress-induced concentrations of 
corticosterone was measured. We also examined whether adrenal hormones mediate the 2-
DG-induced changes in thymus parameters. The results from this study indicate that 2-DG-
induced stress affects thymocytes, resulting in altered numbers of functional thymocytes after 
initially altering T-cell responses in peripheral immime organs. 
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Materials and Methods 
Animals 
Inbred, male rats of the Lewis strain (55-60 days old, 220-250 g) were purchased 
from Harlan-Sprague-Dawley Laboratories (Indianapolis, Indiana). Upon arrival, the 
subjects were individually caged in a colony room in which a 12-h reversed light-dark cycle 
was maintained through artificial illumination. They received free access to both food and 
water (0.9% saline for the adrenalectomized rats) throughout the experiment, except as noted, 
and a 2-week acclimation period before the experimental manipulation. Additionally. 
animals were handled every two days to prevent the hyperactivity that occurs when they are 
left untouched for a prolonged period. All animal manipulations were approved by the Iowa 
State University Committee on Animal Use. 
Reagents and Chemicals 
The assays employed two kinds of culture media: "supplemented medium" refers to 
RPMI-1640 supplemented with L-glutamine (2 mM), gentamicin (50 fig/ml), and Hepes (10 
mM)(Gibco Lab., Grand Island, NY), and "complete medium" refers to "supplemented 
medium" containing 10% Fetal Bovine Serum (FBS) (JHR Biosciences, Lenexa, KS). The 
mitogens concanavalin A (Con A) and Lipopolysaccharide (LPS) from Escherichia coli were 
purchased from Sigma (St. Louis, MO), and phytohemaggiutinin (PHA) was purchased from 
Burroughs Wellcome (England). Heparin (100 units/ml, ELKINS-SINN, NJ) and 2-DG 
(Sigma) were diluted in Hanks' Balanced Salt Solution (HBSS)(Gibco Lab.). [^H]thymidine 
(specific activity 6.7 Ci/mmol) from Dupont-New England Nuclear (Wilmington, DE) was 
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used as specified below. All cultures were prepared in flat-bottomed 96-weIl tissue culture 
plates (Costar, Cambridge, MA). 
Experimental Paradigm 1: Acute and Repeated 2-DG Exposure 
Rats were assigned to one control or one of two experimental groups (n=8/group). 
Each control or experimental animal was injected a total of five times, and subjects were 
manipulated so that groups of rats differed only in the content of the inoculum. Injections 
were performed once per 48 hours, 2 hr. after lights off For each injection, a total inoculum 
of 0.28 ml/rat was administered subcutaneously. Control rats received a total of five 
injections of sterile HBSS. The experimental groups of animals received a total of five 
injections composed of either 4 HBSS plus one 2-DG (acute) or five (repeated) exposures to 
2-DG (500 mg/kg body wt) dissolved in sterile HBSS. Thus, 2 groups of rats received 2-DG 
on the final test day. For 1 hour following each injection of 2-DG or HBSS, all animals were 
deprived of food and water. One hour following the last injection, each subject was rapidly 
sacrificed by cervical dislocation. 
Experimental Paradigm 2: Duration of Stress Effects on the Thymus 
Lewis rats were pretreated with four injections of saline or four injections of 2-DG 
(500 mg/kg; subcutaneously; one every 48 hours). On the test day, rats were assigned to four 
groups (n = 4 / group): half of the HBSS pretreatment group received saline (0-2-DG) or 2-
DG (1X-2-DG), and half of the 2-DG pretreatment group received no injection (4X-2-DG) or 
2-DG (5X-2-DG). On the test day, saline was not administered to the 4X-2-DG to prevent 
any conditioned response to the injection procedure. This group was included to examine the 
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duration of thymic changes induced by repeated 2-DG exposure. All animals were deprived 
of food and water for I hour following each injection of 2-DG or saline. 
Experimental Paradigm 3: Adrenalectomy Manipulation 
Adrenalectomized (ADX), sham-adrenalectomized (SHAM), or unoperated (UNOP) 
male rats were used to determine the role of adrenal hormones in 2-DG-induced immune 
alteration. The experiment was performed as two replicates. Each animal of the surgery-
treated groups was assigned to one of two subgroups (n=6). One subgroup (stress) received a 
single injection of 2-DG, 500 mg/kg body weight dissolved in sterile HBSS. The other group 
(control) received a single injection of sterile HBSS. The injection was administered 
subcutaneously and performed 2-hour into the dark phase. For one hour following each 
injection of 2-DG or HBSS, all animals were deprived of food and water. One hour 
following injection, each subject was rapidly sacrificed by cervical dislocation with a clamp. 
Quantification of Thymus Weight and Thymocytes Content 
After sacrifice, blood collected via the abdominal aorta into heparinized syringes was 
used as a source of plasma to determine endogenous corticosterone and glucose 
concentrations. Each thymus was removed and placed in a preweighed polypropylene tube 
containing 8 ml of complete media. Each organ was weighed to the nearest mg immediately 
after removal from the body. Each subject's thymus was dissociated into a single-cell 
suspension by grinding the thymus between the frosted ends of two glass slides. The single-
cell suspension was collected after 10 min. of unit gravity sedimentation to remove cell 
debris and clumps. Subsequently, the thymocyte suspensions were counted by using a 
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Celltrak 2 (NOVA Biomedical, Waitham, MA) cell-analyzer to determine the total leukocyte 
count per organ. 
Plasma Glucose Assay 
The level of glucose present in the plasma was measured by two methods: one was 
based upon the glucose oxidase (Trinder) reaction, which detects endogenous glucose and 2-
DG, and the second was based upon the hexokinase (HK) reaction, which detects only 
endogenous glucose (Sigma, St. Louis, MO). For all subjects, plasma was obtained from 
whole blood by centrifugation (12,000 rpm/5 min.) and stored at -70 until assayed. The 
samples were tested in duplicate and read at 505 nm for the Trinder and 340 nm for the HK 
assay using a spectrophotometer (UVIKON 930, Kontron Instruments AG, Switzerland). A 
glucose standard curve was performed with each assay, and sample glucose concentrations 
were calculated based upon linear regression analysis of the standard. 
Plasma Corticosterone Assay 
To test for the completeness of adrenalectomy and the stress effect of 2-DG 
administration, plasma samples were assayed for corticosterone. Plasma corticosterone levels 
were determined by using a standard radioimmunoassay kit for rat corticosterone (ICN, 
Biomedical, Inc., CA). The error for the corticosterone radioassay is 0.2 ^g/dl and values 
below this level, as in the ADX groups, can be interpreted as lack of corticosterone. 
Mitogen Stimulation Assay 
The mitogen stimulation assay was performed with thymocytes to assess lymphocyte 
proliferation. Con A and PHA were used as T-lymphocyte mitogens and LPS as a B-
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lymphocyte mitogen as described previously (Cunnick et al., 1990). 
Nitric Oxide Assay 
Supematants were harvested from cultures of mitogen-stimulated lymphocytes before 
pulsing with thymidine. The nitric oxide concentrations were determined by measuring 
nitrite in a microplate assay (Stuehr and Nathan, 1989). Sample aliquots (50 ^1) were mixed 
with 100 (il of Griess reagent (0.5% sulfanilamide/0.05% naphthylethylene diamine 
dihydrochloride/2.5% H3PO4) and incubated at room temperature for 10 min. The optical 
density was measured using a microtiter plate reader (BIO Kinetics Reader, BIO-TEK 
Instruments, Winooski, VT) at 550 nm against PBS as a blank. A sodium nitrite (NaN02) 
standard curve (0-100 |iM) was generated in parallel. Results are expressed as the mean of 
nitrite concentrations in the supematants of triplicate wells. 
Flow Cytometric Analysis of Lymphocyte Subsets 
The percentages of CD4^ and CD8^ lymphocyte subsets were studied by fluorescent-
cell-surface staining with monoclonal antibodies and analysis on an EPICS PROFILE-1 flow 
cytometer. Monoclonal mouse antibodies to lymphocyte populations were purchased from 
PharMingen or Bioproducts for Science. The anti-CD4 antibody (W3/25) was conjugated to 
fluorescein iso-thiocyanate (FITC), and the anti-CD8 antibody (OX-8) biotinylated 
(PharMingen) for conjugation to avidin phycoerythrin (PE) (Vector Labs) to be used for 
double staining. The FITC or Bio tin-conjugated mouse IgGl.k-isotype standard antibodies 
(PharMingen, San Diego, CA) were used as control antibodies. Thymus suspensions 
(-1x10^) diluted in HBSS supplemented with 6 % FBS were diluted in 100 |il of cold 
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PBS/Azide (0.2%) and incubated in the dark at 4°C for 20 min. with ~l .5 ^g of the 
monoclonal antibodies or isotypic control antibodies. The erythrocytes were lysed with 
freshly diluted lysing solution (ammonium chloride [150 mM], sodium bicarbonate [1 mM], 
and EDTA disodium [1 mM]) for 10 min. at room temperature. The remaining lymphocytes 
were washed twice with PBS/Azide. An avidin-PE solution (Vecta stain) was incubated with 
the cells for 20 min, (4°C) according to the instructions. The cells were washed twice with 
PBS/Azide and placed in 2% paraformaldehyde before analysis. 
Corticosterone-Induced Apoptosis Assay 
Apoptotic cells were quantified by flow cytometry to measure the incorporation of 
Hoechst 33342 (Molecular Probes, INC) fluorescent dye in thymocytes (Sun et al., 1992). A 
single cell suspension of thymocytes (2x10^) were incubated with or without corticosterone 
(0, 0.1. & 1.0 ^iM) for four hours and stained for 10 min. with 1 ng/ml Hoechst 33342 at 37 
°C. The cells were rapidly centrifuged for 5 min. at 1500 rpm, and all media and Hoechst dye 
were removed. The thymocytes were resuspended in propidium iodide (PI, 5 ^g/ml; Sigma) 
in PBS and analyzed on a flow cytometer (EPICS, Coulter Co.). The cells staining positive 
for PI were excluded from the analysis because they constitute dead cells. The apoptotic cell 
was identified by a decrease in mean size and bright blue staining with Hoechst dye. Data 
was reported as percentage apoptotic cells. 
Statistical Treatment of Data 
A computerized program for analysis of variance (ANOVA; Statistix, NH Analytical 
Software) was used to assess differences among experimental and control groups. For the 
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first experiment to characterize the effects of acute (IX) and chronic (5X) 2-DG 
administration, an ANOVA to compare 3 stress-levels (saline injection, IX 2-DG injection, 
and 5X 2-DG injection) was used to assess significance of the various measures. For the 
second experiment to examine the duration of the 2-DG effect on the thymus, an ANOVA to 
compare 4 levels of stress (0-2-DG injection, 1X-2-DG injection, 4X-2-DG injections, and 
5X-2-DG injections) was used to determine differences in T-cell parameters between the 
groups. For the ADX experiment to assess the effects of adrenalectomy on attenuation of 
acute stress effects of 2-DG, a 2 x 3 analysis was used. One factor was treatment, a 2-DG 
injection, or saline injection. The second factor was surgery, adrenalectomy (ADX), sham 
operated or unoperated. To analyze data from apoptosis experiments a 4 x 3 analysis was 
used; One factor was 2-DG treatment (0-2-DG injection, 1X-2-DG injection, 4X-2-DG 
injections, and 5X-2-DG injections), and the second factor was a dose of corticosterone (0. 
0.1, 1.0 nM). The level of significance for the F test was set at P < 0.05. 
Results 
Experiment 1: Acute and Repeated 2-DG Exposure 
2-DG administration elevated plasma endogenous glucose and corticosterone levels 
An elevated level of endogenous glucose and corticosterone in plasma provided an 
indicator of the 2-DG-induced stress response. In the current study, analysis of variance 
indicated that rats that received 2-DG administration on the test day had a significant increase 
of endogenous plasma glucose (mean = 319.37 ± 8.41 mg/dl) and corticosterone (mean = 
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54.69 ± 4.51 ng/dl) in comparison to rats that received a HBSS injection (glucose = 123.65 ± 
4.61 mg/dl; corticosterone = 7.27 ±2.18 ng/dl). 
Repeated 2-DG administration reduced thymus weight and thymocytes number 
The number of thymocytes were enumerated and the ratio of thymus weight / body 
weight was calculated (Table 1). Analysis of variance indicated a significant effect of 2-DG 
on thymocytes and thymus weight, F(2, 23) > 17.00,/? < 0.0002. Orthogonal contrasts 
indicated that repeated administration (5X) of 2-DG induced a significant reduction in 
thymus weight, F(l, 23) = 41.60,/? < 0.0001 in comparison with the HBSS and 1 X 2-DG 
injection groups. Also, the number of thymocytes was significantly decreased in rats that 
received 5X 2-DG injections, F(l, 23) = 33.29,p < 0.0001. But, there was no difference 
between the animals that received one injection of 2-DG or ffflSS. 
Repeated exposure to 2-DG suppressed thymus mitogenic responses and nitrite production 
The proliferative response of thymic leukocytes to mitogen stimulation was measured 
as an indicator of functional potential. The assay results showed comparable effects across 
all concentrations of Con A, PHA, and LPS. The results of stimulation of thymic leukocytes 
v^dth the optimal concentration of the mitogens are shown in Table 1. Analysis of variance of 
the optimal concentration of Con A and LPS indicated a significant effect of treatment for 
Con A, F(2, 22) = 5.91, p < 0.01 and a marginal effect of treatment for LPS, F (2, 22) >3.17, 
p < 0.07, however, there was no significant treatment effect for PHA, F (2, 22) > 1. 
Orthogonal contrasts indicated that the responses to Con A and LPS were significantly 
depressed in the 2-DG injected groups(lX and 5X) in comparison with the saline injected 
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group, F (1,22) > 6.25, p < 0.02, but the effect of 2-DG on the response to PHA was 
marginally suppressed, F (1. 22) = 3.27, p < 0.09. Furthermore, contrasts indicated that there 
was no difference between the groups that received 5X 2-DG and IX 2-DG except for Con 
A, F(l, 22) = 4.45,/? < 0.05. Thus, the 2-DG-induced suppression of the Con A mitogen 
response was more pronounced in rats that received 5X 2-DG than IX 2-DG. 
The results of nitrite production from thymic stromal cells stimulated with the optimal 
concentration of Con A (3 mg/ml), PHA (5 rag/ml), and LPS (2.5 mg/ml) are also presented 
in Table 1. Overall analysis of data from all three mitogens indicated a significant effect due 
to treatment, F(2,23) > 9.84, p < 0.002. Orthogonal contrasts indicated that the 2-DG treated 
groups showed a significant decrease of nitrite production relative to the saline-treated group. 
F (1. 23) > 12.80,/? < 0.002. Additionally, there was less nitrite in cultures of thymocytes 
from chronically-stressed (5 X 2-DG) animals than from acutely stressed (1 X 2-DG) 
animals, F (1,23) > 19.5, p < 0.001. This finding indicated that 2-DG not only changed the 
number of thymocytes, but also changed the function of thymic stromal cells 
Experiment 2: Duration of Stress Effect on the Thymus 
Plasma endogenous glucose and corticosterone concentration 
Rats that received 2-DG injection on the test day (IX and 5X 2-DG) produced a 
significant increase of plasma glucose (mean = 276 ± 8.32 mg/dl) and corticosterone (mean = 
34.44 ± 6.62). In contrast, the 4X 2-DG group that did not receive a 2-DG injection on the 
test day showed a basal concentration of plasma glucose (104.75 ± 2.80 mg/dl) and 
corticosterone (6.44 ± 2.80 |ig/dl). Saline injected rats had a mean plasma glucose 
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concentration of 130.11 ± 4.47 mg/dl and a mean corticosterone concentration of 1.57 ± 0.39 
Hg/ml. 
2-DG induced a decrease of CD4^ population, but an increase of CD8* T-cell population 
The results of CD4 and CDS surface-molecule staining of thymocytes are displayed in 
Figure 1 and Figure 2, panel A-F, respectively. The percentage positive for single CD4" or 
CD8^ and double positive CD4VCD8^ populations is displayed in Figure 1. These data were 
then transformed to the actual number of cells for each subpopulation per thymus (Figure 2). 
Analysis of variance of CDA* and CD8^ populations indicated a significant treatment effect. 
F(3, 15) > 5.10,p < 0.02. Orthogonal contrasts demonstrated that rats that received repeated 
2-DG administration (4X 2-DG; 5X 2-DG) showed a marked decrease in the percent of 
CD4^ cells, F (1, 15) = 16.16,p < 0.002 (Fig. lA), whereas there was an increase in the 
percent CD8^ population, F(l, 15) = 14.36,p < 0.003 (Fig. IB). There was no significant 
change in the percentage of double positive (Fig. IC) or double negative (mean = 2.6 %; data 
not shown) cell populations. The increase in the percentage of CD8^ cells translated into a 
real increase in the actual number of CD8^ cells in the thymus from stressed rats. F(I. 15) = 
5.29, p < 0.04 (Fig. 2E). Because of a decrease in the total number of thymocytes/thymus, 
the number of CD4^, CD4VCD8^. and null populations were significantly decreased in rats 
that received multiple injections of 2-DG (4X 2-DG; 5X 2-DG), F(l, 15) > 6.80,/? < 0.02 
(Fig. 2). Thus, even though the thymus was decreased in size, the CD8^ population 
increased. 
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2-DG increases the rate of apoptosis in the thymus in vitro 
The results of corticosterone induced apoptosis in the thymus were displayed in Fig. 
3. For this assay, thymocytes were exposed to various concentrations of corticosterone [0. 
0.1, or 1.0 fiM] for 4 hours. The 0.1 fiM dose of corticosterone represented a basal 
concentration found in resting rats (3.4 |ig/dl), and the 1.0 }iM corticosterone represents a 
concentration obtained (and often exceeded) during a stress response. The analysis of 
variance of the percentage of apoptosis demonstrated a significant treatment effect. F(3.47) = 
7.97, p < 0.004. The results indicated that 2-DG-induced stress increased thymocyte 
sensitivity to corticosterone-induced apoptosis in animals that had received a single injection 
or multiple injections of 2-DG, F(l, 43) = 21.34, p < 0.0002. There was no difference 
between groups in which rats received 4 injections of 2-DG and 5 injections of 2-DG. Note 
that the 4x 2-DG group did not receive 2-DG on the test day, but had received the last 
injection 2 days prior to the test day and had a basal concentration of corticosterone. Thus, 
the rate of corticosterone induced apoptosis remained elevated for up to 2-days poststress. 
and the increased sensitivity to corticosterone was not due to elevated serum corticosterone 
concentration in the animal when the thymocytes were harvested. 
Experiment 3: Adrenalectomy Manipulation 
Plasma corticosterone and endogenous glucose concentrations 
As observed in experiment 1 and 2, administration of 2-DG induced a significant 
increase in the plasma concentration of corticosterone (64.74 ± 4.20 |ig/dl) and endogenous 
glucose (337.19 ± 8.66) in both the sham-operated and unoperated groups; however, 
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adrenalectomy attenuated the 2-DG-induced increase of endogenous glucose (152.55 ± 5.06 
mg/dl) and corticosterone (1.93 ± 0.53 |ig/d). Saline injected rats had mean plasma glucose 
concentrations of 110.77 ± 6.66 mg/dl and mean corticosterone concentrations of 9.54 ± 2.7 
Hg/dl (SHAM and UNOP) or 1.85 ± 0.35 ng/dl (ADX). 
Adrenal hormones affect thymus weight and cellularity 
To determine the role of adrenal hormones as mediators in 2-DG-induced changes of 
the thymus, the stress effect of 2-DG administration on thymus weight and thymocyte 
number in adrenalectomized. sham-operated, and unoperated rats was examined (Table 2). 
Analysis of variance demonstrated a significant effect of surgery on thymus weight and 
thymocyte number, F(2, 35) > 19.62,/? < 0.0001. Contrasts indicated that the weight of the 
thymus gland and the number of thymocytes were greater in the ADX group than in sham-
operated and unoperated groups, F(l, 35) > 37.08,/? < 0.0001, however, there was no 
difference between the sham-operated and unoperated groups. Additionally, there was no 
significant effect of treatment or a significant interaction. These results indicate that adrenal 
hormones regulate thymus growth. 
Adrenal hormones are involved in regulation of mitogen-stimulated lymphocyte response 
Results of 2-DG administration on the mitogen response in adrenalectomized, sham-
operated, and unoperated rats were examined (Table 2). Overall analysis of variance of the 
optimal concentration of Con A, PHA, and LPS indicated a significant main effect of surger>-. 
F (2. 35) > 6.43, p < 0.006; however, there was no significant effect of 2-DG treatment or 
interaction of surgery with 2-DG. Orthogonal contrasts revealed that adrenalectomized rats 
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had a pronounced suppression of proliferation in response to mitogens in comparison with 
sham-operated and unoperated rats, F(l, 35) > 1.9,p< 0.01. 
Adrenalectomy attenuated corticosterone-induced apoptosis in the thymus 
Thymocytes from adrenalectomized, sham-operated, and unoperated rats injected with 
saline or 2-DG were incubated with corticosterone to induce apoptosis (Table 3). The 
ANOVA demonstrated a significant effect of surgery, F(2, 105) = 56.36,/? < 0.0001 and a 
significant effect of corticosterone concentration, F(2, 105) = 1280.78,/? < 0.0001. 
Orthogonal contrasts of the surgery effect on thymocyte apoptosis showed that thymocytes 
from the ADX group had less apoptosis than cells obtained from sham-operated and 
unoperated groups, F(l, 105) > 14.50./? < 0.001. The adrenalectomized group also contained 
a higher percentage of live cells from the thymus after incubation with corticosterone. F(l. 
105) > 12.50,/7 < 0.001. Although ANOVA did not indicate a main effect of 2-DG 
treatment, there was a marginal interaction of surgery and stress, F(2,105)=2.41,p = 0.095. 
A contrast comparing apoptosis in cells from unoperated and sham-operated rats that received 
2-DG and saline injections demonstrated a significant elevation of apoptosis in 2-DG injected 
rats F(l,105) = 5.11,;? < 0.03. The 2-DG-induced elevation of apoptosis was more marked in 
the unoperated group, F(l,105)=6.35,/7 < 0.02. The elevation in apoptosis could be clearly 
observed at 0 and 0.1 |iM corticosterone for the unoperated group, but was only evident at 0 
|iM corticosterone for the sham-operated group. Interestingly, the 2-DG-induced increase in 
percentage apoptosis for the unoperated group was equivalent to the baseline rate of 
apoptosis for the sham-operated group injected with saline. This indicates that surgery stress 
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can increase the rate of apoptosis in rats with intact adrenal glands. In addition, the stress of 
sham-surgery increased the rate of apoptosis for a period of time greater than two weeks. 
These results support the hypothesis that adrenal hormones are involved in basal rates of 
apoptosis in the thymus. Because the stress of 2-DG administration elevated the 
concentration of plasma corticosterone, the endogenous corticosterone may have exacerbated 
the sensitivity to corticosterone-induced apoptosis in vitro in the unoperated rats. But 
apoptosis was not prevented 100 % by adrenalectomy, therefore, adrenal hormones are not 
solely responsible for apoptosis in the thymus. 
Discussion 
The present study demonstrated that the cells of the thymus are profoundly influenced 
by 2-DG injection; however, changes of thymic parameters were most evident in the groups 
what received multiple injections of 2-DG. Hence, the 2-DG-induced modulation of thymic 
parameters was more resistant to stress-induced changes than cells from the spleen and blood. 
Our previous work has shown that the alteration of function of lymphocytes from blood and 
spleen can be observed after ether an acute (IX) or repeated (5X) 2-DG injection animals. 
The porfile of T-lymphocyte subpopulations was altered in the thymus of 2-DG-
injected rats. There was a marked decrease in the percentage of CD4^ cells, an increase of 
the CD8^ cells, and no change in the percentage of double positive and double negative cells. 
As thymic size decreased with repeated stress, the actual numbers of each cell type in the 
thymus were calculated. Thus, the actual number of CD4^, CD4^CD8", and double negative 
cells were decreased due to 2-DG stress. Conversely, the increase in the percentage of CD8^ 
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cells represented a real increase in the total number of CDS"^ cells in the thymus. Previously, 
other researchers have reported that metabolic stress decreases in only the double positive 
CD4^CD8^ cells by using chronic morphine treatment (Freier and Fuchs, 1993), 
dexamethasone injection (Jondal and McConkey, 1993), or glucocorticoid administration 
(Ferry et al.. 1993). The difference between these results may be due to a difference in the 
temporal pattern of 2-DG administration or a species difference (rats vs. mice). 
The 2-DG -induced decrease of CD4^ and CD4^CD8^ populations in the thymus was 
correlated with an increased rate of apoptosis. The percentage of apoptosis was higher in 2-
DG treated animals than in control animals. Administration of 2-DG like other stressors 
induced a marked increase of the concentration of plasma corticosterone. In addition, 
animals lacking adrenal glands, are unable to produce baseline or stress levels of 
corticosterone. and had lower rates of apoptosis in comparison to sham-operated and intact 
animals; this supports a causal role for corticosterone in apoptosis. Note that in experiment 2 
the 4X 2-DG group had received their last injection 2 days before the test day and had 
baseline concentrations of plasma corticosterone. In addition, the SHAM-operated group in 
experiment 3 had experienced the stress of surgery more than two weeks before the 
experiment. Both of these groups demonstrated elevated rates of apoptosis without high 
concentations of plasma corticosterone in the animals. Thus, the increase of corticosterone-
induced apoptosis remained elevated for a long time post-stress and was not due solely to 
increased plasma corticosterone levels in the animals on the day the thymocytes were 
harvested. 
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The current study did not identify whether the CD4"^ or CD4'^CD8"^ populations were 
preferentially induced to undergo apoptosis more than the CD8^ cell population. Although 
stress induced a decrease in thymic size, the CD8^ population was protected or induced to 
differentiate. The CD8^ T lymphocytes express both cytotoxic and regulatory functions. An 
increase of T suppressor cells may be responsible for some or all aspects of decreased 
function observed in the thymus or secondary immune organs. A shift to greater production 
of CD8^ T-Iymphocytes could have profound effects on the health of immunocompromised 
animals or animals prone to autoimmune diseases (Ackerman, et al., 1996). 
Maturation and differentiation of developing T-lymphocytes depends upon the 
interaction of these cells with the microenvironment of the thymus and thymic hormones. 
The stress of 2-DG administration also affected the flmction of cells responsible for the 
microenvironment. Experiment 1 indicated that there was less nitrite in cultures of 
thymocytes from the chronically-stressed group (5X 2-DG) than from the saline-treated and 
acutely-stressed (IX 2-DG) groups. Nitrite production reflects one component of 
macrophage function and indicates that the macrophages in the thymus were changed in 
stressed animals. Alternatively, there may be fewer macrophages present. In either instance, 
the microenvironment for the thymocytes is changed and should result in changes in 
thymocyte differentiation such as those found in repeatedly stressed rats. In our study, 
adrenalectomy prevented thymic involution. Additionally, Con A stimulated responsiveness 
was decreased in adrenalectomized rats. Hence, adrenal hormones may affect the interaction 
of thymocytes and macrophages and change their functional capacity. 
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In conclusion, the primary role of the thymus is to educate and produce the T-cell 
repertoire, which can migrate into secondary immune compartments to perform their 
function. Stress-induced alterations of thymic development can have long-term implications 
for immune function in secondary immune organs. In the current study, 2-DG altered 
immime parameters of the thymus suggesting that the effect of stress on thymocytes could 
result in altered numbers of fiinctional T-lymphocytes that can migrate to secondary immune 
organs resulting in an alteration of the T-cell responses and interactions in those organs. In 
support of this hypothesis, our previous paper demonstrated an increase in splenic CD8^ T-
cells after both acute and chronic stress (Chou et al., 1996). Additionally, the stress-induced 
increase of apoptosis may selectively alter the profile of the T-cell subpopulations in the 
thymus. 
There are many neuroendocrine pathways that may influence thymic development. 
Stress-induced corticosterone is a known modulator of thymic involution. This study 
supports that hypothesis. Recently, the noradrenergic pathway, cholinergic pathway, and 
opioid system have also been linked to modulation of thymic function (Teshima, et al., 1991; 
Madden and Felten, 1995; Dabrowski and Dabrowska-Bemstein, 1990). The regulation of 
the thymus is complex and needs further study. 
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Table 1. Effects of one or five injections of 2-DG (500 mg/kg) or saline injection(s) on the thymus weight, 
thymocyte number, the mitogen responsiveness and nitric oxide production of thymocytes. 
Injection Manipulation 
1 X 2-DG 5X 2-DG Saline 
Ratio of Thymus Weight / Body Weight (mg/gm) 1.53 ±0.04' 1.21 ±0.05 1.56 ±0.05 
Thymocytes Number (x 10' /organ) 561.00 ± 19.45" 478.20± 14.72 591.20±24.06 
Mitogen response (cpm x 10'^) 
Con A (3 |ig/ml) 223.10 ±33.35" 173.20 ±37.23 253.80 ±24.85 
PHA (5 |ag/ml) 75.12 ±5.52 62.89 ±2.76 83.76 ±8.71 
LPS (2.5 |ig/ml) 2.87 ±0.21 2.59 ±0.09 4.68 ± 1.03 
Nitrite production (|imole/mi)" 
Con A (3 ^g/ml) 4.38 ± 0.53" 3.37 ±0.58 5.07 ± 0.76 
PHA (5 |ig/ml) 2.95 ± 1.03 2.74 ± 1.01 3.52 ±0.96 
LPS (2.5 ^g/ml) 3.48 ± 1.07 3.18 ± 1.09 3.97 ± 0.94 
" Results are expressed as the mean (± SB), n = 8 / grp. 
Data are expressed as the mean ± SE of triplicate wells; n = 8 /grp. 
Nitric oxide was measured as nitrite in the supernatant of mitogen-stimulated cultures using Griess reagent. 
'' Nitrite concentrations are expressed as the mean ± SE of triplicate well; n = 8 /grp. 
Table 2. Thymus weight, thymocyte number, and the mitogen response in adrenalectomized (ADX), sham-operated 
(SHAM), and unoperated (UNOP) rats. 
Surgery Manipulation 
ADX SHAM UNOP 
Ratio of Thymus Weight / Body Weight (mg/gm) 2.19±0.13'' 1.59± 0.04 1.74 ±0.07 
Thymocytes Number (x 10'^/organ) 828.13 ±48.77'' 464.87 ±51.05 465.40 ±53.37 
Mitogen Response (cpm x 10"^) 
Con A (3 |ig/ml) 66.5 ± 6.43" 92.3 ± 11.32 108 ±8.42 
PHA (5 ^g/ml) 1.46 ±0.11 1.926 ±0.14 1.68 ±0.11 
LPS (2.5 ^g/ml) 0.983 ±0.18 1.24 ±0.24 1.08 ±0.23 
" Results are expressed as the mean (± SE), n = 12 / grp. 
^ Data are expressed as the mean ± SE of average triplicate wells; n = 12 / grp. 
Table 3. Effect of corticosterone-induced apoptosis in adrenalectomized (ADX), sham-operated (SHAM), and unoperated 
(LTNOP) rats. Thymocytes from each rat were exposed to corticosterone (0, 0.1, 1.0 ^M) for 4 hours. Results are expressed 
as percentage of live cells positive for apoptosis. 
Corticosterone Concentration 
Q^M 0.1 1.0 nM~ 
Surgery Manipulation 
ADX 2-DG " 13.78 ± 0.69 ' 26.55 ± 2.04 32.00 ± 1.96 
Saline^ 14.67± 1.10 26.33 ± 1.30 32.28 ± 1.61 
SHAM 2-DG 17.68 ± 1.0 30.13 ±0.83 37.52 ±1.11 
Saline 16.43 ±0.67 30.38 ±0.42 37.38 ±0.56 
UNOP 2-DG 16.90±0.71 29.96± 1.38 37.82±0.79 
Saline 15.02 ± 0.54 28.32 ± 1.03 37.07 ± 0.66 
° Stress rats received 2-DG, 500 mg/kg subcutaneous injection. 
^ Nonstress rat received an equalvolume of saline injection. 
Results are expressed as the mean (± SE) of the percentage of apoptosis, n = 6 / grp. 
Figure 1 Effect of one, four, or five injections of 2-DG (500 mg/kg) or saline injections on T-
cell subpopulations in the tiiymus, expressed as the percentage of positive cells 
staining with antibody to (A) CD4 (W3/25), (B) CDS (0X8), or (C) CD4 and CDS 
(double positive). Results are expressed as the mean (± SE); n = 4 / group. 
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Figure 2 Effect of one, four, or five injections of 2-DG (500 mg/kg) or saline injections on T-
cell subpopulations in the thymus, expressed as the actual number of positive cells 
staining with antibody to (D) CD4 (W3/25), (E) CDS (0X8), or (F) CD4 and CDS 
(double positive). Results are expressed as the mean (± SE); n = 4 / group. 
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Figure 3 Effect of one, four, or five injections of 2-DG (500 mg/kg) or saline injections on 
corticosterone-induced apoptosis in the thymus. Thymocytes from each rat were 
exposed to corticosterone (0, 0.1, or 1.0 (jM) for 4 hours. Percentage of apoptotic 
cells were calculated based on the results of flow cytometric analysis. Results are 
expressed as the mean (± SE); n = 4 / group. 
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CHAPTER 6. GENERAL CONCLUSION 
General Discussion 
The progression of illness is aggravated if an animal experiences a stress state 
(Plotnikofif et al., 1991). Metabolic disorders represent stress situation that can be caused by 
improper diet, alcohol abuse, or drugs of abuse. Metabolic disorders suppress immune 
defenses of an animal and enhance its susceptibility to invading pathogens (Sharp et al., 
1995; Schuppan et al., 1995). Therefore, studies of metabolic stressors as 
immunomodulators may provide a means to understand the consequences of enhanced 
microbial or viral infections. To this end, administration of 2-DG, a metabolic stressor, in 
rats provides a model system used in this dissertation for studying the effects of metabolic 
stress on the immune system. 
The advantages of using 2-DG are based on several criteria. Administration of 2-DG 
induces well characterized physiological responses, decreased escape behavior, lowers 
locomotor activity, and significant neurological activity. These criteria for stress can be used 
to monitor animals during experimental processes. Also, the neural responses to 2-DG 
provide a useful tool for investigating the relationship between the immune system and the 
neuroendocrine system. The objectives of this study were to characterize the changes in 
selected immune parameters subsequent to treatment with 2-DG; and to examine possible 
mechanisms of neuroendocrine mediation by 2-DG-induced immunomodulation. 
The first set of experiments was designed to characterize the effects of 2-DG stress on 
secondary immune compartments: Spleen and peripheral blood. Elevated concentrations of 
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plasma corticosterone and exaggerated endogenous glucose confirm a stress response and 
effective 2-DG treatment. These measurements were made in all subsequent experiments. 
The 2-DG-induced metabolic stress altered the immune cellular flmction of both innate and 
adaptive immunity in the spleen and blood. The concentration of leukocytes in the spleen 
and blood and the organ weight of the spleen were markedly reduced in rats which received 
repeated 2-DG injections. The splenic T-lymphocytes subpopulations showed a decreased 
ratio of CD4^/CD8^ cells due to a significant increase of the CD8^ T-cell subpopulation. In 
addition, the innate immunity of splenic natural killer cell activity, nitrite production of 
spleen and blood leukocytes, and IL-1 production of blood macrophages were changed due to 
2-DG administration. 
Adaptive immune mechanisms were suppressed by 2-DG including mitogenic 
responsiveness and IFN-y production in both whole blood and splenic lymphocytes. 
Additionally, this study showed that the 2-DG-induced suppression of splenic T-cell mitogen 
response was habituated in the group which received five 2-DG injections. Conversely, the 
suppressive effect of 2-DG on the whole blood lymphocytes was not attenuated after repeated 
administration. A difference between splenic and blood responses also was observed in the 
results of IL-1 production. The production of IL-1 by macrophages and IL-2 by T-
lymphocytes was significantly reduced in the blood, but not in the spleen. This difference is 
consistent with other studies showing that stress differentially affects various compartments 
of the immune system (Lysle et al., 1988; Cunnick et al., 1990). To this end, identification of 
the mechanism(s) responsible for the differences in kinetics of 2-DG-induced 
175 
immunomodulation in spleen and whole blood was a major goal in the second and third sets 
of experiments. 
Numerous experiments provide anatomic and pharmacological evidence that 
catecolamines are involved in stress-induced immunomodulation in the spleen, while adrenal 
hormones mediated hypothaiamic-pituitary-adrenal pathway are responsible for stress-
induced alteration of blood (Madden & Felten, 1995). We followed this track in designing 
experiments to determine mechanisms of 2-DG-induced immune modulation. 
The purpose of the second set of experiments was to examine the role of 
catecholamines in 2-DG-induced immune alteration. Rats were pretreated with a 
nonselective P-adrenergic receptor antagonist, nadolol, and then received either a saline or 2-
DG injection. As expected, nadolol prevented 2-DG-induced suppression of splenic T-cell 
mitogenic responses, decreased of IFN-y production, and increased of nitrite production by 
macrophages in a dose-dependent maimer. In contrast, nadolol did not attenuate the 2-DG-
induced changes in immune parameters of peripheral blood. These results illustrated that the 
peripheral release of catecholamines is responsible for 2-DG-induced splenic immune 
alterations, but not for those of the peripheral blood. 
The evidence for adrenal hormone involvement in 2-DG-induced alteration of 
immune parameters in the blood was established in third set of experiments. 2-DG-induced 
changes in leukocyte concentration, mitogenic response of lymphocytes, and cytokine 
production (IL-2, IFN-y, TNF) of blood lymphocytes were attenuated in rats lacking adrenal 
glands, implicating adrenal hormones as mediators of 2-DG-induced immunomodulation of 
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blood. Interestingly, removal of adrenal glands exacerbated the production of IL-2 and TNF 
by blood lymphocytes from 2-DG stressed animals. This suggests that stress-induced release 
of adrenal hormones may serve to maintain immune homeostasis. 
The objective of fourth study was to characterize the alteration of thymic parameters 
and apoptosis after acute and chronic administration of 2-DG in rats. This study 
demonstrated that 2-DG-induced alteration of thymic parameters are prolonged (48hr). 
Repeated 2-DG administration induced a marked reduction of total thymocyte numbers, 
thymus weight, mitogen response of thymocytes, and nitrite production of thymic 
macrophages. The profile of T lymphocyte subpopulations was changed after 2-DG 
administration. A significant decrease in the percentage and actual number of CD4* and 
CD4^CD8^ and null population was observed. The actual numbers of CD8^ T-cells in 
thymus increased in response to multiple injections of 2-DG and may explain the observed 
increase of CDS"^ T-lymphocytes in the spleen. Since apoptosis is involved in the 
maintenance and establishment of the T-cell repertoire, an increased of rate of corticosterone-
induced apoptosis in the thymus after acute and repeated 2-DG administration may have 
important consequences when coupled with thymus modulation during stress. However, 
adrenalectomy attenuated the 2-DG-induced increase of thymocyte apoptosis, suggesting 
adrenal hormones are responsible for mediating apoptosis. These results suggest that adrenal 
hormones produced during stress differentially increased apoptosis in the thymus resulting in 
altered distribution of thymocyte subset and changing the concentration of functional T-
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lymphocytes which can migrate to peripheral immune organs. Thus, changes in T-
lymphocyte maturation can alter the peripheral T-cell responses. 
Modulation of immune function by stressful events is a well accepted concept clearly 
supported by the results from this dissertation. Studies such as these provide important 
information for understanding the disruption of immime homeostasis by stress, and can also 
provide a way to smdy the interaction of the immune system with other physiological 
systems. 
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